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ABSTRACT 
This thesis examines the potential of a one year programme of brisk walking to 
influence endurance fitness, lipoprotein metabolism and other risk factors for 
coronary heart disease (CHO) in previously sedentary, middle-aged men. 
Seventy-two asymptomatic males were recruited into the study and randomly 
allocated on a two to one basis into either a walking group (n = 48) or a control 
group (n = 24). Walkers were asked to build up to an average of 45 minutes of 
brisk walking per day and maintain this level thereafter. Control subjects 
continued with their habitual lifestyle. Both groups undertook not to change 
their dietary habits. 
Maximum oxygen uptake (V02max) was predicted at base line, three, six and 
12 months from submaximal heart rate and oxygen uptake data during 
treadmill walking. Endurance fitness was assessed at similar intervals by 
measuring heart rate and blood lactate concentration during standardised 
submaximal treadmill walking. Serum concentrations of total cholesterol, high 
density lipoprotein cholesterol, apoproteins A-I and B, triglycerides and 
lipoprotein(a) were measured at each observation point. -Additionally,. plasma 
fibrinogen, resting arterial blood pressure and indices of pulmonary function 
were determined. Differences in the response of walkers and controls over 
time were examined using two way analysis of variance for repeated 
measures employing the 5% level of significance. 
-Adherence to the walking programme was high and 42 of the walkers (88%) 
remained in the study for the year completing an average of 28 ± 9 (mean ± 
SO) minutes of brisk walking each day (self-report). The response of the 
walkers over time was significantly different to that of the controls for predicted 
V02max and for heart rate and blood lactate concentration during 
standardised submaximal exercise indicating that brisk walking favourably 
influenced endurance fitness. No significant differences were observed 
between groups for any of the lipoprotein variables or other CHD risk factors 
monitored during the study. 
It was concluded that brisk walking did not influence established CHO risk 
factors in this group of previously sedentary middle-aged men despite the 
evidence of improved endurance fitness. 
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1 INTRODUCTION 
"Close to 100% of the existence of the hominid/homo species has been 
dominated by outdoor activities ... now ... we have in some 'privileged' societies 
ended up in an urbanized, highly technologic society dominated by a 
sedentary lifestyle" (Astrand, 1988). This relatively recent change in the 
habitual iifestyle of homo sapiens has been accompanied by associated 
changes in the occurrence of certain lifestyle diseases. In particular " ... the 
incidence of coronary heart disease (CHD) increased relentlessly in 
technically developed countries during the first half of the 20th century and 
reached epidemic proportions in mid-century" (McGill, 1988). Furthermore, 
although the death rate from CHD is now falling in some westernised 
countries it is still a major cause of death. In the year 1990, for example, 
ischaemic heart disease accounted for 29% of all male deaths and 23% of all 
female deaths in England and Wales (Office of Population Censuses and 
Surveys, 1991). 
The three major factors associated with increased risk of CHD are raised 
blood cholesterol concentration, hypertension and cigarette smoking but other 
factors also play a role. These include age, sex, obesity, diabetes and genetic 
predisposition (Kannel, 1988; Kuller and Orchard, 1988; Study Group; 
European Atherosclerosis Society, 1987). The possibility that a sedentary 
lifestyle might be implicated in the development of CHD was highlighted by 
the pioneering work of Morris and co-workers in the 1950s and 1960s (cited in 
Eichner, 1983 and Heyden and Fodor, 1988). These studies showed that men 
involved in physically active occupations had a lower incidence of CHD than 
their less active counterparts. Subsequently many other studies confirmed the 
relationship between physical activity and CH D. These included the 
investigations of Paffenbarger and colleagues on San Francisco 
longshoremen (1970) and on Harvard college alumni (1978) and the studies 
of Morris and co-workers on British civil servants (Morris et al. 1973; Morris et 
al. 1980). 
Recently, many large and well designed studies have provided further 
evidence to support an independent and inverse relationship between 
physical activity and CHD (Donahue et al. 1988; Leon et al. 1987; Shaper and 
Wannamethee, 1991; Slattery et al. 1989; Morris et al. 1990). Moreover, 
Powell and colleagues (1987) in a review of 43 prospective studies on 
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physical activity and CHD concluded that: "The relative risk of physical 
inactivity is similar in magnitude to that of hypertension, hypercholesterol-
aemia and smoking". 
Despite this mounting evidence, there is no definite proof of the 'exercise 
hypothesis'. As Blackburn and Jacobs (1988) state "a basic uncertainty is 
whether the effect (of exercise) is due to environment [activity) or constitution 
[genes) ... Fitness, with its strong constitutional component may ... determine 
both who will be fit and who will be protected from clinical CHD". Although the 
notion that fitness has a strong constitutional component could be challenged, 
on the grounds that training can profoundly influence an individual's capacity 
for exercise, it is evident that an intervention study seeking to determine if 
there is a strong and independent effect of physical activity on CHD rates in 
previously sedentary subjects is unlikely to be conducted. Not only would it be 
immensely expensive but it would also be extremely difficult to control and 
require a huge logistical effort (Despres, 1989; Tunstall Pedoe, 1990). 
Notwithstanding this fact, however, many authorities believe that it is prudent 
to regard exercise at least as a minor and if not a major risk factor for CHD due 
to the strength of the epidemiological evidence (Gordon and Scot!, 1991; 
Sadlo and Wenger, 1990). 
The means by which exercise might protect against CHD is the subject of 
debate but is thought by many to include an effect on lipoprotein metabolism. 
Although the evidence suggesting that exercise can lower total cholesterol or 
low density lipoprotein cholesterol (LDL-C) is equivocal, many studies have 
shown that exercise is an effective means of elevating high density lipoprotein 
cholesterol (HDL-C) (see Haskell, 1986). High density lipoprotein cholesterol 
is negatively associated with heart disease and is increasingly becoming 
accepted as a strong and independent risk factor for CHD (Rifkind, 1990). 
Intervention trials using diet and/or drug treatments have now provided strong 
evidence to demonstrate that lowering serum cholesterol reduces mortality 
rates from CHD (see Rossouw and Rifkind, 1990; Ball and Mann, 1988). 
Moreover, results from the Helsinki Heart Study suggest that interventions 
which increase HDL-C concentration are also of benefit in reducing CHD 
mortality (Frick et al. 1987). If exercise is an effective means of reducing total 
cholesterol or LDL-C and/or increasing HDL-C it would seem likely that it 
should lead to a reduced incidence of CHD. 
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The mode of exercise most often associated with increased concentrations of 
HDL-C is endurance training involving activities such as running, swimming 
and cycling (Wood et al. 1984; Fang et al. 1988). Studies attempting to relate 
improvements in endurance fitness with increased concentrations of HDL-C 
have not always been successful however (Allison et al. 1981; Brownell et al. 
1982; Haskell et al. 1980). One reason for this may be that the traditional 
physiological index used to appraise changes in endurance fitness, the 
maximal oxygen uptake (V02max), is a relatively insensitive measure in this 
respect. A high V02max is a prerequisite for elite endurance performance 
because of the strong linear relationship between oxygen uptake and speed 
of running, swimming or cycling. However, V02max is to a large extent 
genetically predetermined (Klissouras et al. 1973) and training programmes 
have been found to improve endurance performance dramatically with little or 
no effect on V02max values (Williams and Nute, 1982; Lortie et al. 1984). 
The insensitivity of V02max as a marker for changes in endurance fitness may 
relate to the fact that improved endurance (the ability to maintain a given 
exercise pace or intensity for longer) is largely the result of peripheral rather 
than central factors Le. an improvement in the oxidative capacity of skeletal 
muscle (Gollnick et al. 1973; Davies et al. 1981; Hardman and Williams, 
1983). An enhanced oxidative capacity of skeletal muscle facilitates 
endurance performance by reducing the anaerobic contribution to energy 
provision at a given exercise intensity thus delaying fatigue (Matoba and 
Gollnick, 1984). A reproducible means of indirectly assessing changes in the 
oxidative capacity of skeletal muscle may be obtained through the 
measurement of blood lactate concentration during submaximal exercise. 
Running studies have shown that changes in blood lactate concentration 
during submaximal exercise provide a better indication of improvements in 
endurance fitness than V02max per se (Sjodin and Svedenhag, 1985; 
Williams and Nute, 1986). There is a need then to re-examine the relationship 
between changes in endurance fitness and HDL-C using a more sensitive 
index of training adaptations than the traditional V02max measurement. 
Aside from its potential to modify cholesterol metabolism there is also 
evidence that exercise may be effective as a means of ameliorating another of 
the major risk factors for CHD, hypertension (Tipton, 1991). Moreover, there is 
limited evidence that exercise has a beneficial influence on additional risk 
factors which are linked to the development of heart disease including plasma 
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fibrinogen concentration (Ernst, 1990), lipoprotein(a) concentration (He listen 
et al. 1989) and lung function (Shaper and Wannamethee, 1991). The above 
three factors have recently become more prominent as markers for CHO risk 
and thus an examination of the potential of exercise to modify them is justified. 
Assuming that physical activity does have the potential to modify CHO risk its 
ability to make an effective contribution towards the reduction of CHO mortality 
in the U.K. depends on at least two other factors. The first of these factors is the 
current level of physical activity amongst the U.K. population. If participation 
rates in physical activity are already high then efforts to reduce CHO risk 
would be better focused on other areas. This does not appear to be the case, 
however. Until recently there was only limited evidence regarding participation 
rates in physical activity amongst the U.K. population. This came from the 
General Household Survey and the Welsh Heart Study (cited in Jacobson et 
al. 1991) both of which indicated that physical activity levels amongst the 
general population were low. This year, however, the results of the National 
Fitness Survey have been published. These provide a much more detailed 
examination of physical activity patterns in the U.K. 
The National Fitness Survey was conducted in England and examined 3,949 
men and women aged between 16 and 74 years old. Questionnaires were 
used to assess the mode, duration, frequency and intensity of exercise 
completed by each individual over a four week period. The results of this 
survey indicated that only 14% of men and 4% of women took part in vigorous 
physical activity three times per week for at least 20 minutes on each occasion 
i.e ...... the level of activity often identified as valuable for building stamina and 
offering protection against CHO" (The Sports Council and the Health 
Education Authority, 1992). Vigorous activities were defined as those requiring 
an energy expenditure of above 7.5 kilocalories per minute and were equated 
with an exercise intensity of above 60% of V02max. The survey also found 
that there was a decline in physical activity with increasing age, especially 
vigorous activity. 
A second important criterion for any type of intervention which seeks to 
improve the primary prevention of CHO is that it is socially acceptable to the 
population which it is aimed at. In this respect, it is of interest that the National 
Fitness Survey found that in each age group, over 50% of the men and 
women interviewed reported that they had walked continuously for at least a 
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mile in the week prior to interview. The survey concluded that ..... the high 
prevalence of walking among men and women of all ages ... suggests that 
there is scope for increasing activity levels by encouraging those who do walk 
to do so more frequently, for longer distances and at a faster pace". It should 
also be emphasised that there is a lower adherence to, and higher incidence 
of injuries during, high intensity exercise programmes, such as running, than 
with less vigorous forms of exercise such as walking (Martin and Dubbert, 
1982; Seals et al. 1984). An appropriate form of exercise then in a population 
based strategy for the primary prevention of CHD might be brisk walking since 
this is a form of exercise which is likely to be acceptable to a majority of 
people. 
It has been demonstrated that brisk walking can serve as an adequate aerobic 
training stimulus for middle-aged men and women (see Porcari et al. 1989). In 
addition Cook and co-workers (1986) found a relationship between the 
reported number of miles walked per day and HDL2-C concentration in active 
postal carriers. Moreover, there is epidemiological evidence to support a 
beneficial effect of walking exercise on all-cause mortality (Paffenbarger et al. 
1986) and Morris and colleagues (1990) have shown that men claiming that 
their regular speed of walking is fast (>4.0 mph) suffer a lower incidence of 
CHD than others. 
Recently a study from this laboratory examined the influence of brisk walking 
on lipoprotein metabolism in a group of previously sedentary middle-aged 
women and found a 27% increase in HDL-C concentration over a one year 
period (Hardman et al. 1989a). To the author's knowledge, however, there 
have been no controlled, randomised studies examining the effects of a 
prolonged (one year) programme of brisk walking on blood lipids and other 
CHD risk factors in previously sedentary men. Yet risk factor reduction in men 
should have a greater impact on the total number of deaths attributable to 
CHD than changes in women because there is a higher incidence of CHD in 
men than in women. 
The purpose of the present study then was to examine the influence of a one 
year programme of brisk walking on endurance fitness, lipoprotein metabolism 
and other CHD risk factors in a group of previously sedentary, asymptomatic, 
middle-aged men. In particular this study sought firstly to determine the effect 
of brisk walking on endurance fitness. This was assessed by monitoring 
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changes in blood lactate concentration during submaximal exercise which are 
thought to provide a more sensitive index of changes in endurance fitness 
than the traditionally used V02max measurement. Secondly, this study sought 
to examine the potential of brisk walking to modify lipoprotein metabolism and 
in particular to increase HDL-C concentration. Finally, the effect of brisk 
walking on other markers for cardiovascular disease including blood pressure, 
pulmonary function and plasma fibrinogen concentration was assessed. Thus, 
this study represents a thorough examination of the potential of brisk walking 
to modify a number of factors related to CHD risk. 
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2 REVIEW OF LITERATURE 
2.1 Overview 
This review begins by discussing the epidemiological evidence linking 
physical activity and CHD. In the next Section the different types of lipids and 
lipoproteins are defined, their role in lipoprotein metabolism is explained and 
their possible relationships with CHD are discussed. After this there is a short 
Section on the potential sources of error inherent in lipid and lipoprotein 
measurement including biological and analytical variation. The interaction 
between exercise and lipoproteins is then reviewed and possible mechanisms 
which may explain this interaction are examined. Following this the 
relationship between exercise and other selected risk factors for CHD 
including hypertension, elevated plasma fibrinogen concentration and 
impaired pulmonary function is addressed. In the final Section the 
cardiovascular and metabolic adaptations to endurance exercise are 
investigated. This Section includes a discussion on the use of measurements 
of blood lactate concentration in assessing improvements in endurance 
fitness. Also included is an assessment of the effectiveness of walking 
exercise as a means of enhancing endurance fitness. 
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2.2 Exercise and coronary heart disease: epidemiological 
evidence 
Evidence to suggest that there may be a link between exercise and CHD first 
emerged in the middle of this century. Logan (1952) collected mortality data in 
England from 1931 to 1951. This data revealed an enormous increase in 
coronary deaths and a remarkable difference among the social classes. 
Coronary deaths were most common in professional men and least common 
in unskilled workers. These findings implied that individuals engaged in 
sedentary occupations were predisposed to an increased risk of CHD. The 
"exercise hypothesis" was born. 
The following year Morris and colleagues (1953) presented data on a group of 
31,000 London Transport workers many of whom were either bus drivers or 
bus conductors. This data showed that rates of myocardial infarction and 
sudden death were significantly lower among bus conductors, whose 
occupations required more physical activity, than bus drivers. This study was 
subsequently challenged on the basis that driver recruits tended to be fatter 
than conductor recruits, suggesting that different men chose different jobs. 
However, Morris (1959) subsequently showed that all drivers, including those 
who were thin, had a higher incidence of sudden death than the 
corresponding conductors. Morris (1959) concluded that " ... physique is not 
the crucial factor in producing the occupational differences reported". 
The pioneering work of Morris and colleagues stimulated great interest in the 
relationship between exercise and CHD and their findings were confirmed in 
many subsequent studies. The populations under observation in these studies 
were diverse and included white males employed by the United States 
railroad industry (Taylor et al. 1962), black and white men from Evans County, 
Georgia (McDonough et al. 1965), San Francisco Longshoremen 
(Paffenbarger et al. 1970) and Jewish men and women living in kibbutzim in 
Israel (Brunner et al. 1974) to name just a few. These studies have been 
reviewed by many authors (i.e. Eichner, 1983; Heyden and Fodor, 1988; 
Murray et al. 1989; Sadlo and Wenger, 1990) but probably the most 
systematic review is that of Powell and colleagues (1987). These authors 
collected 121 articles representing at least 54 studies examining physical 
activity and CHD. Of these, 43 met up to their selection criteria and were 
included in their review. These 43 studies provided information primarily about 
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North American and European working-aged men. Powell and colleagues 
(1987) found that "the relative risk of CHD associated with inactivity varies 
among studies but generally ranges from 1.5 to 2.4, with a median of about 
1.9 ... (Moreover), better studies tended to report higher relative risks". These 
findings have been reaffirmed recently in a meta-analysis performed by Berlin 
and Colditz (1990) and they are significant because, as noted by Powell and 
colleagues (1987), they suggest that the relative risk of inactivity is equivalent 
in size to that of hypertension, hypercholesterolaemia and smoking. 
Sadlo and Wenger (1990) have emphasised that one of the shortcomings of 
many of the earlier studies was that they focused more on the measurement of 
coronary events than on the measurement of physical activity. Moreover, 
Powell and colleagues (1987) pOint out that the operational definition of 
physical activity is crucial to the value of epidemiological studies and the 
unsatisfactory physical activity measures used in many of the earlier 
investigations meant that comparison between these studies was difficult. The 
last two decades have seen a shift in the emphasis of epidemiological studies 
from occupational activity to leisure-time activity. Moreover, attempts have 
been made to improve the way in which physical activity is assessed and 
quantified. As a result the evidence linking exercise with the development of 
CHD has been strengthened. However, there have been some conflicting 
findings regarding the amount and intensity of physical activity required to 
provide protection from CHD. 
In Britain, Morris and colleagues (Morris et al. 1973) followed up their earlier 
studies by examining leisure-time exercise in 16,882 middle-aged, male civil 
servants. Leisure-time physical activity was assessed from detailed individual 
records of all activity over a two day period. The results revealed that "in men 
recording vigorous exercise the relative risk of developing coronary disease 
was about a third that in comparable men who did nol. .. Lighter exercise, and 
provisional estimates of overall activity, showed no such advantage" (Morris et 
aL 1973). Vigorous was defined here as exercise likely to result in peaks of 
energy output of 7.5 kcaL per minute and an oxygen uptake above 1.5 Lmin-1. 
This included such activities as active recreations (e.g. swimming), "keep fit" 
exercises, heavy work (e.g. digging) and getting about quickly. 
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In their most recent study of leisure-time activity in 9,376 male civil servants, 
Morris and colleagues (1990) have confirmed their earlier findings. Men 
reporting vigorous physical activity experienced less than half the non-fatal 
and fatal CHD of other men while, once again, non-vigorous exercise or high 
totals of physical activity per se offered no protection. There were, however, 
some interesting differences between this study and the previous one. In the 
more recent study, for example, recreational heavy work, which previously had 
been weakly associated with protection from CHD, was not beneficial. Morris 
and colleagues (1990) hypothesised that this was due to the fact that 
recreational heavy work is often periodic (Le. seasonal) or occasional. 
Moreover, the nature of heavy work, which often " ... entails discontinuous 
lifting and carrying, pushing and pulling of heavy objects" is very different from 
the " ... predominantly dynamic, rhythmic contraction of large skeletal muscles" 
which occurs in such activities as swimming, walking, running and cycling. 
The implication here is that some adaptation associated specifically with 
endurance exercise, Le. the type of exercise likely to elicit a cardiorespiratory 
training effect, is responsible for the protection which is gained from CHD. 
Another interesting finding from Morris and colleagues' (1990) more recent 
study was that amongst the older men (Le. those aged 55 to 64 at entry) there 
was evidence of a dose response relationship between vigorous aerobic 
exercise and CHD. Thus, when the men were divided into four groups 
according to the frequency and intensity of exercise, group one who reported 
the most frequenUintense vigorous aerobic exercise had the lowest incidence 
of CHD. However, the men in group two and to a lesser extent group three, 
where exercise was either not so frequent or not so intense Le. "fairly brisk 
walking"instead of "fast walking", still had a lower incidence of CHD than the 
men in group four who reported no vigorous aerobic exercise. This trend was 
not evident in the younger men (Le. those aged 45 to 54 at entry) where only a 
threshold effect was seen. However, it is important to note that even in the 
older men it was still only vigorous exercise which was protective even if there 
was less of it or the intensity was slightly reduced. Thus, it may be supposed 
that with advancing age the absolute exercise intensity required to provide 
protection from CHD may be lower providing that, in relative terms, the 
exercise is still vigorous. 
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While Morris and colleagues pursued their investigations in Britain, 
Paffenbarger and co-workers followed their examination of San Francisco 
longshoremen with a study of physical activity and all-cause mortality in 
16,936 Harvard college alumni (Paffenbarger et al. 1978; Paffenbarger et al. 
1984; Paffenbarger et al. 1986). Questionnaires were used to assess the 
amount of time spent each week in activities such as walking, stair climbing 
and light and vigorous sports play. The weekly energy expenditure resulting 
from these activities was then estimated and used as an index of physical 
activity. The results were very interesting since they showed that death rates 
(the major cause of death was cardiovascular disease) declined steadily as 
energy expenditure increased from less than 500 to 3500 kcal. per week, 
beyond which there was a slight increase in rates (Figure 2.1). 
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Figure 2.1 The relationship between physical activity and mortality rates in 
Harvard collegealumni (Paffenbarger et al. 1986). Redrawn from 
Murray et al. (1989). 
Death rates were between one quarter and one third lower among alumni 
expending 2000 or more kcal. during exercise each week than among the less 
active men. This relationship was independent of such factors as hypertension 
and cigarette smoking. One other important finding from the Harvard alumni 
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study was that only those ex-varsity athletes who maintained a high physical 
activity index were at a reduced risk of death while sedentary students who 
subsequently became physically active acquired low risk (Paffenbarger et al. 
1984). Morris and colleagues (1990) made similar observations in their study 
of civil servants i.e. a history of vigorous sports in the past was not protective. 
Together these findings argue against a self-selection effect. 
The studies of British civil servants (Morris et al. 1973; Morris et al. 1980; 
Morris et al. 1990) and Harvard college alumni (Paffenbarger et al. 1978; 
Paffenbarger et al. 1986) provide strong support for the hypothesis that 
exercise and CHD are inversely related. However, since only "vigorous" 
aerobic exercise was associated with a reduced incidence of CHD in the 
studies of Morris and colleagues the implication is that exercise must provide 
a training effect on the cardiovascular system in order to be protective. 
Paffenbarger's findings, on the other hand, suggest that it is the overall level of 
energy expenditure which is important regardless of exercise intensity. 
It is difficult to reconcile the above findings although they may be due in part to 
differences in study design, as discussed below. It is important to recognise, 
however, that energy expenditure was not determined directly in these studies 
but was estimated with the aid of published average values and therefore 
some inaccuracy in measurement was inevitable. In the Harvard college 
alumni study (Paffebarger et al. 1978), for example, the values of Passmore 
and Durnin (1955) were used. Thus, sporting activity was graded as light, 
strenuous or a combination of the two and assigned an energy expenditure of 
either 5, 10 or 7.5 kcal. per minute respectively. Weekly energy output (kcal. 
week-1) was then calculated from records of the time spent in these activities. 
Yet this fails to take into account the fact that the energy expenditure of any 
given activity will vary greatly depending on the intensity of that activity. For 
example, a 65 kg man running at a speed of 11 minutes and 30 seconds per 
mile will expend less than half the energy (8.8 kcal.min-1) of a man whose 
mass is similar but whose running speed is 5 minutes and 30 seconds per 
mile (18.8 kcal. per minute) (McArdle et al. 1981). Moreover, body weight was 
not considered in the estimations of energy expenditure. Again this is 
important since, to take another example, a 50 kg man running at a speed of 
nine minutes per mile will expend approximately half the energy of a 98 kg 
man running at the same speed (9.7 kcal.min- 1 versus 18.9 kcal.min- 1 
respectively) (McArdle et al. 1981). Thu!" it is possible that many individuals 
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were placed into inappropriate activity (energy expenditure) bands. Similarly, 
there may have been some misclassification in the study of Morris and 
colleagues (1973) where activities such as swimming and dancing were listed 
as vigorous although they would not necessarily elicit peaks in energy 
expenditure of 7.5 kcal. per minute in all individuals. 
The disparity between Paffenbarger's findings and those of Morris and 
colleagues could be due to the way in which the former's physical activity 
index was calculated. This index was a measure of the total energy expended 
in all assessed activities and thus is insensitive to the different physiological 
effects of light and strenuous activities. Furthermore, no attempt was made to 
assess the speed of walking or stair climbing in the Harvard alumni study 
though again the physiological effects of these activities will vary depending 
on the speed/intensity at which they are performed. Therefore, it is possible 
that the majority of the relationship between total energy expenditure and 
heart attack risk was due to the energy expended in the more vigorous 
activities e.g. strenuous sports and relatively brisk walking/stair climbing. In 
other words, the type of activities likely to elicit a cardiovascular training effect 
and therefore confer some protection from CHD. This suggestion is supported 
by the finding of Paffenbarger and colleagues (1978) that " ... at any given level 
of energy expenditure, the risk of heart attack tends to be lower with strenuous 
sports than with more casual activities". 
Aside from the studies of Morris and co-workers and Paffenbarger and 
colleagues a few other investigations have also grouped individuals 
according to the type and quantity of physical activity performed. One such 
study is the Multiple Risk Factor Intervention Trial (Leon et al. 1987). This study 
examined the relationship between leisure-time physical activity and CHD and 
overall mortality in a high risk group of North American middle-aged men. 
Physical activity was assessed using the Minnesota Leisure-Time Physical 
Activity Questionnaire and subjects were divided into tertiles (Iow, moderate 
and high) based on the amount of time and energy expended in physical 
activity. The low activity group averaged about 107 minutes of leisure-time 
physical activity per week at base line and expended about 500 kcal. 
compared with about 332 minutes and 1500 kcal. per week for the moderately 
active group and 935 minutes and 4400 kcal. per week for the most active 
group. During the seven years of follow-up there were only 63% as many fatal 
CHD events and sudden deaths and only 70% as many total deaths in the 
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moderate activity group compared to the low activity group. Mortality rates in 
the high activity group were similar to those in the moderate activity group. 
As with the study of Harvard college alumni, the findings of the Multiple Risk 
Factor Intervention Trial appear to conflict with those of the British civil 
servants studied by Morris and colleagues. However, an examination of the 
activity gradings in the Multiple Risk Factor Intervention Trial reveals that they 
are dissimilar to the gradings used by Morris and colleagues. For example, 
walking for pleasure and bicycling were graded as light by Leon and co-
workers (1987) and gardening, yard work, home repairs, dancing, swimming 
and home exercise were graded as moderate. Morris and colleagues (1973), 
however, graded brisk walking, cycling, dancing, swimming, keep fit exercise 
and some types of gardening and do-it-yourself work as vigorous. It is possible 
then, that much of the exercise performed by the moderate activity group in the 
Multiple Risk Factor Intervention Trial would have been classified as 
"vigorous" by Morris and colleagues. If this is the case then the findings of 
these studies are not as contradictory as they at first appear. 
The U.S. Railroad Study (Slattery et al. 1989) also examined the relationship 
between the energy expended in leisure-time physical activity and death from 
CHD. The participants in this study were 3,043 white males. As in the Multiple 
Risk Factor Intervention Trial, leisure-time physical activity was assessed 
using the Minnesota Leisure-Time Physical Activity Questionnaire. The results 
of this study showed that there was a 30% to 40% greater risk of dying from 
CHD or from all-causes in sedentary individuals compared with those who 
expended over 1000 kcal. per week in leisure-time physical activity. There 
was little further reduction in mortality risk, however, beyond 1000 kcal. per 
week of activity. These results are similar to those of the Multiple Risk Factor 
Intervention Trial. Once again, however, some of the activities graded as 
moderate in the U.S. Railroad Study would have been graded as vigorous in 
the studies of Morris and colleagues. 
One other recent study worthy of mention is the British Regional Heart Study 
(Shaper and Wannamethee, 1991). This study examined the relationship 
between leisure-time physical activity and ischaemic heart disease in middle-
aged men. A total of 7,735 men who were representative of the socioeconomic 
distribution of men in Great Britain were included in the study. Some of these 
men had pre-existing ischaemic heart disease. A physical activity score was 
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calculated for each individual based on the amount of time they spent 
engaged in regular walking, cycling, recreational activity and sporting activity. 
For the recreational and sporting classifications the type of activity was also 
taken into account thus giving a relative measure of energy expenditure. The 
men were grouped into six broad categories based on their total scores. The 
category headings were: inactive, occasional, light, moderate, moderately 
vigorous and vigorous. The follow up period was eight years and during this 
time the men who were inactive had a significantly higher heart attack rate 
than all other men. The lowest heart attack rates were seen in the moderate 
and moderately vigorous categories and men in these categories had a 50% 
reduction in heart attack risk compared to men in the inactive group. 
Furthermore, when all men who reported doing sporting exercise at least once 
a month were excluded from the analysis, a strong inverse relationship 
between physical activity and heart attack risk remained in men without pre-
existing ischaemic heart disease. The authors concluded that "the overall level 
of physical activity is an important independent protective factor in ischaemic 
heart disease and that vigorous (sporting) exercise, although beneficial in its 
own right, is not essential in order to obtain such an effect" (Shaper and 
Wannamethee, 1991). 
Although the British Regional Heart Study provides further evidence to support 
the link between exercise and CHD there are some shortcomings in the way in 
which this study categorised physical activity. A major criticism is that this 
study equated sporting activity with vigorous activity. Thus, vigorous was 
defined as "very frequent sporting exercise or frequent sporting exercise plus 
other recreational activities". As a result of this, activities such as golf and 
sailing were graded as vigorous exercise. Although during certain periods 
sailing can be "hard physical work" when performed by national competitors 
(Shephard, 1990) it is unlikely that many of the men in the British Regional 
Heart Study would have performed this activity at an intensity sufficient to be 
described as vigorous. Furthermore, it is doubtful that golf would qualify as 
vigorous at any level of play although it may be an attractive activity for many 
overweight men who feel that they should do some exercise. 
In addition to the above, no reported attempt was made at measuring the 
speed of walking or cycling, two of the major activities assessed in the British 
Regional Heart Study. Only the amount of time spent in these activities was 
taken into account. As a result of this many of the men may have been given 
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inaccurate physical activity ratings. For example, a man walking at a speed of 
4.5 miles per hour for 40 minutes would have been given a similar physical 
activity score to that of a man walking 3 miles per hour for 40 minutes, yet the 
distance walked would be 3 miles in the first instance and only 2 miles in the 
second. Thus, the second man would expend only two-thirds of the energy of 
the first man provided that the body mass of the two men did not differ. 
Moreover, although an attempt was made to validate the physical activity 
score by correlating it with measures of physical fitness, the fitness measures 
employed, i.e. resting heart rate and forced expiratory volume in one second, 
are of doubtful validity and are not widely used (Brooks and Fahey, 1984; 
McArdle et al. 1981). 
From the preceding discussion it is clear that although more has been learned 
about the relationship between physical activity and CHD there are still many 
issues to be resolved. One major issue is the apparent difference in the 
findings of Morris and colleagues and those of others i.e. whether it is physical 
activity per se or physical fitness which protects from CHD. It has already been 
noted that one explanation for the inconsistencies between studies may be the 
differential grading of various physical activities in the studies. Another 
possibility is that the differences are related to the nature of the populations 
under observation. For example, Morris and colleagues (1990) state that the 
participants in their most recent study were ..... probably more healthy and fit 
than average because they are a working population and because we 
excluded men with a clinical history of coronary heart disease; they were more 
active too than the national population of their age and social class". In 
contrast to this the population studied by Leon and colleagues (1987) in the 
Multiple Risk Factor Intervention Trial was a high risk population and some of 
the participants in the British Regional Heart Study (Shaper -and 
Wannamethee, 1991) had pre-existing ischaemic heart disease. On this basis 
it may be that the participants in the studies of Morris and colleagues were 
fitter than those in many of the other studies and therefore they required a 
greater exercise stimulus to gain additional protection from CHD. 
The recent trend to assess the relationship between physical fitness and CHD 
may help to resolve some of the uncertainties regarding the interrelationships 
between physical fitness, physical activity and CHD. An inverse relationship 
between physical fitness and CHD has now been shown by many studies. 
These include the Dallas Aerobics Centre Study (Blair et al. 1989), the 
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Belgian Physical Fitness Study (Sobolski et al. 1987) the Lipid Research 
Clinics Mortality Follow-up Study (Ekelund et al. 1988), the U.S. Railroad 
Study (Slattery and Jacobs, 1988) and studies carried out in Los Angeles 
(Peters et al. 1983) and Norway (Erikssen, 1986). In three of these studies 
(Blair et al. 1989; Ekelund et al. 1988; Sobolski et al. 1987) the relative risks of 
CHD, obtained when comparing those in the top and bottom fitness groups, 
were much higher than the relative risks of physical inactivity found in large 
scale epidemiological studies. 
Despite this evidence of a link between physical fitness and CHD there are 
still problems to be resolved. Of crucial importance is the way in which 
physical fitness is defined and measured. In the studies mentioned above 
fitness was defined in absolute terms. Blair and colleagues (1989), for 
example, used total treadmill time on a maximal exercise test as their measure 
of fitness and Sobolski and co-workers (1987) used the relative physical 
working capacity to indicate fitness i.e. the work load attained at a heart rate of 
150 beats.min-1, divided by body weight. The problem with these definitions is 
that they are influenced by inherited characteristics to an important degree. In 
Blair and colleagues' study, for example, treadmill time was highly correlated 
with V02max and the latter variable is known to have a strong genetic 
component (Klissouras et al. 1973). Similarly, because of the strong 
relationship between work rate and oxygen uptake, V02max would have been 
an important determinant of fitness as measured in the study of Sobolski and 
co-workers (1987). 
Because of the inherent genetic influence when fitness is defined in absolute 
terms it is difficult to quantify the contribution which physical activity has made 
to CHD protection. In some cases it does not appear to be that great. In the 
Belgian Physical Fitness Study, for instance, correlations between leisure-time 
physical activity and fitness and between occupational physical activity and 
fitness were 0.10 and 0.07 respectively. Given that physical activity should 
have some influence on physical fitness this suggests that either the measures 
of physical activity or those of physical fitness were inappropriate. In future 
studies it would be useful if fitness could be defined and measured in relative 
terms e.g. by measuring the heart rate or blood lactate concentration at a 
given relative exercise intensity. If the definition and measurement of physical 
fitness can be improved in future studies and a relationship between physical 
fitness and CHD is still found to exist, then this will give greater credibility to 
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the assertion that physical activity rather than constitutional factors affects 
physical fitness and therefore CHD. Despite their limitations, however, the 
studies which have examined physical fitness and CHD have been of value 
since they have confirmed that these two variables are related. Moreover, 
since a dose response relationship between physical fitness and CHD has 
been demonstrated in some studies (Blair et al. 1989; Ekelund et al. 1988; 
Sobolski et al. 1987) and since Morris and colleagues (1990) found a dose 
response relationship between the frequency of vigorous aerobic exercise 
and CHD incidence in their study (for men aged 55 to 64 at entry), it may be 
postulated that the greater the effect which physical activity has on physical 
fitness, the greater will be the benefit in terms of protection from CHD. 
Just as improvements in the measurement of physical fitness are required, so 
are improvements in the way in which physical activity is measured. These 
may help to reconcile some of the conflicting findings from previous 
epidemiological studies. The predominant tool used to measure physical 
activity by epidemiologists, the questionnaire, has inherent limitations. There 
will always be inaccuracies in recall data and this will reduce the precision 
with which physical activity can be quantified. To give an example, in the 
Multiple Risk Factor Intervention Trial the relationships between leisure-time 
physical activity at base line and at the first, fourth and sixth annual visits were 
all weak (r = 0.38, 0.31 and 0.30 respectively) (Leon et al. 1987). Slattery and 
colleagues (1989) also reported poor relationships between physical activity 
scores on the first and second assessment in the U.S. Railroad Study. This 
disparity· probably reflects both true changes in physical activity and also 
inaccurate reporting. 
Despite these problems it is difficult to see an alternative to the use of 
questionnaires for assessing physical activity in large scale epidemiological 
studies. However, a greater degree of consistency between questionnaires as 
regards the grading of physical activity would be an attainable goal. Subjects 
could also be asked to keep a record of activity over some future period as an 
adjunct to the questionnaires used to measure previous exercise habits. 
Attempts could be made to assess the speed and intensity of activities such as 
walking, cycling and swimming, at least in a subgroup of study participants. 
Measurements of distance and time could be used to get an estimation of 
speed and portable pulse rate monitors could be employed to measure the 
heart rate of subjects over one or a number of days. Another means of 
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validating intensity scores would be to use Borg's scale of perceived exertion 
and to ask questions regarding the symptoms associated with exercise, Le. 
heavy breathing and sweating, as suggested by Morris (personal 
communication). If future studies can improve on the accuracy with which 
physical activity is measured and classified this should allow for a more 
confident identification of the types of exercise most closely associated with 
reduced CHD risk. This in turn would have important consequences for the 
promotion of various forms of physcial activity. 
In conclusion it may be stated that although there is still much to be learned, 
the relationship between exercise and CHD is now firmly established. It 
appears that the most beneficial type of activities for reducing CHD risk are 
those which are endurance based. That is, activities which are sustained, 
rhythmic and aerobic in nature such as walking, jogging, swimming and 
cycling and which have an important effect on the heart and cardiovascular 
system. As to the amount of exercise required to reduce CHD risk this will 
obviously vary depending on an individual's age and fitness level as well as 
other factors. Whether vigorous exercise is essential or not remains 
contentious but evidence certainly suggests that this form of exercise is the 
most beneficial. This is supported by the fact that even in studies where overall 
energy expenditure is found to be protective, energy expended in vigorous 
exercise is usually associated with a lower risk than energy expended in non-
vigorous exercise (Paffenbarger et al. 1978; Slattery et al. 1989). It should be 
noted, however, that the energy expenditure considered to represent vigorous 
exercise by Morris and colleagues (Le. 7.5 kcal.min-1) is still somewhat lower 
than the highest levels of energy expenditure which are possible during 
exercise. Moreover, Morris and colleagues (1980) themselves note that the 
men which they studied were no athletes. Therefore, vigorous exercise 
according to the above definition still represents an attainable goal for most 
individuals. 
The mechanisms by which exercise might lead to a reduction in CHD risk are 
not well understood. Some of the influence of exercise on CHD may be 
mediated through the effect which exercise has on other CHD risk factors such 
as lipoprotein metabolism, hypertension and obesity. However, in most of the 
epidemiological studies discussed above the relationship between exercise 
and CHD remained significant (though it was sometimes attenuated) even 
when other risk factors were controlled for. This suggests that at least part of 
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the reduction in risk associated with physical activity results from a direct 
influence of that activity. In the following Sections of this review, some of the 
plausible mechanisms by which exercise may directly or indirectly reduce the 
risk of CHD are examined. 
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2.3 Llplds, lipoprotein metabolism and coronary heart disease 
2.3.1 Llpids 
Lipids, which account for approximately 40 per cent of the body's organic 
matter, are molecules composed of predominantly carbon and hydrogen 
atoms. These atoms are joined by electrically neutral covalent bonds which 
means that the resulting lipid molecules are nonpolar and thus insoluble in 
water since they have no electrical affinity for water molecules. It is this 
insolubility in water that characterises lipids. There are three major subclasses 
. of lipids: triglycerides (also known as triacylglycerols), phospholipids and 
steroids. In addition, fatty acids compose another class of lipids which are 
either incorporated into triglycerides and phospholipids or exist simply as 
"free" molecules (Vander, Sherman and Luciano, 1990). 
Each of the lipid subclasses has a distinct role to play in the maintenance of 
normal body function. Phospholipids, for example, form a major component of 
cell membranes while steroids are precursors of bile acids, used in lipid 
digestion, and steroid hormones, such as the sex hormones, in addition to 
their role as constituents of cell membranes. One very important steroid is 
cholesterol which has received considerable attention in the scientific world 
recently because of its atherogenic properties. The most abundant source of 
lipid in the body, however, occurs in the form of triglycerides which are often 
referred to simply as fat. Triglycerides are highly concentrated stores of 
metabolic energy which serve predominantly as energy substrates. They are 
formed by the joining together of glycerol, a three-carbon carbohydrate, with 
three fatty acid molecules, a process termed esterification. This process is 
reversible i.e. the fatty acid molecules may be cleaved from their glycerol 
backbone resulting in triglyceride dissolution, this is known as lipolysis or 
hydrolysis. Digestion of dietary fats then involves the lipolysis of triglycerides 
which then require re-esterification if the consumed lipids are to be stored. 
Utilisation of the stored triglycerides i.e. for energy metabolism, will require a 
further lipolysis (Brooks and Fahey, 1984; Tortora and Anagnostakos,1981). 
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2.3.2 Llpoproteins 
As mentioned previously most lipids are non-polar and thus insoluble in water. 
Therefore, in order that they can be transported around the body to perform 
their required functions they must combine with apolipoproteins (also termed 
apoproteins) to form lipoproteins which are soluble in plasma due to their 
complex arrangement. Thus, lipoproteins are macromolecular complexes 
composed of various lipids (cholesterol, triglycerides and phospholipids) and 
protein. They exist in a state of dynamic equilibrium among themselves with a 
continuous exchange of lipid and protein between macromolecules. 
Furthermore, all lipoproteins share a common structural make up consisting of 
a hydrophobic core of lipids (triglycerides and cholesterol esters) and a 
hydrophilic shell of polar lipids (phospholipids and free cholesterol) and 
apoproteins (Stryer, 1988). Nevertheless, lipoproteins can be divided into five 
basic categories according to density (determined by ultra-centrifugation) as 
described by Assmann (1982). 
Chylomicrons (density<0.95 g.ml-1) are formed in the intestinal mucosa and 
transport exogenous (dietary) triglycerides. They are composed of 98-99.5% 
lipid and 0.5-2% protein (primarily apoproteins A-I and C). After entering the 
systemic circulation chylomicrons have a half-life of only a few minutes, being 
degraded to core remnants. Thus, in the absence of metabolic disease, 
chylomicrons are found only in post-prandial serum and not in fasting serum. 
Very low density lipoproteins (VLOL) (density<1.006 g.ml-1) are formed in the 
liver and transport the bulk of endogenous triglycerides. They consist of 85-
90% lipid and 10-15% protein (primarily apoproteins 8-100, C and E). 
Intermediate density lipoproteins (IOL) (density = 1.006-1.019 g.ml-1) are 
found only in very low concentrations in normal individuals and are thought to 
be metabolic products of VLOL which then become precursors for LOL. 
Apoproteins 8-100 and E are present in IOL. 
Low density lipoproteins (LOL) (density = 1.019-1.063 g.ml- 1) arise as 
metabolic products of VLOL and are responsible for transporting the bulk of 
cholesterol in the blood. They contain approximately 75% lipid and 25% 
protein (apoprotein 8-100). 
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High density lipoproteins (HDL) (density = 1.063-1.210 g.ml- 1) function 
primarily in cholesterol esterification and exchange reactions within the 
plasma. Thus, HDL receive cholesterol from other lipoproteins and 
extrahepatic cells, modify it and then return it for transport back to the liver. 
High density lipoproteins also serve as a 'reservoir' for apoproteins during 
lipoprotein metabolism (Brewer et al. 1988). They contain approximately 50% 
lipid and 50% protein (primarily apoproteins A-I and A-II) and are synthesised 
in the liver and intestine in nascent (precursor) form but fully develop in the 
plasma (aided by interaction with VLDL and chylomicrons). High density 
lipoproteins can be further divided into various subfractions, the principal ones 
being HDL2 and HDL3. The HDL2 subfraction is larger and less dense than 
HDL3 and although the major portion of HDL is normally present in HDL3, 
individual variability in HDL levels in humans usually reflects different 
amounts of HDL2 (Tall, 1990). The HDL particles circulate with a half-time of 5 
to 6 days which is the longest of all the lipoproteins (Brown et al. 1981). 
2.3.3 Apollpoprotelns (apoprotelns) 
Aside from their role of providing structural stability to the lipoprotein 
molecules apoproteins also act as recognition sites for cell membrane 
receptors and function as cofactors for enzymes which are involved in plasma 
lipid and lipoprotein metabolism (Gotto, 1989). According to Brewer and 
colleagues (1988) fourteen major apoproteins have now been identified and 
characterised, these are classed A, B, C, D, E, F, G and H with subclasses. Of 
these fourteen, ten are commonly discussed in articles on lipids and 
lipoprotein metabolism and these are apoprotein (Apo) A-I, A-II, and A-IV; Apo 
B-48 and B-100; Apo C-I, C-II and C-III; Apo D and Apo E. The importance 
and function of these apoproteins will now be highlighted. 
Apoprotein A-I is synthesised in both the liver and the small intestine and is 
the major protein present in HDL, constituting 70-80% of the protein mass. It is 
also present in chylomicrons. One of the major roles of Apo A-I is as an 
activator of the enzyme lecithin: cholesterol acyltransferase (see below) 
(Rosseneu and Labeur, 1990). Apoprotein A-I may also interact with a 
proposed HDL receptor and facilitate the removal of cholesterol from 
peripheral cells for transport back to the liver (Brewer et al. 1988). Apoprotein 
A-II is the second most abundant apoprotein in HDL and is also synthesised in 
both the liver and small intestine. Although its physiological role has not been 
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well established it has considerable lipid binding ability (Roheim, 1986). 
Apoprotein A-IV is synthesised in the intestine and the majority of Apo A-IV in 
the plasma is unassociated with lipoproteins. No definite function has yet been 
attributed to this apoprotein but it may aid in the activation of lecithin: 
cholesterol acyltransferase (Ginsberg, 1990). 
There are two B apoproteins, Apo B-48 and Apo B-l00. Apoprotein B-48, 
which is 48% as large as Apo B-l00, is the major structural component of 
chylomicrons and is formed in the intestine. Apoprotein B-l00, synthesised in 
the liver, is the largest of the apoproteins containing 4,563 amino acids and is 
present in VLDL, IDL and LDL (Brown and Goldstein, 1987). Apoprotein 8-100 
is an extremely important apoprotein since it is virtually the sole protein 
component of LDL and it is the ligand that delivers cholesterol to all parts of 
the body by the LDL receptor pathway (see below) (Assmann, 1982). 
The C apoproteins are present in varying amounts in practically every 
lipoprotein class and are all synthesised in the liver. At present only Apo C-II 
has a clearly established physiologic function which is as an activator of the 
enzyme lipoprotein lipase (Mahley, 1991). Apoprotein D (sometimes termed 
Apo A-Ill) is a minor component of HDL and its site of synthesis is thought to 
be the liver. Its role is yet to be confirmed but may involve the transfer of 
cholesterol ester from HDL to triglyceride rich lipoproteins (Ginsberg, 1990). 
Finally, Apo E, which is present in all of the lipoproteins, is synthesised 
primarily in the liver but also by various other cells including the brain (Gotto, 
1989). Together with Apo B-l00, Apo E acts as a ligand for the LDL receptor 
(sometimes referred to as the Apo B,E or Apo 8,E [LDLl receptor). This means 
that it is responsible for the recognition of lipoproteins by the specific cell-
surface receptors that mediate the uptake of lipoprotein cholesterol into the 
cells. It may also interact with the putative chylomicron remnant receptor (Apo 
E receptor) which is thought to play an important role in the removal of 
chylomicron remnants by the liver (Mahley, 1991; Brewer et al. 1988). 
2.3.4 Enzymes involved in lipoprotein metabolism· 
Three key enzymes which are involved in lipoprotein metabolism are 
lipoprotein lipase, hepatic lipase and lecithin: cholesterol acyltransferase 
(LCAT). Lipoprotein lipase is bound to the endothelial surface in adipose 
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tissue and muscle and serves to hydrolyse circulating triglycerides to'free fatty 
acids and glycerol. The concentration of lipoprotein lipase in the general 
circulation is kept low by an avid uptake in the liver thus lipoprotein lipase 
facilitates the movement of fatty acids to peripheral cells. Patients deficient in 
lipoprotein lipase or in its activator apoprotein (Apo C-II) demonstrate a 
massive hypertriglyceridaemia (Olivecrona. and Bengtsson-Olivecrona, 1990). 
Hepatic lipase is responsible for the hydrolysis of triglycerides and 
phospholipids in HDL particles and is therefore involved in the catabolism of 
HDL. Thus, there is a strong negative correlation between hepatic lipase 
activity and levels of HDL, particularly HDL2 (Olivecrona and Bengtsson-
Olivecrona, 1990). Lecithin: cholesterol acyltransferase (activated by Apo A-I) 
is the enzyme which promotes the esterification of cholesterol on the surface 
of HDL. The cholesterol esters formed in this reaction are then incorporated 
into the hydrophobic core of HDL. Lecithin: cholesterol acyltransferase, then, 
plays a crucial role in HDL metabolism since it is responsible for converting 
the nascent HDL formed in the liver and intestine into its complete form in the 
plasma. Any reduction in LCAT activity and/or increase in hepatic lipase 
activity could theoretically reduce plasma HDL concentrations (Eisenberg, 
1984). 
2.3.5 Lipid digestion 
Lipids undergo no significant digestion in the stomach and thus their digestion 
begins in the small intestine where they encounter the action of bile salts 
secreted from the liver. Bile salts are amphipathic molecules having a polar 
and nonpolar surface. The non polar surface of the bile salts associates with 
the nonpolar surface of the lipids, leaving the polar side exposed to water. 
Mechanical agitation in the intestine breaks up large fat globules and the 
resulting smaller droplets become coated with bile salts. Aggregation of the 
droplets is prevented since the negative charges on the exposed surfaces of 
the bile salts repel each other. The resulting suspension of lipid droplets in an 
aqueous solution is termed emulsion. 
In this emulsified form, fat globules are then hydrolysed into monoglycerides 
and free fatty acids by the action of pancreatic lipase. The products of this 
hydrolYSiS now aggregate into micelles, which are similar in structure to 
emulsion droplets but much smaller and consist of bile salts, fatty acids, 
monoglycerides and phospholipids. These micelles facilitate the absorption of 
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lipids from the intestinal lumen into the epithelial cells lining the small intestine 
as described by Vander, Sherman and Luciano (p.523, 1990). 
During their passage through epithelial cells fatty acids and monoglycerides 
are resynthesised into triglycerides, a process occurring in the endoplasmic 
reticulum where the enzymes for triglyceride synthesis are located. These new 
triglycerides, along with absorbed cholesterol and phospholipids, are 
encapsulated into globules with a protein coat forming chylomicron particles. 
The chylomicrons are now expelled from the epithelial cells and pass into the 
lacteals from where they reach the lymph. The lymph from the small intestine 
eventually empties into the left subclavian vein in the neck through the 
thoracic duct and thus gains access to the systemic circulation (Vander, 
Sherman and Luciano, 1990; Brooks and Fahey, 1984; Tortora and 
Anagnostakos, 1981). 
2.3.6 Lipoprotein transport 
Before they can be used by cells, triglycerides and cholesterol esters (esters of 
cholesterol and long chain fatty acids) must be hydrolysed to liberate fatty 
acids and unesterified cholesterol respectively. By means of the lipoprotein 
transport system these two classes of hydrophobic lipids are delivered to their 
separate destinations; triglycerides to adipose tissue and muscle where the 
fatty acids can be stored or oxidised for energy and cholesterol esters to all 
body cells where the unesterified sterol can be used in the construction of 
plasma membranes. It should be pointed out that almost all cells can 
synthesise some of the cholesterol required for their own plasma membranes, 
but most cannot do so in sufficient quantities and thus depend on receiving 
cholesterol from plasma LDL (Vander, Sherman and Luciano, 1990). The 
lipoprotein transport system can be divided conceptually into exogenous and 
endogenous sections involved in the transport of dietary and hepatic lipids 
respectively. What follows is a briel summary 01 these two systems which are 
described in more detail elsewhere (Assmann, 1982; Betteridge, 1989; Brewer 
et al. 1988; Brown and Goldstein, 1984; Brown et al. 1981; Eisenberg, 1990; 
Ginsberg, 1990; Tikkanen, 1990). 
Exogenous lipid transport: Dietary lipids are digested and packaged into 
triglyceride rich chylomicrons as described above. The major function of these 
chylomicrons is to transport the dietary lipids from the intestine to peripheral 
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tissues and the liver. The principle protein components of chylomicrons in the 
lymph are Apo A-I, A-II, A-IV and Apo B-48. Once chylomicrons have gained 
access to the bloodstream they acquire other apoproteins from HDL including 
Apo C-II and E. Apoprotein C-II activates the lipoprotein lipase enzyme 
residing in the capillaries of adipose and muscle tissues. This enzyme partially 
hydrolyses the triglycerides contained in the chylomicron to monoglycerides 
and free fatty acids and allows them to gain access to muscle or fat tissues. 
The chylomicron also gives up the excess phospholipids, free cholesterol and 
apoproteins contained on its surface, these are transferred to HDL. As much 
as 50% of the circulating HDL particles may be derived from this process 
(Betteridge, 1989). The chylomicron retains its load of cholesterol ester and 
Apo E. 
Depleted of its triglyceride core, the chylomicron remnant (as it now becomes 
known) is released from the capillary wall and re-enters the circulation to be 
carried to the liver where it is internalised, off loading its cholesterol. The 
internalisation of the chylomicron remnant by the liver is accomplished via a 
process termed 'receptor mediated endocytosis' (Brown et al. 1981) and is 
thought to involve a remnant receptor with an affinity for Apo E and perhaps 
the LDL receptor as well. The liver disposes of the delivered cholesterol in 
bile, either as unesterified cholesterol or as bile acids. A large portion of this 
cholesterol and bile acid is secreted by the liver, re absorbed in the intestine 
and then again delivered to the liver, thus forming a continuous cycle. Some 
cholesterol and bile acid avoids reabsorption, however, and is excreted in the 
faeces. 
Endogenous lipid transport: Carbohydrates and fatty acids are converted into 
triglycerides in the liver. In addition the liver synthesises its own supply of 
cholesterol, via the activity of the rate controlling enzyme 3-hydroxy-3-
methylglutaryl coenzyme A reductase (HMG CoA reductase), to complement 
its dietary sources. Triglycerides and cholesterol in the liver are packaged into 
VLDL for their transport to adipose tissue and ex1rahepatic cells respectively. 
Once in the circulation VLDL acquires Apo E and Apo C-II from HDL and then 
surrenders most of its triglyceride when it encounters lipoprotein lipase activity 
in the capillaries of adipose tissue. The interaction of VLDL with lipoprotein 
lipase is not as effective as the interaction of chylomicrons with this enzyme, 
thus, the half life of VLDL is one to three hours in contrast to that of four to five 
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minutes for chylomicrons (Brown et al. 1981). Some of the VLDLs are 
removed from the circulation by way of Apo B-100/Apo E interaction with LDL 
receptors located on the liver. The remaining particles are converted into IDL. 
During this process excess surface material (proteins, phospholipids and 
cholesterol) are passed to HDL which esterifies the excess cholesterol with 
fatty acids, via interaction with the enzyme LCAT and transfers it back to IDL. 
The net result of this conversion is the replacement of most of the triglyceride 
core of VLDL with cholesterol esters. 
After lipolysis, IDLs are released from the capillary wall back into the 
circulation and some are returned to the liver where they are catabolised. 
Most, however, undergo a further transformation in which they are converted 
into LDL. The conversion process is not yet fully understood but involves the 
removal of all of the remaining triglyceride and most of the apoproteins from 
IDL leaving a particle which contains almost pure cholesterol ester in its core 
and Apo B-100 at the surface. The LDL, which has an average lifespan of two 
and a half days (Brown and Goldstein, 1984) delivers cholesterol to 
extrahepatic cells and the liver. Delivery is accomplished when the LDL binds 
to high affinity receptors located on the surface of hepatic and peripheral cells 
and is internalised by endocytosis as described by Brown and Goldstein 
(1984). If the circulating plasma levels of LDL are high other methods for the 
removal of this lipoprotein can be utilised including the degradation of LDL by 
'scavenger cells'. However, if these scavenger cells are overloaded with 
cholesterol they become converted into 'foam cells' which form components of 
atherosclerotic plaques as described below. 
The extrahepatic and scavenger cells themselves excrete a significant portion 
of cholesterol as a result of cell death and membrane turnover. This 
cholesterol is collected by HDL, again in conjunction with the action of LCAT, 
and transferred back to the liver, either directly, or via exchange with VLDL, 
IDL and LDL. This transfer of cholesterol esters from HDL back to other 
lipoproteins is thought to be aided by the action of an enzyme termed 
cholesterol ester transfer protein (Barter, 1990a). The involvement of HDL in 
returning cholesterol from extrahepatic cells to the liver may involve specific 
HDL receptors located on peripheral cells and perhaps also on the liver. 
Moreover, unlike LDL, HDL is not thought to be catabolised by these receptors 
but is released back into the circulation after delivery/collection of cholesterol 
esters so that further transport of cholesterol may continue. However, at 
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present this process is not well understood (Tall, 1990). It is clear though that 
HDL plays a central and quite unique role in the continuous cycle of 
lipoprotein transport. 
2.3.7 Low density lipoprotein receptors, the liver and regulation 
of plasma cholesterol 
The liver can be considered as the "centre of the cholesterol universe" since it 
may be simultaneously synthesising new cholesterol, picking cholesterol up 
from the blood and excreting it into bile and converting cholesterol into bile 
acids (Vander, Sherman and Luciano, 1990). Regulation of plasma 
cholesterol concentration is attained by manipulation of all of these processes 
the most crucial one being control of cholesterol production. The rate of 
hepatic cholesterol synthesis is highly responsive to the quantity of absorbed 
exogenous cholesterol. Thus, an increase in the intake of dietary cholesterol 
will lead to a reduced hepatic output and vice versa. This control mechanism 
is achieved by changes in the activity of HMG CoA reductase (Stryer, 1988). 
A key role in the control of plasma cholesterol levels is performed by the LDL 
receptors. Uptake of cholesterol by these receptors results in a cellular 
increase in free cholesterol which activates three regulatory mechanisms to 
oppose further increases; 1: The synthesis of HMG CoA reductase is 
suppressed; 2: The activity of acyl coenzyme A: cholesterol acyltransferase is 
enhanced so that excess cholesterol can be stored in the form of cholesterol 
esters, and; 3: The synthesis of LDL receptors is inhibited, thus preventing a 
further uptake of cholesterol by the cells and therefore protecting them from an 
over accumulation of cholesterol (Assmann, 1982. Stryer, 1988). 
The fundamental importance of the role of LDL receptors in the regulation of 
plasma cholesterol levels is demonstrated in those people who have a 
genetically inherited defect in LDL metabolism. This defect usually manifests 
itself in a marked reduction in the number of LDL receptors located on hepatic 
and peripheral cells, entry of LDL into the cells is impaired as a consequence 
and the plasma level of LDL rises. This condition is termed familial 
hypercholesterolaemia and there are two forms of the disease, a 
heterozogous form and a more severe homozygous form. Heterozygotes 
(approximately one in 500 people) have one nonfunctional gene and one 
normal gene in each cell for LDL receptor synthesis, thus they produce about 
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half the normal number of receptors and exhibit plasma LDL levels twice that 
in normal people even before birth. Homozygotes (about one in a million 
people) inherit two abnormal genes, one from each parent, and produce 
virtually no functional LDL receptors at a". They usually have circulating LDL 
levels which are six times greater than normal and most homozygotes die of 
CHD in childhood (Ba" and Mann, 1988; Stryer, 1988; Brown and Goldstein, 
1984). 
2.3.8 Cholesterol, atherosclerosis and coronary heart disease 
The underlying cause of CHD in most cases is the formation, over many years, 
of atherosclerotic plaques. These plaques are rich in cholesterol, most of 
which is derived from plasma lipoproteins (Grundy, 1990a). The precise 
mechanism responsible for the development of these plaques has yet to be 
resolved but many theories have been proposed (see Davies et al. 1991; 
Getz, 1990; Havel, 1989; McGi", 1988; Woo If, 1990). Briefly, cholesterol and 
blood platelets penetrate the walls of one or a number of arteries, possibly 
prompted by endothelial injury, and are degraded by smooth muscle cells and 
macrophages (white blood corpuscles sited in the walls of blood vessels) to 
form what are termed foam cells (so named because of their microscopic 
appearance). These cells contain a critical concentration of cholesterol esters 
which ultimately leads to their death. If the circulating level of plasma 
cholesterol is too high, cholesterol accumulates in and among the foam cells 
causing an 'atheroma' or atherosclerotic plaque. This narrows the artery and 
may eventually rupture releasing thrombotic material which causes total 
occlusion of the artery and thus heart attack. 
Since a" of the plasma lipoproteins exhibit different structural and functional 
roles each lipoprotein class is thought to be differently related to 
atherosclerosis. What follows is a brief examination of the role of each of the 
major lipoprotein species in the development of atherosclerosis. 
2.3.9 Low density lipoproteins and atherosclerosis 
Low density lipoproteins are generally thought to be the major atherosclerotic 
lipoproteins .. The Lipid Research Clinics Coronary Prevention Trial (Lipid 
Research Clinics Programme, 1984) and many other epidemiological studies 
(see Grundy, 1990a) have revealed a strong and independent relationship 
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between plasma concentrations of LDL and the risk of developing 
atherosclerotic heart disease. Perhaps the most compelling evidence 
implicating LDL in the development of CHD, however, comes from the 
genetically determined condition homozygous familial hypercholesterolaemia. 
This "vivid experiment of nature ... demonstrates unequivocally the casual 
relation between an elevated circulating LDL level and atherosclerosis" 
(Brown and Goldstein, 1984). Furthermore, direct evidence linking LDL with 
CHD has now been provided from studies in which LDL like lipoproteins have 
been eX1racted from atherosclerotic plaques (Getz, 1990). 
Recent studies suggest that certain subclasses of LDL may be more 
atherogenic than others. One of these (LDL-III) is characterised by relatively 
small particle size and increased density and has been found to be linked to 
many interrelated hormonal and metabolic factors also implicated in CHD risk 
(Krauss, 1991). Furthermore, the atherogenicity of LDL appears to be 
increased by oxidisation (Luc and Fruchart, 1991; Olsson, 1990). Oxidised 
LDL gains access to macrophages via the scavenger receptor pathway, 
which, unlike the LDL receptor is not subject to feedback regulation (McGill, 
1988; Betteridge, 1989). Thus, the higher the concentration of circulating LDL, 
the higher its influx into the arterial wall (Stender, 1990). 
2.3.10 High density lipoprotelns and atherosclerosis 
Interest in the role of HDL in the aetiology of CHD was heightened when Miller 
and Miller (1975) published a "rediscovery" of the inverse relationship 
between this lipoprotein and heart disease first proposed by Barr and co-
workers in 1951 (cited in Jacobs et al. 1990). A subsequent study found HDL 
cholesterol to be a three-fold better predictor of CHD than LDL cholesterol in a 
relationship which was independent of all other variables (including LDL 
cholesterol) (Miller et al. 1977). These findings have subsequently been 
confirmed in a number of large clinical and population based North American 
and European studies (Frick et al. 1990; Gordon et al. 1989; Jacobs et al. 
1990). Moreover, although the British Regional Heart Study found that HDL 
cholesterol was not a major risk factor for ischaemic heart disease in British 
men (Pocock et al. 1986), this inconsistency arose from a "statistical artefact" 
which has since been corrected yielding results consistent with other studies 
(Gordon and Rifkind, 1989). 
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In addition to epidemiological studies, evidence supporting an inverse 
relationship between HDL and CHD is provided by investigations examining 
patients with genetic disorders such as familial hyperalphalipoproteinaemia. 
This disease was first reported by Glueck and co-workers (1975) and later 
Patsch and colleagues (1981) and is characterised by elevated levels of 
serum HDL cholesterol and low morbidity and mortality from CHD. 
Angiographic studies have also demonstrated that HDL concentrations are 
negatively associated with the development of CHD (Miller et al. 1990) and 
positively related to increased longevity (Nikkila and Heikkinen, 1990). 
Two main theories have been proposed to explain the seemingly protective 
role of HDL in preventing CHD. The most popular of these proposes that HDL 
collects cholesterol from LDL, peripheral tissues and the arterial wall and 
returns it to the liver for disposal in a process termed 'reverse cholesterol 
transport' (see Barter, 1990b; Kottke, 1986; Miller 1990; Roheim, 1986). High 
density lipoprotein is a good acceptor of unesterified cholesterol from cell 
membranes and a high concentration of HDL within the walls of coronary 
arteries could mobilise cholesterol out of foam cells (Grundy, 1990a). This is 
supported by evidence that the cholesterol content of healthy vascular tissue 
is a negative function of plasma HDL cholesterol in humans (Miller, 1990). It 
has also been shown recently that there is a net transfer of cholesterol esters 
from LDL to HDL in the plasma of normolipidaemic humans (Van Tol et al. 
1991). The level of HDL cholesterol in the plasma then is seen as a marker for 
the efficiency of the system, with low levels indicating a reduced capacity for 
cholesterol removal and thus increased peripheral cholesterol deposition. 
However, although the reverse cholesterol transport hypothesis is attractive, 
evidence to support it is limited and many precise details related to its 
proposed workings remain to be elucidated (Barter, 1990b). 
Another theory proposed by such investigators as Lechleitner and associates 
(1990) and Gotto (1990) does not involve HDL in such a direct role. These 
authors emphasise the strong inverse relationship between HDL and 
triglycerides and argue that the two cannot be considered separately. Thus, it 
is suggested that a rapid clearance of triglycerides (perhaps due to increased 
lipoprotein lipase activity) promotes the formation of HDL2 and that the low 
levels of triglyceride rich lipoproteins reduce the transfer of HDL cholesterol 
esters into these lipoproteins. Therefore, HDL cholesterol is kept high 
reducing the amount of cholesterol available for incorporation into lipoprotein 
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subfractions associated with increased CHD risk. Conversely, delayed 
clearance of triglyceride rich lipoproteins prevents the formation of HDL2 and 
leads to enhanced loss of cholesterol esters into atherogenic lipoproteins 
(Lechleitner et al. 1990). Once again, however, more experimental evidence is 
required to substantiate this theory. 
In conclusion then, despite overwhelming evidence linking increased levels of 
HDL cholesterol to reduced CHD risk, the mechanisms of interaction are still 
uncertain. Moreover, it remains to be shown definitively whether high HDL 
levels are predominantly causative or coincidental in their relationship to 
reduced CHD risk. 
2.3.11 Triglycerides and atherosclerosis 
Research findings examining the relationship between triglycerides and CHD 
are still largely ambiguous as shown in a recent review by Austin (1991). This 
ambiguity may be related to many factors. Triglyceride levels correlate 
positively with LDL cholesterol and inversely with HDL cholesterol and these 
correlations could confound the triglyceride-CHD link (Grundy, 1990b). 
Although epidemiological studies have often found an association between 
triglyceride concentration and the incidence of CHD when univariate statistical 
analyses are employed, this relationship frequently loses significance when 
multivariate analyses are employed (Gordon, 1990). Thus, the role of plasma 
triglycerides as an independent risk factor for CHD remains uncertain but has 
not been discounted since CHD risk is increased in some genetic disorders 
resulting in hypertriglyceridaemia without simultaneous hypercholesterol-
aemia (Havel, 1990). 
The complexity of this issue is increased by the fact that a number of 
triglyceride rich lipoproteins are responsible for the transport of triglyceride 
within the body. These include chylomicrons, chylomicron remnants, VLDLs 
and VLDL remnants. Evidence certainly exists to suggest that at least some of 
these lipoproteins are atherogenic (see Grundy, 1990a; Schwandt, 1990 and 
Ginsberg, 1990) but their quantitative importance in cases where other risk 
factors are also elevated is unknown. Much further study is needed to resolve 
this issue and will require measurement of the postprandial concentrations of 
the various triglyceride rich lipoproteins rather than their postabsorptive 
concentrations. Indeed it is possible that much important information 
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concerning coronary risk has been missed due to the common practice of 
collecting plasma only in the postabsorptive state (Pearson, 1991). 
2.3.12 Lipoprotein(a) (Lp(a» 
Current understanding of Lp(a) structure and metabolism is described in 
several recent reviews (Lawn, 1992; Loscalzo, 1990; Scanu, 1990; Utermann, 
1990). Lipoprotein(a) is an LDL-like particle which is heterogeneous in size 
and density and contains a single copy of Apo B-l00 linked to a high 
molecular mass glycoprotein called apoprotein(a). This Apo B-l00/ 
apoprotein(a) combination occurs in the plasma either in lipid free form, bound 
to cholesterol rich lipoproteins, or in association with triglyceride rich like 
particles. The major site of apoprotein(a) synthesis is the liver but it is not yet 
known whether apoprotein(a) combines with Apo B-l00 in the liver or the 
plasma to form Lp(a). The site and mechanism of Lp(a) catabolism has still to 
be determined though the LDL receptor may be involved since Lp(a) contains 
Apo B-l00. The concentration of Lp(a) in the plasma is thought to be 
determined largely by genetic factors (Boerwinkle, 1992). The physiological 
function of Lp(a) remains uncertain although it is probably related to lipid 
transport, blood clotting or both. 
Since its discovery in 1963 by Kare Berg many studies have demonstrated 
that high levels of Lp(a) are related to CHD (Boerwinkle, 1992; Dahlen et al. 
1986; Genest et al. 1991). Moreover, there is currently much interest in Lp(a) 
since many feel that it will provide a link between atherosclerosis and 
thrombosis. This hope comes from the fact that there is a striking similarity 
between apoprotein(a). and plasminogen regarding particular configurations 
called kringles which enable molecules to bind to cells. Plasminogen is a 
precursor of plasmin which is capable of decomposing fibrin and therefore 
dissolving blood clots. Because of its Similarity with plasminogen, Lp(a) is 
thought to act as an invader in the fibrinolytic system, interfering with 
fibrinolysis in many ways as described by Miles and Plow (1990) and thus 
promoting thrombotic events. 
Although the evidence is still controversial it has been proposed that Lp(a) 
penetrates the arterial wall following endothelial damage and binds to fibrin. 
This may be beneficial since Lp(a) would provide cholesterol to the site of 
tissue injury. If the concentration of Lp(a) was too high, however, 
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'microthrombi' may be formed on the arterial wall and become incorporated 
into atherosclerotic plaques (Brown and Goldstein, 1987). Moreover, Lp(a) 
may inhibit the action of plasminogen by preferentially binding to the 
plasminogen receptors located on endothelial cell surfaces, thus hindering the 
cleavage of fibrin clots (Lawn, 1992). It has also been suggested that Lp(a) 
might be involved in the final acute event in atherosclerosis where an 
atheroma becomes 'active' and ruptures (Loscalzo, 1990). At present, 
however, none of the above hypotheses have been proved and it cannot be 
excluded that Lp(a),s homology with plasminogen is merely coincidental and 
unrelated to its atherogenic role. If this is the case the atherogenicity of Lp(a) 
may be related to the covalent linkage formed between apoprotein(a) and Apo 
B-100 which could prevent uptake of Apo 8-100 containing particles via LDL 
receptors. As a consequence Lp(a) would be diverted to the scavenger 
receptor pathway leading to intracellular accumulation and the transformation 
of macrophages into foam cells (Scanu, 1990; 8reckenridge, 1990). 
To conclude then, Lp(a) may be involved in both the clinically quiescent 
evolutionary development of atherosclerosis and the clinically active acute 
phase of atherosclerosis via interference in the fibrinolytic system. It could be, 
however, that Lp(a) is atherogenic only on the basis of its properties as a 
lipoprotein or that Lp(a) disrupts both lipoprotein metabolism and fibrinolytic 
activity. 
2.3.13 Apoprotelns A and B and coronary heart disease 
Recent trends in the assessment of CHD risk include measurements of the 
apoproteins A-I and 8 due to their relationships with HDL and LDL cholesterol 
respectively. In some studies the discriminative value of Apo A-I in detecting 
CHD has been shown to be superior to that of HDL and other lipoproteins 
(8reckenridge, 1990; Durrington, 1989). Similarly Apo 8 may be more strongly 
related to the risk of atherosclerosis than LDL cholesterol (Durrington, 1989; 
Krauss, 1991). At present it is not known whether the predictive powers of 
apoproteins A-I and 8 in detecting atherosclerosis are related simply to their 
role as markers for HDL and LDL cholesterol or whether they are directly 
atherogenic themselves. 
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2.4 Variablllties In lipid and lipoprotein measurement 
Interest into the problems inherent in lipid and lipoprotein -measurement has 
proliferated recently due to the publication of guidelines for the diagnosis and 
treatment of hypercholesterolaemia in Britain (Shepherd et al. 1987), Europe 
(Study Group: European Atherosclerosis Society, 1987) and North America 
(Report of the National Cholesterol Education Programme, 1988). Clearly 
inaccuracies in the measurement of serum lipids and lipoproteins have 
serious implications for cholesterol screening programmes and also individual 
patients, but factors which may confound lipid and lipoprotein determinations 
are also of great interest and relevance to the research scientist who relies on 
accurate and reproducible data. The factors which may cause the 
concentration of a given lipid or lipoprotein to vary between different samples 
collected from the same individual can be divided into three main areas: 
biological variation, analytical variation and variation due to sampling and 
handling procedures. 
Variation due to sampling and handling may be caused by many factors which 
have been reviewed by Cooper and colleagues (1988). In particular changes 
in posture and the length of venous occlusion may cause inconsistent results. 
Standing increases serum cholesterol concentration while levels are 
decreased in the recumbent position and changes of up to 10 to 15% may 
occur depending on the period of recumbency (Breckenridge, 1990). These 
differences are due to a rapid and progressive haemodilution and 
haemoconcentration caused by moving to and from supine and standing 
positions respectively. Prolonged application of a tourniquet also results in a 
haemoconcentration since it increases the pressure within the veins and 
causes serum water to move into interstitial spaces. Venous occlusions for 
less than one minute are unlikely to affect the concentration of serum lipids but 
longer periods of occlusion may result in serum lipid elevations of up to 15%. 
Other factors which may cause pre·analytical variation are the type of 
collection tube used, the addition of anticoagulants to samples and differences 
in storage and shipping procedures (Cooper et al. 1988). 
There are two important components related to analytical variation: accuracy 
and precision. Accuracy, agreement with the true value, is a measure of any 
inherent bias in an analytical procedure when compared to a gold standard for 
the determination of a particular lipid or lipoprotein. Precision can be defined 
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as the ability of an analytical procedure to reproduce a result regardless of 
whether or not that result represents a true value (Breckenridge, 1990). Both 
within day and day-to-day precision are extremely important since constant 
accuracy is not possible if the measurements are imprecise (Naito, 1988). 
Analytical imprecision may be expressed as the coefficient of variation (CV) 
and this can be used to calculate the possible range of values which may be 
obtained when analysing a serum sample for a particular lipid or lipoprotein. If 
a cholesterol assay has a CV of 10%, for example, repeated measurements of 
a sample with a 'true value' of 6.2 mmoLl-l would result in a spread of values 
95% of which would fall within the range of 5.0 - 7.4 mmoLl-l (Warwick et al. 
1990). Clearly such an imprecise method of cholesterol analysis would be 
undesirable. Naito (1988) states that for total cholesterol a CV of 5% is 
acceptable while a CV below 3% would be ideal. Yet even with these levels of 
precision the 95% range would span from 5.6 to 6.8 mmoLl-l and from 5.8 to 
6.6 mmoLl-l respectively given a 'true value' of 6.2 mmoLl-l (See Figure 2.2). 
Ideal Acceptable 
1 ! 7.4 +2 SD 
Coefficient 
6.2 4% 5% 6% 7% 8% 9% 10% of 
variation 
5.2 1 
5. 5.0 -2 SD 
Figure 2.2 The effect of analytical imprecision on the range of cholesterol 
values reported at a 'true value' of 6.2 mmoLl-l (from Warwick et al. 
1990). 
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Measurements of other lipids and lipoproteins are confounded by further 
sources of analytical error. For example, the potential for analytical variation is 
increased during HDL analysis because of the precipitation procedure and 
triglyceride measurements which are not corrected for free glycerol will 
obviously result in a positive measurement bias (Naito, 1988). Finally, 
analytical variation is usually greater for apolipoproteins than it is for 
lipoproteins due to the inherent problems with immunoassays (see Cooper et 
al. 1988). Although duplicate analysis will reduce the amount of analytical 
variation to some extent this should not be seen as an alternative to improving 
the accuracy and precision of measurement procedures and a total analytical 
variability of below 3% should be aimed for (Von Schenck and Olsson, 1990). 
Despite the potential sources of error discussed above, in most cases 
biological variation has been shown to account for the majority of the total 
variability which occurs in lipid and lipoprotein assessment. Natelson and co-
workers (1988) measured serum cholesterol concentrations in one subject 
over a six hour period by sampling blood every 20 minutes. The assay CV was 
below 1.5% but cholesterol concentration varied from a low of 4.9 mmoLl-l to a 
peak of 5.5 mmoLl-l. Moreover, Bremner and colleagues (1990) have studied 
the biological variation of total cholesterol, HDL-C and triglycerides over a 24 
hour period in nine subjects who gave blood every three hours. Mean values 
for the group ranged form 4.6 to 5.9 mmoLl-l for total cholesterol, from 0.9 to 
1.2 mmoLl-l for HDL-C and from 1.6 to 3.4 mmoLl-l for triglyceride. More 
profound differences were found when examining individual data and in one 
subject total cholesterol concentration varied from 3.5 to 5.3 mmoLl-l over the 
course of the 24 hours. 
Other investigators have examined the variation in lipids and lipoproteins over 
longer periods. Bookstein and associates (1990), for example, measured 
serum lipids in 51 men and women three times in one week on an every other 
day schedule. They found a day-to-day variability of 5% for total cholesterol, 
10% for HDL-C, 20% for triglyceride and 8% for calculated LDL-C. In each 
case the biological variation was greater than the analytical variation although 
analytical variation did contribute significantly to the total variation in HDL-C 
and LDL-C. Mogadam and colleagues (1990) assessed weekly variation in 
the serum lipid levels of 20 male and female subjects by collecting samples 
once a week for four consecutive weeks. Variations of more than ±20% in the 
concentrations of total cholesterol, LDL-C (calculated) and HDL-C were seen 
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in 75%, 95% and 65% of the subjects respectively and triglyceride 
concentrations varied by more than ±30% in 95% of the subjects. In all cases 
biological variation was by far the most significant component of the total 
variation. Finally, Demacker and co-workers (1982) examined the variation in 
serum lipids and lipoproteins over a period of one year in 28 men. Biological 
variation (expressed as the CV of all measurements within a person) ranged 
from 3.9% to 10.9% for total cholesterol, from 5.6% to 12.4% for HDL-C and 
from 12.9% to 39.9% for triglycerides. 
Few studies have investigated the intra-individual variation of apolipoproteins 
or HDL-C subfractions but some data is available. Wasenius and co-workers 
(1990) reported a daily biological variation of 6.5% for both Apo A and Apo B 
while the monthly values increased to 9.4% and 9.7% respectively. Brown and 
colleagues (1990) have reported slightly higher values of 10.4% and 12.2% 
for the biological variation of Apo A-I and Apo B over a six month period. In this 
same study Brown and colleagues (1990) also measured H DL2-C and 
H D L3-C and found an intra-individual variation of 18.6% and 16.0% 
respectively. 
The causes of the biological variation in serum lipids and lipoproteins in the 
short term are not well understood but they may be related to spontaneous 
fluctuations in metabolism (Rotterdam et al. 1987). It has also been suggested 
that circadian rhythms may explain the daily variation in lipids and 
lipoproteins. However, experimental evidence does not support this 
suggestion except in the case of triglycerides which have been shown to vary 
significantly according to the time of day but this is usually related to the 
proximity of meals (Bremner et al. 1990; Demacker et al. 1982; Wasenius et al. 
1990). In the longer term a whole host of factors may explain fluctuations in 
lipids and lipoproteins including body weight changes and changes in dietary, 
smoking, alcohol and exercise habits, the development of underlying disease 
and seasonal variation (Breckenridge, 1990; Cooper et al. 1988; Durrington, 
1990). 
It is clear from the above discussion that biological and analytical variation can 
have a substantial influence on lipid and lipoprotein determinations. Just how 
profound this influence can be has been demonstrated by Hyltoft Petersen 
and colleagues (1990). In a project on risk factors for CHD they measured 
serum cholesterol in three specimens from each subject drawn at two to three 
39 
week intervals. In 100 of their patients the measured cholesterol 
concentrations were between 7.0 and 8.0 mmoLl-1 in the first sample. 
However, repeat analysis resulted in a spread of values which ranged from 
5.0 to 10.0 mmoLl-1 by the third sample despite an assay CV of less than 1% 
at a concentration of 7.5 mmoLl-1 (see Figure 2.3). If this had been an 
intervention trial a decrease in cholesterol concentration in any given 
individual could easily have been wrongly attributed to therapeutic success. 
Although this problem cannot be completely overcome it is vital that sampling 
procedures are rigourously standardised and that assay inaccuracy and 
imprecision are reduced to a minimum. Furthermore, several specimens need 
to be collected to reduce biological variation and it may take as many as six 
samples to estimate an individual's cholesterol value to within 5% of the true 
mean value (Rotterdam et al. 1987). 
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Figure 2.3 Cholesterol values in the third of three samples taken from 100 
individuals, where the first sample had values between 7.0 and 8.0 
mmoLl-1 (adapted from Hyltoft Petersen et al. 1990). 
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2.5 Exercise, liplds and lipoproteins 
2.5.1 Introduction 
Interest in the effects of exercise on lipoproteins has proliferated in recent 
years due to the finding that exercise may exert favourable changes on 
plasma lipoprotein concentrations. Although there is little direct evidence to 
suggest that exercise can independently alter plasma total cholesterol or 
LDL-C, there is strong evidence to support the hypothesis that exercise, more 
especially endurance type exercise, is an effective means of increasing 
HDL-C and thus reducing the risk of CHD. 
Some of the research findings related to exercise and lipoproteins must be 
interpreted with a certain amount of caution, however, due to factors related to 
poor study design. An inadequate number of participants and the omission of 
a control group are fundamental flaws in some training studies. Moreover, 
cross-sectional studies comparing the lipoprotein profiles of groups of active 
and inactive people have often failed to control for the effects of such variables 
as diet, smoking habits, alcohol consumption and body composition, all of 
which are known to have an effect on lipoproteins (Goldberg and Elliot, 1987). 
Inappropriate use of statistical procedures has also been "extensive" which 
makes the conclusions of many studies unfounded (Wood et al. 1984). 
Other confounding factors related to findings on exercise and lipoprotein 
metabolism are the differing mode and duration of exercise examined. Thus, 
longitudinal training studies have been conducted for as little as six weeks 
(Lipson et al. 1980) to as long as two years (Wood et al. 1985) and exercise 
studies of various kinds have investigated such diverse activities as brisk 
walking (Hardman et al. 1989a), endurance running (Williams et al. 1982), 
cycling (Giada et al. 1988), aerobic dance training (Williford et al. 1988), 
volleyball playing (80netti et al. 1988), endurance triathlon (Lamon-Fava et al. 
1989), speed skating (Farrell et al. 1982), tennis playing (Vodak et al. 1980) 
and weight training (Goldberg et al. 1984). Variations in the frequency and 
intensity of the exercise performed in these studies is another factor adding to 
the complexity of the issue and when taken together all of the above 
observations make generalisation of research findings into exercise and 
lipoprotein metabolism difficult and sometimes confusing. Nevertheless, some 
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conclusions can be drawn from the available research and these will be 
discussed here. 
2.5.2 Exercise, total cholesterol and low density lipoprotein 
cholesterol 
Haskell (1986) and Goldberg and Elliot (1987) have conducted fairly 
extensive reviews of the literature concerning exercise and lipids and both 
conclude that the evidence for an independent effect of exercise on total 
cholesterol and LDL-C is limited. Although some observational studies have 
shown lower levels of these variables in trained subjects, many have found no 
differences. Moreover, the results of longitudinal studies are no more 
consistent and when changes are found they are usually quite small (five to 
seven per cent) unless the exercise is accompanied by a substantial weight 
loss or change in dietary intake (Haskell, 1986). 
On balance, the findings of more recent investigations are probably in line with 
the above conclusions but some are worthy of a mention. Studies by Hill and 
colleagues (1989) and Hespel and colleagues (1988a) examining 
asymptomatic males, Despres and co-workers (1990) with moderately 
overweight young men and Mendoza and associates (1991) investigating 
men with premature myocardial infarction, have all found reductions of around 
11 to 15% in the concentration of total cholesterol and/or LDL-C after 
endurance training programmes lasting from between ten weeks to four 
months. Unfortunately, however, none of these studies used control groups 
and thus these changes are questionable. 
Of the latest longitudinal studies that are well designed the majority have 
found no significant changes in total cholesterol or LDL-C after endurance 
exercise programmes. These include studies by Hardman and colleagues 
(1989a) examining a one year programme of brisk walking in middle-aged 
women; Marti and associates (1990) assessing the effects of four months of 
walking/jogging in middle-aged Swiss men and Sasaki and co-workers 
(1987) investigating the responses of obese children to a running schedule 
over a two year period. Recent cross-sectional studies, however, have 
continued to yield conflicting results with some finding no differences in total 
cholesterol and/or LDL-C between endurance trained athletes and their 
sedentary counterparts (Northcote et al. 1988; Tamai et al. 1988) and others 
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finding lower values in the trained subjects (Giada et al. 1988; Higuchi et al. 
1988). 
In general then exercise does not dramatically alter total cholesterol or LDL-C. 
Nevertheless, some observational studies have found lower concentrations of 
these parameters in endurance trained subjects compared with their inactive 
counterparts (Giada et al. 1988; Higuchi et al. 1988). Furthermore, well 
designed and executed training studies have shown reductions in total 
cholesterol and LDL-C with endurance training (Brownell et al. 1982; Peltonen 
et al. 1981; Wood et al. 1985). It may be that the effects of exercise on total 
cholesterol and LDL-C are determined largely by pretraining levels. Merrill 
and Friedrichs (1990) examined the potential of endurance exercise to 
influence total cholesterol and LDL-C concentrations in groups of subjects 
with low (3.7 mmoLl-l), medium (4.5 mmol.l-l) and high (5.7 mmoLl-l) 
concentrations of total cholesterol and found reductions in both variables after 
training but only in the group which had initially high values. Since studies 
rarely show increased concentrations of these variables in physically active 
people it might be concluded that endurance exercise has some small 
potential to improve lipoprotein profiles in this respect. 
Some investigators are now examining the effects of exercise on LDL 
subfractions due to the finding that the smaller, denser LDL subfractions may 
be more atherogenic than other LDL subfractions (Krauss et al. 1987). It has 
been shown that distance runners have significantly lower concentrations of 
the smaller LDL subfractions than age matched non-runners (Williams et al. 
1986) and that endurance training can lead to a reduction in the concentration 
of small LDL subfractions (Williams et al. 1990a). Moreover, in a one year 
training study, distance run correlated negatively with the concentration of 
small LDL although changes were not significantly different between the 
exercise and control group (Williams et al. 1989). However, additional 
research is required before any firm conclusions can be reached as to the 
potential of exercise to alter LDL subfractions. 
2.5.3 Exercise and high density lipoprotein cholesterol 
Results from studies examining the relationship between exercise and HDL-C 
have been more consistent than those examining total cholesterol or LDL-C 
and there is strong evidence supporting the hypothesis that endurance type 
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exercise is associated with increases of HDL-C. Wood and associates (1984) 
list the results of 14 observational running studies and eight observational 
studies examining activities other than running which have shown significantly 
higher HDL-C concentrations in active subjects as compared to inactive 
controls. More recently the results of many cross-sectional studies have 
confirmed these findings (Frey et al. 1990, Giada et al. 1988; Higuchi et al. 
1988; Higuchi et al. 1989; Marti et al. 1991; Nagao et al. 1988; Northcote et al. 
1988; Sady et al. 1988; Tamai et al. 1988). Although it is true that 
observational studies are not proof of an exercise effect, since they cannot 
discount the possibility that both HDL-C and exercise are associated with 
some secondary variable e.g. leanness or some other constitutional factor, 
they do provide evidence supporting an influence of physical activity on 
HDL-C concentration. 
One particularly convincing observational study is that of LaPorte and co-
workers (1983) who compared the HDL-C concentration of subjects with 
habitual exertion levels spanning a whole spectrum of physical activity from 
quadriplegia to marathon running. They found a graded relationship between 
activity and HDL-C with the lowest levels of both existing in newly injured 
spinal cord patients and progressive increases in both through groups of 
recently injured spinal cord patients, patients with long term spinal cord 
injuries, patients disabled with chronic back pain, normal sedentary controls, 
recreational joggers and finally elite marathon runners (Figure 2.4). Another 
well designed cross-sectional study is that of Nakamura and colleagues 
(1983). They compared a group of regular joggers with a control group 
matched for sex, age, bodyweight index, total cholesterol and triglycerides and 
found significantly higher (23%) concentrations of HDL-C among the joggers 
than the controls. 
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Figure 2.4 High density lipoprotein cholesterol concentration in groups of 
subjects who have different habitual physical activity levels. SCI = 
Spinal cord injury. (Adapted from LaPorte et al. 1983). 
Although evidence from longitudinal studies is not as consistent as that from 
cross-sectional studies there are still many studies showing elevations of 
HDL-C with endurance training (Despres et al. 1990; Faria and Faria, 1991; 
Hardman and Hudson, 1991; Hespel et al. 1988b; Marti et al. 1990; Mendoza 
et al. 1991; Sasaki et al. 1987; Stein et al. 1990; Thompson et al. 1988; Wood 
et al. 1988). These have involved exercise training programmes of between 
12 weeks (Stein et al. 1990) and two years (Sasaki et al. 1987) in length and 
have found increases in HDL-C of between 5.9% (Marti et al. 1990) and 27% 
(Hardman and Hudson, 1991). In contrast a number of the latest longitudinal 
studies have not shown increases in HDL·C with exercise (Hill et al. 1989; 
McNaughton and Davies, 1987; Palank and Hargreaves, 1990; Raz et al. 
1988; Tanaka et al. 1988 and Williford et al. 1988). 
Many factors could be responsible for the less consistent results obtained from 
longitudinal studies. Firstly, the quantity and quality of training achieved over a 
given period in these studies is usually considerably less than that of the 
trained subjects examined in cross·sectional studies. Moreover, many of the 
longitudinal studies are conducted over very short periods of time which 
possibly are not sufficient for changes in lipoproteins to occur and even in the 
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longer studies the amounts of exercise performed do not approximate the 
quantities achieved by elite athletes and other sports participants in their many 
years of consistent training. Other reasons for the inconsistencies could be 
related to differences in the characteristics of the groups investigated. For 
example, Sutherland and Woodhouse (1980) have found that changes in 
HDL-C are often dependent on pretraining levels. Thus, subjects with initially 
low levels of HDL-C have a greater potential to increase their levels than 
subjects with high levels initially. Similarly, those with poor fitness at the outset 
of a study may have a greater potential to improve their fitness and therefore 
perhaps their HDL-C concentration, as has been shown (Hill et al. 1989). 
In an effort to elucidate more precisely the relationship between exercise, 
HDL-C and CHD some investigations have measured the principle 
subfractions of HDL-C. In particular attention has focused on the HDL2-C 
subfraction since this subfraction is thought to be largely responsible for the 
protective effects of HDL-C (Miller et al. 1981). This has proved fruitful and 
many studies, both observational and longitudinal, have shown increased 
concentrations of HDL2-C with physical activity (Frey et al. 1990; Giada et al. 
1988; Hespel et al. 1988b; Northcote et al. 1988; Stubbe et al. 1983; Williams 
et al. 1986). Especially impressive here is the finding by Northcote and co-
workers (1988) of a 37% higher concentration of HDL2-C in elite veteran 
endurance athletes as compared to age matched sedentary controls. 
Attempts to correlate various indices of fitness with HDL-C have produced 
ambiguous results. Schnabel and Kindermann (1982) have found a significant 
direct relationship between V02max and HDL-C and Kuusi and colleagues 
(1982) detected a positive correlation between HDL2-C and fitness (defined 
by a standard amount of work achieved on a maximal exercise test). Other 
investigations, however, have failed to demonstrate correlations between 
V02max or exercise performance and HDL-C (Allison et al. 1981; Brownell et 
al. 1982; Haskell et al. 1980; Stein et al. 1990). One of the reasons for these 
inconsistencies may be that V02max is a relatively insensitive index of 
endurance fitness and of the changes in endurance capacity which often 
accompany training (Williams and Nute, 1982). 
Another approach taken by some investigators has been to relate the quantity 
of exercise performed to changes in HDL-C concentration. Moore and co-
workers (1983) found that distance ran correlated well with HDL-C 
46 
concentrations in a group of female distance runners and a study by Cook and 
colleagues (1986) examining active postal carriers showed a significant 
relationship between the reported number of miles walked per day and 
HDL2-C. Other cross-sectional studies, however, categorising runners into 
groups according to running mileage, have been unable to demonstrate 
increased concentrations of HDL-C in the most prolific runners (Higuchi et al. 
1989; Watt et al. 1990). In their one year longitudinal study Wood and co-
workers (1983) found a dose-response relationship between miles ran and 
HDL-C although the changes in HDL-C did not start to occur until a threshold 
of about eight miles of running per week had been reached. Interestingly in 
this study, those subjects who had the highest initial HDL-C concentrations 
also ran the most miles during the study. This suggests that a self-selection 
effect may be important in determining who will gain the most benefit from 
exercise which could in turn be influenced partly by genetic factors (Despres 
et al. 1988). 
The influence of exercise intensity on lipoprotein concentration remains 
controversial and has not been researched into as extensively as some other 
areas. Gaesser and Rich (1984) found no differences in the effects of high (80-
85% of V02max) or low (45% of V02max) intensity exercise on blood lipids 
over an 18 week training period, neither treatment was effective in elevating 
HDL-C levels significantly. In contrast, Stein and colleagues (1990) found 
cycling at 75% of maximal heart rate to be optimal for elevating HDL-C 
compared to cycling at 65% and 85% of maximal heart rate. A limitation to this 
study, however, was the fact that the group training at 75% of maximal heart 
rate had the lowest concentrations of HDL-C to begin with. To add to this 
confusion Stubbe and associates (1983) found a significant negative 
correlation between changes in HDL-C and training intensity (expressed as a 
percentage of maximal pulse) albeit a weak one. There is inadequate 
information then for the prescription of an optimal training intensity but it is 
clear that both high intensity exercise i.e. running (Wood et al. 1985) and low 
intensity exercise such as walking (Hardman and Hudson, 1991) can 
stimulate increases in HDL-C. 
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2.5.4 Exercise, trlglycerldes, chylomicrons and very low density 
lipoprotein cholesterol 
Both cross-sectional and longitudinal studies have usually reported lower 
values of plasma triglycerides for endurance trained subjects as compared to 
sedentary controls (Giada et al. 1988; Moore et al. 1983; Northcote et al. 1988; 
Sady et al. 1988; Thompson et al. 1988; Weintraub et al. 1989). This lower 
triglyceride concentration is usually mirrored by lower plasma concentrations 
of VLDL since it is these particles which carry the bulk of triglyceride in the 
body in the fasted state (Haskell, 1986). 
The effect of exercise on chylomicrons has to be studied in the postprandial 
state since the half-life of chylomicron triglyceride is less than five minutes. 
After consumption of a high fat meal endurance trained subjects usually 
exhibit lower levels of chylomicrons than untrained controls (Cohen et al. 
1989; Weintraub et al. 1989). This is due to a decrease in chylomicron 
triglyceride half-life mediated partly by a reduction in the fasting serum 
triglyceride pool size and partly by a direct effect of chronic exercise on the 
triglyceride removal system (Cohen et al. 1989). 
2.5.5 Exercise and Apoprotelns 
Relatively few studies have examined the influence of exercise on apoproteins 
although their measurement has become more common recently. Attention 
has focused primarily on apoproteins A and B due to their relationships with 
HDL-C and LDL-C respectively and the hypothesis that apoproteins A-I and B 
may provide a better indication of CHD risk than either HDL-C or LDL-C 
(Durrington, 1989). 
Cross-sectional studies which have measured apoproteins A-I and A-II usually 
find increased concentrations in those who are physically active (Herbert et al. 
1984; Nagao et al. 1988; Sady et al. 1988; Thompson et al. 1983) although 
this is not always the case (Giada et al. 1988). Moreover, total inactivity is 
related to decreased concentrations of Apo A-I (Nikkila et al. 1980). The 
results from longitudinal studies are much less consistent and although some 
have shown increases in Apo A-I and/or Apo A-II after a period of training 
(Kiens et al. 1980; Mendoza et al. 1991; Stubbe et al. 1983) many others have 
not (Despres et al. 1990; Hespel et al. 1988a; litis et al. 1984; Marti et al. 1990; 
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Thompson et al. 1988; Weintraub et al. 1989; Wood et al. 1983). On the basis 
of these findings Despres and colleagues (1990) suggest that exercise may 
lead to 00". an increase in HDL content rather than HDL particle number" but 
this suggestion is not consistent with the findings from cross-sectional studies. 
80th observational and longitudinal studies have reported lower levels of Apo 
8 in physically active subjects as compared to control subjects (Despres et al. 
1990; Giada et al. 1988) but more frequently Apo 8 concentrations appear to 
be unchanged by training (Despres et al. 1988; litis et al. 1984; Marti et al. 
1990; Weintraub et al. 1989; Wood et al. 1983) although Wood and 
colleagues (1983) did find a negative correlation between Apo 8 and miles 
ran per week in their one year training study. At present there is insufficient 
information to come to any firm conclusions regarding the effects of physical 
conditioning on apoproteins and this will remain the case until future well 
designed studies address this issue. 
2.5.6 Mechanisms of Influence 
The means by which endurance exercise provokes changes in plasma 
lipoproteins is not fully understood but most explanations propose that the 
enzyme lipoprotein lipase plays a central role in this process (Katan, 1990; 
Krauss, 1989; Thompson, 1990). As mentioned in the Section on lipid 
metabolism, lipoprotein lipase is the rate limiting enzyme which facilitates the 
removal of triglyceride from chylomicrons and VLDL. In this process 
cholesterol, protein and phospholipid remnants are transferred to 'nascent' 
HDL particles which have been secreated from the liver. Taskinen and Nikkila 
(1981) have demonstrated a positive correlation between the lipoprotein 
lipase activity of both adipose tissue and skeletal muscle and H DL2- C 
concentrations. It has been hypothesised, therefore, that an exercise induced 
increase in lipoprotein lipase activity leads to enhanced triglyceride 
catabolism and thus augments HDL-C production via the provision of 
additional substrate for HDL formation. 
Considerable evidence exists to support this theory. It has been demonstrated, 
for example, that the activity of lipoprotein lipase is significantly higher in 
distance runners than sedentary individuals (Herbert et al. 1984; Williams et 
al. 1986) and that lipoprotein lipase activity can be increased after a 
programme of endurance training (Peltonen et al. 1981; Thompson et al. 
1988). In addition physically active individuals have reduced concentrations of 
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triglycerides which are inversely correlated to their increased lipoprotein 
lipase activity (Sady et al. 1984). Furthermore, endurance trained subjects 
have an enhanced ability to clear an intravenous infusion of fat which is 
directly related to both their increased concentrations of HDL-C (and HDL2-C) 
and their elevated lipoprotein lipase activity (Sady et al. 1986; Sady et al. 
1988). 
More direct evidence to support the above theory has been provided by two 
recent well designed studies, one by Kiens and Lithell (1989) and the other by 
Ruys and co-workers (1989). Keins and Lithell (1989) isolated the quadriceps 
femoris muscle group in six men and trained one leg by dynamic exercise for 
eight weeks while the other leg served as a control. After training there was a 
70% greater muscle lipoprotein lipase activity as well as a significantly higher 
formation of HDL-C and HDL2-C in the trained muscle as compared to the 
untrained muscle. There was also an increase in muscle capillary density in 
the trained leg which correlated well with the increased lipoprotein lipase 
activity and provides evidence that greater muscle capillarisation increases 
the number of binding sites for the lipoprotein lipase enzyme to cleave 
triglyceride from VLDL. In addition a larger capillary density would imply a 
longer mean transit time of blood through the muscle thus increasing the 
potential for fatty acid oxidation as well as the contact time between VLDL and 
lipoprotein lipase (Kiens and Lithell, 1989). 
Ruys and co-workers (1989) examined the peripheral production of HDL-C by 
measuring the arteriovenous blood flow across the forearm muscle at rest and 
after 20 minutes of isometric exercise. Subjects were studied twice, once after 
a fast and once after a high fat meal. Exercise led to an increased production 
of HDL-C in both conditions but this was much more pronounced in the fed as 
compared to the fasted condition. By contrast, there was no peripheral 
production of HDL-C in two subjects with lipoprotein lipase deficiency. These 
findings give weight to the theory that lipoprotein lipase activity in the muscle 
capillary bed is at least in part responsible for the exercise related increase in 
HDL-C and suggest that the supply of chylomicrons and VLDL (and therefore 
triglyceride) influences the amount of HDL-C formed by lipoprotein lipase. A 
suggestion which is supported by the high correlation between HDL 
production and VLDL triglyceride degradation found during. exercise by Kiens 
and Lithell (1989). 
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Although HDL-C production may be enhanced during acute exercise there is 
evidence to suggest that the primary effect of chronic exercise is not to 
increase HDL-C synthesis but to reduce HDL-C degradation. Herbert and 
associates (1984) using radioiodinated autologous HDL have found that 
runners do not produce more HDL protein than sedentary subjects but rather 
catabolise less (the mean biologic half-life of HDL proteins was 6.2 days in the 
runners compared with 3.8 days in the sedentary men). These findings have 
been confirmed in the longitudinal training study of Thompson and colleagues 
(1988) in which the synthetic rates of apoproteins A-I and A-I! were not 
affected but the biological half-life of Apo A-II was increased. The mechanisms 
by which training might prolong HDL survival are unknown but they may relate 
to the lipid enrichment of HDL particles both during and after exercise which 
could theoretically increase the core to surface ratio and therefore retard HDL 
degradation (Thompson, 1990). 
Another possible explanation for the prolonged survival of HDL may be an 
altered activity of the enzyme hepatic lipase which is thought to be involved in 
the catabolism of HDL-C. Hepatic lipase activity has been shown to correlate 
negatively with HDL-C in runners (Sady et al. 1984) and is lower in runners 
than sedentary men (Marniemi et al. 1980; Williams et al. 1986). Moreover, the 
activity of hepatic lipase has been found to be negatively correlated with 
HDL2-C and positively correlated with HDL3-C perhaps indicating that hepatic 
lipase is involved in the conversion of HDL2-C to HDL3-C as proposed by 
Nikkila and colleagues (cited in Haskell, 1986). The reduced level of hepatic 
lipase activity associated with exercise training may thus be an explanation for 
the higher levels of HDL2-C often reported in those who are physically fit 
(Kuusi et al. 1982). 
The LCAT enzyme has also been implicated in the processes leading to 
elevated HDL-C with endurance exercise. As mentioned this enzyme 
catalyses the transfer of fatty acids in the plasma from lecithin to cholesterol 
(forming cholesterol esters) during the production of HDL-C. An enhanced 
activity of LCAT would therefore suggest an increased production of HDL-C. 
However, although some studies have demonstrated an increase in the 
activity of LCAT after both acute (Frey et al. 1991) and chronic exercise 
(Marniemi et al. 1982) other studies have failed to show any changes in LCAT 
activity with training (litis et al. 1984; Williams et al. 1990b) and thus the LCAT 
hypothesis remains controversial. 
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The means by which exercise leads to reduced levels of LDL-C are very 
poorly understood. Several mechanisms have been proposed acting 
separately or in combination with each other. These include a reduced 
synthesis of VLDL (the precursor for LDL-C) by the liver or an impaired 
conversion of VLDL remnants to LDL-C; an increased uptake of LDL-C by 
peripheral cells mediated through enhanced LDL receptor activity or an 
increase in the removal of LDL-C by the liver. To date, very little direct 
evidence is available to substantiate any of these theories (Haskell, 1986). 
2.5.7 Exercise, weight loss and changes in lipoprotelns 
There is considerable debate as to whether or not the changes in lipoproteins 
which occur during exercise operate independently from the reductions in 
body weight, or more especially the reductions in body fat, which are often 
concurrent with training. Attempts to correlate the percentage of body fat with 
HDL-C in observational studies have produced ambiguous results with some 
investigations revealing an inverse correlation between these two variables 
(Thompson et al. 1983) while others show them to be unrelated (Sady et al. 
1984). Findings from longitudinal investigations have generally been more 
consistent, however, and although exercise results in an increase in HDL-C 
without changing body fat in some studies (e.g. Hardman and Hudson, 1991; 
Stein et al. 1990; Thompson et al. 1988) more often elevations in HDL-C occur 
concomitantly with reductions in body weightlbody fat (Despres et al. 1990; 
Hespel et al. 1988b; Marti et al. 1990; Sasaki et al. 1987; Wood et al. 1985). 
Williams and co-workers (1983) investigated the question of whether or not 
weight loss is responsible for the exercise induced increase in HDL-C in their 
one year training study. Although the changes in HDL-C were not significantly 
different between the exercise and control group, within the exercise group 
one year changes in HDL-C were strongly correlated with body weight 
changes. Interestingly, however, comparison between the exercise and 
control groups by regression analysis revealed that equivalent amounts of 
weight change corresponded to a significantly greater change in HDL-C in the 
exercisers than the controls. Williams and colleagues (1983) concluded that 
the metabolic consequences of an exercise induced weight loss are different 
from the consequences of weight change in the sedentary state. This seems 
plausible since in the first instance weight loss is associated with an increased 
energy turnover while in the second case energy turnover is decreased. 
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However, further studies by this group have provided conflicting results. For 
example, in one study fat loss caused by either diet or exercise was equally 
effective in elevating HDL-C concentrations (Wood et al. 1988). In a more 
recent study, however, a dietary induced weight loss was not effective in 
elevating HDL-C concentration whereas weight loss elicited by a combination 
of diet and exercise did significantly increase HDL-C concentration (Wood et 
al. 1991). 
Williams (1990) has postulated that weight loss is an essential factor in the 
exercise provoked increase in HDL-C and that level of HDL-C is more strongly 
related to the amount of weight lost than the actual leanness achieved. To 
support his argument Williams (1990) cites the following evidence. Firstly, 
although it is true that lipoprotein lipase activity is increased in runners it is the 
adipose tissue lipoprotein lipase activity which predominates accounting for 
79% of the whole body lipoprotein lipase activity (Nikkila et al. 1978). 
Therefore, greater triglyceride hydrolysis is likely to occur in adipose tissue 
than skeletal muscle. Moreover, Savard and co-workers (1985) have shown 
that adipose tissue lipoprotein lipase activity is negatively correlated with fat 
cell diameter in runners and Tremblay and colleagues (1984) found that 
runners who were fat before running had smaller fat cells than those who were 
lean initially. Therefore, those people who lose the most weight during an 
exercise programme are likely to have the smallest fat cells, the highest 
adipose tissue lipoprotein lipase activity and thus the greatest concentrations 
of HDL-C (Williams, 1990). 
Despite the evidence cited above it is not certain that weight loss is the means 
by which exercise exerts a beneficial effect on lipoproteins. Changes in body 
composition are an integral part of exercise conditioning and the extent of 
these changes may be a reflection of the effectiveness of the training 
programme while being merely coincidental to the changes in lipoprotein 
concentration. It has already been stated, for example, that at least some of the 
increase in HDL-C found with exercise is due to training induced adaptations 
in skeletal muscle tissue (Kiens and Lithell, 1989). It is likely, however, that 
both exercise and weight loss have independent effects which are most 
pronounced when operating in conjunction with one another. This proposal is 
supported by Tran and Weltman's (1985) 'meta-analysis' of 95 studies which 
measured changes in lipoprotein levels in response to exercise training. Their 
findings indicated that although changes in total cholesterol and LDL-C did 
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occur in the absence of any effect on body weight, reductions were greatest 
when exercise training was combined with weight loss. 
Before concluding this discussion it is worth mentioning that there are several 
advantages to a weight loss caused through exercise as compared to a weight 
loss elicited by diet alone. Firstly, an exercise induced weight loss is not 
associated with the decrease in lean body mass which often accompanies a 
weight loss induced by diet (Wood et al. 1988). Secondly, an exercise induced 
weight loss has been shown to cause a greater increase in HDL2-C than a 
weight loss induced by diet alone (Williams et al. 1990a). Finally, there is 
evidence that changes in body fat are more easily achieved and maintained 
when exercise forms part of a weight loss programme (Martin and Dubbert, 
1982). 
2.5.8 Conclusion 
Sportsmen and women performing large amounts of endurance exercise 
exhibit plasma lipoprotein profiles which denote a low risk of developing CHD. 
When previously inactive individuals undertake a programme of regular 
endurance type exercise they often demonstrate changes in their lipoprotein 
profiles which resemble more closely the lipoprotein profiles of elite, 
endurance trained, sportsmen and women. These changes, however, are not 
as great as those seen in elite athletes which may be due to the fact that the 
volume of training performed by such athletes is much greater than that which 
most people can, or are willing to, undertake. 
In all probability the amount of exercise required to provoke changes in 
lipoprotein profiles will vary tremendously depending on subjects' initial 
lipoprotein concentrations and perhaps also their initial level of fitness. As a 
generalisation, however, an exercise level equivalent to 10 miles of jogging 
per week appears to be enough to elicit changes in most previously sedentary 
people (Superko, 1991). This may be related to the amount of energy 
expended in exercise rather than the actual intensity of exercise since chronic 
low intensity activity is also associated with improved lipoprotein profiles 
(Cook et al. 1986). 
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The most consistent effects of exercise are related to alterations in the 
concentration of HDL-C rather than total cholesterol or LDL-C and elevations 
of up to 27% in HDL-C have been reported (Hardman and Hudson, 1991). 
Changes of this nature could have a profound influence on CHD mortality 
since a 1 % increase in HDL-C is associated with a 1.5 to 2% reduction in CHD 
rates (Rifkind, 1990). 
55 
1 ...... ________________________________ __ 
2.6 Exercise and other selected coronary heart disease risk 
factors 
2.6.1 Blood pressure 
Elevated blood pressure is one of the major risk factors for CHD as 
demonstrated by the Framingham study (Kannel et al. 1980). Furthermore, 
Paffenbarger and co-workers (1986) found that hypertensive men had nearly 
twice the risk of death (from all causes) of normotensive men. The link 
between exercise and blood pressure has been clearly established in 
epidemiological studies such as that of Paffenbarger and colleagues (1983) 
which showed that men who did not engage in vigorous sports play were at a 
35% higher risk of suffering from hypertension than those who did. Moreover, 
Blair and co-workers (1984) have demonstrated that men and women with low 
levels of cardiorespiratory fitness have a 52% greater risk of developing 
hypertension than those with high levels of cardiorespiratory fitness. 
Since the findings from epidemiological studies cannot rule out a self-
selection effect a number of longitudinal studies have been conducted to 
assess the potential of exercise to independently influence blood pressure in 
hypertensive subjects (systolic blood pressure> 140 mm Hg and/or diastolic 
blood pressure >90 mm Hg). In a review of these studies Hagberg and Seals 
(1986) concluded that exercise training is capable of eliciting approximately 
10 mm Hg reductions in both systolic and diastolic blood pressure although 
they point out that many studies suffer from design deficiencies, the major one 
being the absence of a control group. Tipton has also reviewed the 
effectiveness of exercise as a means of lowering blood pressure and he 
concluded that training results in 5 to 25 mm Hg reductions in systolic blood 
pressure and 3 to 15 mm Hg reductions in diastolic blood pressure. Moreover, 
Tipton noted that the most profound reductions in blood pressure occur in 
older subjects who have followed prolonged training programmes (Tipton, 
1991; Tipton, 1984). 
Recently the ability of exercise to influence hypertension has been confirmed 
in many training studies varying in length from ten weeks to nine months all of 
which used a control group (Hagberg et al. 1989; Kelemen et al. 1990; Martin 
et al. 1990; Sasaki et al. 1989; Sommers et al. 1991; Tanabe et al. 1988). In 
most of these studies there were no changes in body weight/body fat or other 
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confounding variables supporting an independent blood pressure lowering 
effect of endurance exercise. Moreover, on the basis of findings such as these 
increased physical activity is now recommended by the World Hypertension 
League (1991) as a therapeutic treatment for hypertensive patients. 
As might be expected the influence of exercise on blood pressure in 
normotensive adults is not as pronounced as it is in hypertensive subjects. 
Nevertheless, observational studies usually reveal a difference in blood 
pressure of up to 5 mm Hg between the most and least physically active 
subjects (Fagard, 1985). Furthermore, Tipton (1984) in his extensive review 
concluded that endurance training is likely to lower resting blood pressure 
slightly in normotensive subjects if their initial pressures are in excess of 
125/85 mm Hg. Recently, studies by Gilders and colleagues (1989) and Verity 
and colleagues (1990) have failed to demonstrate any significant reduction in 
the blood pressure of normotensive subjects who completed four months and 
five years of endurance training respectively. Since blood pressure was 
initially below 125/85 mm Hg in these subjects, however, the conclusions of 
Tipton (1984) would seem to be confirmed. 
The most beneficial type of activity for reducing blood pressure appears to be 
continuous exercise involving large muscle groups such as in running, 
swimming and cycling although there is some evidence that weight training 
may also be beneficial (Hagberg and Seals, 1986). The frequency of exercise 
required to reduce blood pressure has been studied and cycling performed 
seven days per week has been found to produce more dramatic drops in 
blood pressure than cycling performed only three days per week (Nelson et al. 
1986). However, as Jennings and co-workers (1989) point out about three-
quarters of the antihypertensive effects of exercise in this study occurred at the 
lower level of activity and this supported their conclusion that the effects of 
exercise on blood pressure are maximal with fairly moderate levels of activity. 
It seems that the intensity of exercise does not need to be severe to influence 
blood pressure. Roman and colleagues (1981) have reported similar 
reductions in blood pressure after one year of either high (80% of V02max) or 
low (50% of V02max) intensity training despite the fact that the high intensity 
training increased the subjects V02max by twice as much as the low intensity 
training. More recently, Hagberg co-workers (1989) have shown that exercise 
performed at 53% of V02max can produce greater reductions in blood 
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pressure than exercise performed at 73% of V02max. In this study V02max 
increased by 28% in the high intensity exercise group but did not change in 
the low intensity group. Findings such as these have led Gordon and 
colleagues (1990) in a recent review to conclude that changes in blood 
pressure do not parallel increases in maximal oxygen uptake and that 
moderate intensity exercise may be more effective in controlling hypertension 
than high intensity exercise. 
The mechanisms by which exercise training might lead to a reduction in blood 
pressure are not well understood. However, since mean blood pressure is the 
product of cardiac output and total peripheral resistance (Astrand and Rodahl, 
1986) one or both of these two variables must be reduced if blood pressure is 
to be lowered. Resting heart rate is often decreased after a period of training 
and therefore it has been proposed that this underlies the changes in blood 
pressure accompanying exercise because if stroke volume and total 
peripheral resistance are unchanged or increase less than the reduction in 
heart rate, blood pressure must be lowered (Hagberg and Seals, 1986). 
Another training adaptation which could be responsible for the 
antihypertensive effect of exercise is the often reported decrease in resting 
concentrations of plasma noradrenaline which would cause a reduction in 
sympathetic nervous system activity and thus a decrease in the total 
peripheral resistance (Jennings et al. 1989). Since the hypertensive state is 
characterised in most cases by systemic arteriolar constriction with an 
increase in systemic vascular resistance while cardiac output remains 
unchanged (Gorlin, 1991) this theory seems more credible. However, it is 
possible that the mechanisms underlying a reduction of blood pressure in the 
hypertensive state are different from those which underlie a reduction of blood 
pressure in the normotensive state. 
Other postulated mechanisms for an exercise induced decrease in blood 
pressure include a resetting of baroreceptors, an altered distribution of blood 
volume and changes in the renin-angiotensin axis although evidence to 
support any of these theories is limited (Gordon et al. 1990). Moreover, it has 
also been shown that a single bout of aerobic exercise leads to reductions in 
blood pressure for one to three hours following activity in hypertensive 
subjects (Hagberg et al. 1987; Kaufman et al. 1987). Therefore, it is possible 
that the reduction in blood pressure associated with regular participation in 
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endurance exercise is due to the cumulative effects of single exercise bouts 
rather than long term adaptations to exercise training. 
In conclusion, exercise can be of benefit in reducing blood pressure in 
hypertensive patients although it should not be regarded as a panacea. 
Exercise is also capable of eliciting small reductions in blood pressure in 
normotensive subjects and can be considered an effective means of offsetting 
the elevations in blood pressure which occur during the ageing process 
(Astrand and Rodahl, 1986). Moreover, the significance of these reductions 
should not be underestimated since Paffenbarger and colleagues (1986) have 
found that amongst normotensive persons mortality rates are lower for those 
whose systolic blood pressure is below 130 mm Hg than it is for those with 
higher readings. The mechanisms by which exercise leads to reductions in 
blood pressure are not well understood and evidence to support the current 
theories is limited. Finally, it seems that the frequency and intensity of exercise 
need only be moderate to exert maximal effects on blood pressure although 
information regarding the ability of low level exercise programmes such as 
walking to influence blood pressure is limited. 
2.6.2 Fibrinogen 
Fibrinogen is a glycoprotein which plays an essential role in haemostasis. 
This complex process is initiated when the collagen fibres of a damaged blood 
vessel become exposed thus promoting the formation of a platelet plug. At the 
same time the coagulation cascade is initiated by the activation of factor XII 
(intrinsic clotting pathway) and/or factor VII (extrinsic clotting pathway) which 
culminates, after many intermediate steps, in the conversion of soluble 
fibrinogen circulating in the blood into insoluble fibrin. This conversion is 
facilitated by the enzymatic action of thrombin and serves to support and 
reinforce the platelet plug by solidifying the blood in the area of the wound. 
Clot formation is halted via the action of prostacyclin (also termed 
prostaglandin 12, or PGI2), protein C and antithrombin C. After the damaged 
vessel has been repaired the clot is dissolved when plasminogen, stimulated 
by activators such as t-PA (tissue plasminogen activator), is converted to 
plasmin which digests fibrin in a process termed fibrinolysis (Vander, 
Sherman and Luciano, 1990; Witt, 1985). 
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The fact that fibrinogen may be implicated in the development of CHD has 
been revealed in many epidemiological studies which were published in the 
1980s. The first of these was the Northwick Park Heart Study (Meade et al. 
1980) which examined 1511 white men aged between 40 and 64 over a six 
year period and found that high levels of fibrinogen at entry to the study were 
strongly related to the incidence of CHD. Furthermore, this relationship was 
even stronger than the relationship between cholesterol and CHD. The 
findings of the Northwick Park Heart Study were subsequently confirmed by 
the Goteborg Study (Wilhelmsen et al. 1984), the Leigh Study (Stone and 
Thorpe, 1985) and the Framingham Study (Kannel et al. 1987) all of which 
found fibrinogen to be a positive risk factor for CHD. Kannel and colleagues 
(1987) concluded that "the impact of fibrinogen value ... on cardiovascular 
disease (is) comparable with the major risk factors ... (and) should be added to 
the cardiovascular risk profile". More recent findings from angiographic 
(Handa et al. 1989), case control (Qizilbash et al. 1991) and epidemiological 
studies (Varnell et al. 1991) support this conclusion. 
Both environmental and genetic factors are probably responsible for causing 
elevated plasma fibrinogen concentrations (Ernst, 1990; Meade, 1987). 
Smoking is the leading environmental determinant of fibrinogen 
concentrations as demonstrated by the Framingham Study where there was a 
dose-dependent relationship between the number of cigarettes smoked per 
day and the age adjusted fibrinogen level in both men and women (Kannel et 
al. 1987). Indeed it is possible that a large portion of the association between 
smoking and CHD could be accounted for by the increased fibrinogen 
concentrations found in smokers (Meade, 1987). 
The means by which elevated fibrinogen levels may predispose individuals to 
CHD are complex and many mechanisms have been proposed (see Cook 
and Ubben, 1990). An obvious possibility is the increased chance of clot 
formation in the coronary vessels associated with a hypercoagulable state. 
However, fibrinogen may also be involved in the early stages of 
atherosclerotic plaque formation since fibrinogen degradation products have 
been found in atherosclerotic lesions and the amount of fibrin depOSition 
correlates linearly with plasma fibrinogen concentrations. Fibrin in turn may 
aid in the migration of cholesterol to atherosclerotic plaques by providing an 
absorptive surface for LDL-C accumulation. Handa and colleagues (1989) 
reported a strong association between plasma fibrinogen and serum 
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cholesterol concentration and it is possible that fibrinogen and LDL-C act 
synergistically in the development of atherosclerosis. Increased levels of 
fibrinogen in vitro have also been shown to elevate measures of platelet 
aggregability. Moreover, aside from erythrocyte concentration, fibrinogen is 
the major determinant of blood viscosity and increased blood viscosity 
characterises many cardiovascular disorders (Cook and Ubben, 1990; Ernst, 
1990). 
There is conflicting evidence as to the interaction between exercise, 
coagulation and fibrinolysis (see Bourey and Santoro, 1988). This is almost 
certainly related to the complex nature of blood haemostasis and the many 
factors involved in both coagulation and fibrinolysis. Acute exercise has been 
shown to cause both an increase (Arai et al. 1990) and decrease (Osterud et 
al. 1989) in plasma fibrinogen levels. The significance of any changes in 
fibrinogen concentration after acute exercise cannot be considered in 
isolation, however, since both coagulability and fibrinolysis are enhanced as a 
result of acute exercise (Arai et al. 1990). These changes in coagulability and 
fibrinolysis after acute exercise are related to increases in factor VIII activity 
and t-PA activity respectively (Bourey and Santoro, 1988). Information 
regarding the long term effects of exercise on fibrinogen concentrations is 
limited but it has been found that endurance trained individuals have lower 
concentrations of fibrinogen and lower plasma viscosity values than sedentary 
controls (Ernst, 1990). 
In summary then, elevated fibrinogen concentrations promote a state of 
hypercoagulability and thus may contribute to the pathological and clinical 
onset of CHD. Cross-sectional studies have revealed lower concentrations of 
fibrinogen in endurance trained individuals and acute exercise has been 
shown to influence both coagulation and fibrinolysis. However, the effect of 
chronic exercise on fibrinogen concentration in previously sedentary subjects 
has yet to be determined. 
2.6.3 Pulmonary Function 
The relationship between pulmonary function and CHD has been examined in 
a number of large epidemiological studies including the Framingham Study 
(Kannel et al. 1983), the Seven Countries Study (Keys et al. 1972), the 
Honolulu Heart Programme (Marcus et al. 1989), the Gothenburg Study in 
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Sweden (Persson et al. 1986) and the British Regional Heart Study (Cook and 
Shaper. 1988). All of these studies have shown that impairments in forced vital 
capacity (FVC) and/or forced expiratory volume in one second (FEV1) are 
associated with an increased risk of developing CHD. Moreover. impaired 
pulmonary function is also predictive of an elevated risk for myocardial 
infarction (Friedman et al. 1976). subsequent development of hypertension 
(Selby et al. 1990; Sparrow et al. 1988) and overall mortality (Beaty et al. 
1982; Krzyzanowski and Wysocki. 1986). 
There is no clear cut explanation for the link between pulmonary function and 
cardiovascular morbidity and mortality but a number of theories have been 
advanced. It has been suggested. for example. that a decreased vital capacity 
is simply reflective of occult or undiagnosed heart disease. However. Weiss 
(1991) argues that this is unlikely because in the above studies there is no 
other initial evidence for coronary disease in the subjects who subsequently 
go on to develop it. Another hypothesis is that cigarette smoking. which is a 
common risk factor for both decreased lung function and CHD. explains the 
link between the two. However. although this appears to be true in some 
studies (Keys et al. 1972; Marcus et al. 1989). more often it does not seem to 
be the case (Ashley et al. 1975; Beaty et al. 1982; Cook and Shaper. 1988; 
Friedman et al. 1976; Krzyzanowski and Wysocki. 1986; Persson et al. 1986). 
Other explanations for the link between reduced lung function and CHD centre 
on the associations between lung function and various established risk factors 
for CHD including exercise. Kannel and colleagues (1983). for example. 
suggest that FVC may be a measure of "overall vigour and general health". 
This suggestion is based on the fact that the correlation between FVC and 
handgrip strength in the Framingham study was stronger than the correlations 
between FVC and the other cardiovascular risk factors which they examined. 
More recently. Higgins and colleagues (1991). examining data from the 
CARDIA Study (Coronary Artery Risk Development in Young Adults) found 
that height adjusted FEVl (FEV1/Ht2) was correlated positively with a history of 
strenuous physical activity and with the duration of exercise on a treadmill. 
Height adjusted FEVl also correlated positively with HDL-C and negatively 
with smoking. triglycerides and skinfold thicknesses in this study. The authors 
concluded that the above associations may well explain the link between 
pulmonary function and heart disease. 
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If physical activity does partly explain the link between CHD and pulmonary 
function it is not necessarily a causative link. Pulmonary function is 
predominantly determined by factors such as age, sex and body size, 
especially height. Measures of lung function have not been shown to be of any 
great value in predicting fitness or exercise performance in healthy individuals 
(McArdle et al. 1981). Moreover, elite athletes often have lung volumes which 
are normal for their age and height (Kaufmann et al. 1974; Ness et al. 1974) 
and although larger than normal lung volumes have been reported in some 
groups of physically active people (Newman et al. 1961) these are generally 
attributed to differences in genetic endowment (Keys et al. 1972; McArdle et al. 
1981 ). 
In conclusion, reduced lung function is now an established risk factor for heart 
disease. The reasons for this link are not clear but are most likely related to the 
association between lung function and other cardiovascular risk factors 
including perhaps exercise. Whether these associations are coincidental to 
the development of heart disease or are causatively involved remains to be 
determined. 
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2.7 Adaptations to endurance training 
2.7.1 Introduction 
in previous Sections of this Chapter the epidemiological evidence linking 
exercise and CHD has been discussed. The literature relating to the influence 
of exercise on lipid and lipoprotein metabolism has been reviewed and the 
effects of exercise on other selected risk factors for CHD including blood 
pressure, fibrinogen and pulmonary function has been investigated. In each 
case there has been some implication that regular exercise may be of value in 
reducing CHD risk. Moreover, in each instance, the evidence cited concerns 
primarily endurance type exercise involving large muscle groups in sustained 
periods of physical activity. In the final Section of this Chapter the 
physiological and metabolic adaptations which result from a period of 
endurance training are discussed. This information could provide clues as to 
the possible mechanisms, direct or indirect, by which exercise may influence 
CHD. 
Endurance training causes many adaptations to take place within the body 
which collectively result in an enhanced ability to perform both maximal and 
submaximal exercise. V02max is the most universally applied measurement 
which has been employed to assess training induced improvements in fitness 
and an increase in V02max after training has been reported in numerous 
studies. Perhaps the most explicit demonstration of the effects of physical 
activity on V02max is provided by the classical bed rest study which was 
devised by Saltin and colleagues (1968). In this study V02max was reduced 
in all five subjects after a three week period of total inactivity. Subsequent to 
this, post bed rest V02max values were enhanced by up to 126% during a 50 
day training programme. More often, however, the increase in V02max after a 
period of training is in the order of 5 to 20% (Astrand and Rodahl, 1986). 
An elevation in V02max will contribute to an enhanced capacity for maximal 
exercise since there is a strong linear relationship between oxygen uptake 
and work rate. In addition to increased oxygen uptakes, however, trained 
individuals are able to exercise at higher relative intensities i.e. higher 
percentages of their individual V02max and can maintain a given percentage 
of their V02max for longer than their less active counterparts (Sjodin and 
Svedenhag, 1985). This ability is reflected in a reduced blood lactate 
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concentration at the same relative and absolute submaximal exercise intensity 
in trained persons (Hurley et al. 1984; Seals et al. 1984b): Also heart rate is 
lower in trained subjects as compared to sedentary subjects at any given 
absolute submaximal exercise intensity (Astrand and Rodahl, 1986). As a 
result of these changes there is a reduced disturbance in the homeostasis of 
the body at any given submaximal exercise intensity in the trained individual 
as compared to the untrained individual and thus the 'stressfulness' of 
exercise is decreased. 
The adaptations responsible for eliciting these changes may be broadly 
classified into cardiovascular and metabolic adaptations. The extent of these 
adaptations will obviously depend on many factors including the mode, 
duration, frequency and intensity of exercise, the period of time over which the 
training programme is conducted, the initial level of fitness possessed by the 
subject and probably also genetic factors. 
2.7.2 Cardiovascular adaptations to endurance training 
Training induced adaptations in the cardiovascular system will result in an 
improvement in oxygen transporting capacity and therefore enhance the 
delivery of oxygen to the working muscles. There is strong evidence that 
cardiovascular rather than respiratory or metabolic factors limit oxygen uptake 
(see Saltin and Rowell, 1980) during whole body exercise and therefore the 
cardiovascular adaptations which occur as a result of training can be 
quantified to some extent by measuring V02max. According to the Fick 
principle, V02max is the product of cardiac output multiplied by the 
arteriovenous oxygen difference ((a-v) 02 difference) and thus for V02max to 
increase one or both of these factors must be enhanced. 
Since maximal (a-v) 02 difference changes little after the early stages of 
training, cardiac output is the most important factor dictating changes in 
V02max (Brooks and Fahey, 1984) and thus there is a strong relationship 
between these two variables. Elite endurance athletes are able to generate 
cardiac outputs of around 40 I.min-l compared to 20 I.min-1 in sedentary 
individuals (McArdle et al. 1981). Indeed Astrand and Rodahl (1986) 
calculated that a cardiac output of around 48.4 I.min-1 was possible in one 
individual who had a V02max of 7.4 I.min-l. "Both an intensive training and 
superb natural endowment (would) contribute to ... (this) remarkable circulatory 
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capacity" (Astrand and Rodahl, 1986). Maximal heart rate is unaffected or 
slightly lowered by endurance training thus the larger cardiac outputs 
exhibited by elite athletes result exclusively from an increase in maximal 
stroke volume (McArdle et al. 1981). Both myocardial and extramyocardial 
adaptations combine to increase stroke volume. 
The effects of exercise on heart size have been examined using 
echocardiography. Peronnet and co-workers (1981) reviewed a number of 
these studies and they concluded that endurance trained individuals generally 
have larger heart volumes than their sedentary counterparts while similar 
although not as profound results have been attained from longitudinal training 
studies. These greater heart volumes are primarily due to increases in the left 
ventricular end diastolic volume since wall thickness does not change 
appreciably with endurance training. This is in contrast to the myocardial 
adaptations occurring as a result of strength training which are characterised 
by an increase in wall thickness without any change in ventricular volume 
(Peronnet et ai, 1981). Whether or not there is any change in the inherent 
contractile ability of the heart remains controversial but seems unlikely 
(Blomqvist and Saltin, 1983). 
The mechanisms responsible for a post-training increase in the end diastoli9 
volume have been reviewed by Blomqvist and Saltin (1983). One possibility is 
that the enlarged end diastolic volume could simply be related to an increased 
ventricular dilation caused by an exercise induced bradycardia. At least some 
of the increase in end diastolic volume, however, appears to be due to a true 
increase in muscle mass since training has been shown to result in an 
elevated heart-weightlbody-weight ratio. Moreover, the cardiac hypertrophy 
consonant with training is widespread since left atrial and right ventricular 
dimensions are also consistently increased in subjects with left ventricular 
hypertrophy. Accompanying the larger cardiac dimensions which result from 
physical conditioning, experimental evidence in animals has revealed that 
exercise training results in an increase in the size of the coronary vascular 
bed, involving both capillaries and larger vessels. This will obviously improve 
the oxygen supply to the myocardium thus facilitating its enhanced pumping 
ability (Blomqvist and Saltin, 1983). 
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In addition to a larger heart size other factors are also related to the elevated 
stroke volume including an increased preload and/or a decreased afterload. 
Endurance training causes an increase in plasma volume and to a lesser 
extent red blood cell volume which together result in approximately an eight 
per cent increase in total blood volume (Lamb, 1984). It is possible that this 
increase in blood volume could enhance the venous return and thus lead to 
an increase in the end diastolic volume (preload). This in turn would stretch 
the myocardium and cause a more powerful ejection stroke in accordance 
with Starling's law of the heart. As a result the normal stroke volume would be 
discharged as well as the extra blood which entered the ventrical and 
stretched the myocardium. There is evidence to support this theory from 
studies in which infusions of 'plasma expanders' or whole blood have resulted 
in an increase in both stroke volume and cardiac output (Kanstrup and 
Ekblom, 1982; Spriet et al. 1980). 
A decrease in the systemic resistance (also termed total peripheral resistance) 
to ventricular filling (afterload) must also be involved in the increased stroke 
volume otherwise the effects of an enhanced heart size and end diastolic 
volume would largely be negated. The reduced afterload may be caused to 
some extent by a more extensive capiliarisation of skeletal muscle but more 
important quantitatively is a reduction in the arteriolar resistance. This occurs 
predominantly in the arterioles supplying the working skeletal muscle and is 
caused by a regulatory vasodilation (Vander, Sherman and Luciano, 1990). 
The mechanisms behind this regulation are poorly understood but it is likely 
that vasodilation is mediated through skeletal muscle receptors and/or 
changes in the metabolic state of the muscle. 
The increase in stroke volume with training is mirrored by a decrease in heart 
rate both at rest and during submaximal exercise. Thus, cardiac output 
remains unchanged at a given submaximal exercise intensity after training. 
The reduced heart rate in the trained individual may be a consequence of an 
elevated vagal activity and a reduced sympathetic activity or it could simply be 
caused by the increase in stroke volume. Whatever the mechanism a 
decreased heart rate will reduce the energy requirement and oxygen demand 
of the heart and therefore improve its economy (Astrand and Rodahl, 1986). 
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As alluded to earlier, endurance training enhances the capillary density of 
skeletal muscle. This was clearly demonstrated by Ingjer (1979) who found 
that the number of capillaries per muscle fibre increased from 1.39 pre-training 
to 1.79 post-training. This amounted to a 28.8% increase over a 24 week 
training period. An enhanced capillary density will have the effect of 
increasing the capillary blood volume and thus the mean transit time of blood 
through the capillaries (since the determinant of mean transit time is capillary 
blood volume divided by the rate of blood flow through the capillaries). In 
addition to the increase in mean transit time there will also be a greater 
capillary surface area and taken together these two factors will promote a 
more complete exchange of gases, substrate and metabolites between the 
blood and muscles thus allowing a high cardiac output to be maintained 
without compromising the (a-v) 02 difference. 
In summary then the cardiovascular adaptations to exercise result in an 
increase in maximal stroke volume and therefore maximal cardiac output. 
Heart rate is reduced at a given submaximal exercise intensity thus reducing 
myocardial oxygen demand and improving the economy of the heart muscle. 
There is also an increase in the capillary density of skeletal muscle and a 
decrease in total peripheral resistance which facilitates blood flow to the 
working muscles and therefore oxygen delivery. Collectively these factors will 
result in an increase in oxygen uptake and the ability td perform maximal 
exercise. 
2.7.3 Metabolic adaptations to endurance training 
The alterations in skeletal muscle metabolism which occur as a consequence 
of training have been reviewed extensively by Saltin and Gollnick (1983). 
Major changes include an increase in the number and size of mitochondria 
and an enhanced activity of various enzymes in the mitochondria including 
those involved in the citric acid cycle and electron transfer chain and the 
enzyme beta-hydro-acyl-CoA-dehydrogenase which is involved in the beta-
oxidation of free fatty acids. As a result of these changes the oxidative capacity 
of skeletal muscle is improved and there is a greater contribution of fat to the 
total energy requirement at a given submaximal exercise intensity (Matoba 
and Gollnick, 1984). 
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Unlike the training induced adaptations in the cardiovascular system changes 
in the metabolic capacity of skeletal muscle do not appear to cause an 
elevation in V02max but rather serve to enhance endurance performance 
during submaximal exercise (Saltin and Rowell, 1980). This is due largely to 
the increased concentrations of the enzymes involved in fat metabolism which 
have the effect of increasing the reaction velocity (Vmax) of fat metabolism at a 
given substrate concentration. The iatty acid flux through the oxidative 
pathways is thus enhanced and the Embden-Meyerhof pathway inhibited 
(Gollnick and Saltin, 1982). The result is a greater reliance on fat for energy 
supply at a given submaximal exercise intensity which reduces the 
contribution of muscle glycogen. Since there is a close correspondence 
between the termination of exercise due to fatigue and the depletion of 
glycogen within the working muscles during endurance activity, a sparing of 
muscle glycogen will have the effect of prolonging exercise performance 
(Coyle and Coggan, 1984). 
The precise mechanism by which an increase in the oxidative capacity of 
skeletal muscle might facilitate submaximal exercise performance remains 
somewhat perplexing however. Although blood lactate concentration is oiten 
reduced in the trained individual at a given submaximal exercise intensity, 
suggesting an increase in the oxidative contribution to energy provision, 
oxygen uptake is usually similar in the trained and untrained state at any given 
submaximal work rate (Holloszy and Coyle, 1984). This anomaly is poorly 
addressed in literature describing the metabolic adaptations to endurance 
exercise but some authors have at1empted to explain it. 
Matoba and Gollnick (1984), for example, argue that it is a misconception to 
consider the appearance of lactate as being synonymous with an insufficiency 
of oxygen since lactate can be produced in skeletal muscle when there is not 
a shortage of oxygen. They suggest that the cause of this situation may be a 
poor control over glycogenolysis. An increase in mitochondrial size, number 
and enzyme activity aiter training then may "function as a great sink for the 
translocation of adenosine diphosphate ... out of the cytosol and into the 
mitochondria". This would reduce the concentration of adenosine diphosphate 
and perhaps also adenosine monophosphate in the cytosol therefore 
inhibiting the activation of glycogenolysis. The end result would be a reduced 
production of pyruvate and a reduced conversion of pyruvate to lactate. 
Holloszy and Coy le (1984) also subscribe to this theory and conclude that 
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exercise at a given work rate "requires a smaller percentage of the muscles' 
maximum respiratory capacity (after training) and therefore results in less 
disturbance in homeostasis". 
Brooks and Fahey (1984) propose an additional mechanism to explain the 
significance of an increase in the size and number of mitochondria. They state 
that the utilisation of oxygen in the mitochondria is associated with a liberation 
of free radicals which accumulate causing mitochondrial damage and 
ultimately fatigue. A greater size and number of mitochondria, however, will 
reduce the impact of a given accumulation of free radicals thus delaying the 
onset of fatigue. Although these hypotheses require clarification there is no 
doubt that the trained individual is able to sustain a given submaximal work 
rate with an increased utilisation of fat (as evidenced by a lower respiratory 
exchange ratio), a reduced degradation of muscle glycogen and a lower 
concentration of lactate in the blood. Together these factors enhance 
submaximal exercise capacity. 
2.7.4 Blood lactate concentration as an Indicator of adaptations 
to endurance training 
As mentioned above V02max has been the traditional measurement used to 
assess the changes in the fitness of an individual after a period of training. It 
should be apparent from the preceding discussion, however, that changes in 
V02max will not fully reflect the adaptations which occur with endurance 
training. This has been demonstrated effectively by Davies and colleagues 
(1981) who found only a 14% elevation in V02max but a 100% increase in the 
mitochondrial content of muscle and a 403% increase in endurance capacity 
after a ten week training programme in rats. Studies using human subjects 
have also found a disparity between changes in V02max and changes in 
endurance capacity after training (Hardman, 1982; Williams and Nute, 1982). 
The reason for these findings is that V02max is to a large extent genetically 
predetermined (Klissouras et al. 1973) and thus can only be enhanced to a 
limited extent under normal circumstances. In contrast, however, skeletal 
muscle has a profound ability to adapt when additional stresses are placed 
upon it and the resultant metabolic changes which occur may have a 
significant impact on endurance pertormance without altering V02max. 
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In an attempt to make a more complete assessment of the adaptations 
consequent to endurance training many physiologists are now measuring the 
concentration of lactate in the blood during submaximal exercise. The rational 
for this procedure is the belief that changes in blood lactate concentration after 
training are reflective of alterations in the oxidative capacity of skeletal muscle 
and in particular improvements in mitochondrial efficiency. In short then, blood 
lactate concentration during submaximal exercise is thought to be indicative of 
muscle respiratory (mitochondrial) activity. Moreover, submaximal blood 
lactate concentration has been shown to correlate well with endurance 
performance (Sjodin and Jacobs, 1981; Williams and Nute, 1983) and may 
provide a better indication of improvements in endurance capacity than 
V02max per se (Williams and Nute, 1986). 
The inter-relationships between exercise and lactate metabolism are 
discussed thoroughly by Brooks and Fahey (1984) and also other authors 
(Astrand and Rodahl, 1986; Lamb, 1984; McArdle et al. 1981). Although a 
detailed discussion of this subject is beyond the scope of this review a few 
points seem worth highlighting. Firstly, at physiological pH lactic acid 
dissociates virtually completely to hydrogen and lactate ions and thus the 
terms lactic acid and lactate are used synonymously. Lactic acid is a product 
of glycogenolysis and glycolysis, processes which involve the chemical 
breakdown of glycogen and glucose respectively to pyruvic acid (the terms 
glycogenolysis and glycolysis are used interchangeably). Glycolysis can occur 
both in the presence and in the absence of oxygen. When oxygen supply is 
plentiful most of the pyruvic acid derived from glycolysis enters the 
mitochondria and is ultimately oxidised in the citric acid cycle. When oxygen 
supply is limited, however, pyruvic acid is converted to lactic acid via the 
enzyme lactate dehydrogenase. Eventually, the lactic acid formed in the 
muscle passes into the blood. 
Anaerobic glycolysis provides a rapid means of supplementing the energy 
provided from aerobic metabolism and is particularly important during 
maximal or near maximal exercise but the resulting increase in lactate and 
thus hydrogen ion concentration is associated with fatigue in some cases. 
Mechanisms do exist for the removal of lactate from the blood and this has 
been studied in animals using radioisotopes (Brooks et al. 1973; Brooks and 
Gaesser, 1980). These studies have revealed that the endpoints of lactate 
metabolism are diverse but the majority of lactate is either oxidised in the citric 
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acid cycle or serves as a precursor for glucose and glycogen synthesis in the 
liver. This process is accomplished via the cori cycle and is termed 
gluconeogenesis. During heavy exercise, however, the capacity for lactate 
removal via gluconeogenesis is limited to a great extent by a reduced hepatic 
blood flow. 
Lactic acid is a dynamic metabolite then which is constantly being produced 
and removed even at rest. During light exercise the production of lactic acid 
may increase several fold without causing significant changes in the 
concentration of lactic acid in the blood due to matching increases in the rate 
of lactate removal. In heavy exercise blood lactate concentration increases to 
a greater extent but provided the removal rate is proportionally elevated a new 
steady state will eventually be attained. This indicates that lactate removal is 
concentration dependent with increased concentrations stimulating enhanced 
removal rates. If increases in lactate concentration are unchecked, however, 
then production outstrips removal and fatigue will eventually follow. One of the 
effects of training is that it enhances the removal of lactate from the blood as 
demonstrated by Donovan and Brooks (1983). 
Before concluding this discussion it is worth noting some reservations about 
the terminology frequently used in this area. Brooks and Fahey (1984) state 
that the term anaerobic glycolysis as applied to lactic acid production is 
misleading because it suggests that a lack of oxygen is responsible for the 
formation of lactate. They contend that this is not the case but that lactate 
formation depends on mitochondrial activity. Moreover, the mitochondria are 
in active competition with lactate dehydrogenase, the terminal enzyme of 
glycolysis, for pyruvate and because of the large equilibrium constant (Keq) of 
this enzyme some lactate will always be formed regardless of the presence of 
oxygen. It is of interest to note that endurance training may lead to a decrease 
in the activity of lactate dehydrogenase (Brooks and Fahey, 1984). 
2.7.5 Adaptations to walking exercise 
Most of the studies investigating the adaptations to training have examined 
relatively intense forms of exercise such as running. Moreover, the subjects 
studied have been predominantly young adult males. However, although the 
literature is comparatively sparse some studies have examined the training 
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effects of low intensity forms of exercise such as walking using older groups of 
people. 
Pollock and colleagues (1971). for example. examined the changes in 
V02max in a group of 16 middle-aged men who walked for 40 minutes four 
times a week over a 20 week period. Walking progressed from 2.5 to 3.25 
miles per session and walking speed increased from 4.3 to 4.7 miles per hour 
over the 20 week period. The average exercise heart rate increased from 132 
beats per minute at the beginning of the study to 146 beats per minute by the 
end and V02max was enhanced by 28%. This relatively large increase in 
V02max was attributed to the poor initial "fitness level" (V02max) of the 
subjects. Supporting this conclusion Porcari and co-workers (1987) have 
found that the potential of fast walking to elicit a training stimulus (exercise 
intensity >70% of maximal heart rate) is negatively related to V02max. 
Moreover. Pollock and colleagues (1975) subsequently repeated their study 
using a younger (presumably fitter) group of subjects and found that the 
increase in V02max was only 11 %. 
Since the studies of Pollock and colleagues (1971) and Pollock and 
colleagues (1975) a number of other investigations have shown that walking 
training can increase V02max in middle-aged and older individuals. In a study 
by Seals and co-workers (1984a). for example. V02max increased by 11% in 
a group of men and women (average age 63 years) after six months of low-
intensity training which included 20-30 minutes of walking (heart rate <120 
beats/min) at least three times per week (average 4.6 times per week). 
Furthermore. Jelle and associates (1988) examined the physiological 
responses of a group of previously sedentary men and women (age range 35-
53 years old) to a 12 week training programme. Subjects were required to 
walk at a pace which elicited 60% of V02max for 30 minutes three times a 
week. This programme increased the V02max of both the males and the 
females by 13.3% and 16.5% respectively. More recently still Steinhaus and 
co-workers (1990) have demonstrated that a four month training programme 
involving walking and jogging can produce beneficial changes in the V02max 
of previously sedentary men and women aged between 55 and 70 years old. 
Very little information is available regarding the mechanisms behind a walking 
induced improvement in the V02max of older individuals but Seals and 
colleagues (1984a) did address this question. Cardiac output was measured 
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during submaximal treadmill walking via a non-invasive C02 rebreathing 
method and since heart rate was also monitored they were able to calculate 
the submaximal stroke volume. Maximal cardiac output was then ascertained 
by multiplying the stroke volume during submaximal exercise by the heart rate 
recorded at V02max. The rational for this being that stroke volume is maximal 
at submaximal exercise intensities (>40% of V02max) in upright exercise. 
Finally, maximal a-v 02 difference was determined by dividing V02max by 
maximal cardiac output. The results revealed a small but significant six per 
cent increase in the estimated maximal stroke volume after six months of low 
intensity training which produced a non-significant six per cent increase in 
maximal cardiac output. The a-v 02 difference was also six per cent higher 
after training and since this was significant the authors concluded that the 
elevated V02max was primarily a consequence of the increase in maximal a-v 
02 difference. 
Aside from increases in V02max walking training has also been shown to 
provoke beneficial changes in the responses to submaximal exercise. For 
example, heart rates are reduced at a given absolute exercise intensity after 
training (Hudson et al. 1988; Jette et al. 1988). Moreover, Hardman and 
colleagues (1989b) have demonstrated lower blood lactate concentrations 
during both walking and stepping exercise after a six month training 
programme and Seals and co-workers (1984b) found that blood lactate 
concentration was reduced at the same absolute and relative exercise 
intensities after the six months of low intensity training completed by their 
subjects. In contrast to these findings Jette and co-workers (1988) did not find 
any significant change in the submaximal blood lactate concentration of their 
subjects after 12 weeks of training despite a significant increase in V02max. 
In the study by Seals and colleagues (1984b) respiratory exchange ratio (R) 
values were also lower at the same absolute work rate after training indicating 
a shift in substrate utilisation toward an increased oxidation of fat. The R 
values were similar, however., at the exercise intensities which produced a 
blood lactate concentration of 2.5 mmol.l-l before and after low intensity 
training despite the higher energy expenditures at this blood lactate 
concentration after training (18.8 ml.kg-1 min-1 before training verses 22.0 
ml.kg- 1min- 1 after training). Therefore, the calculated oxidation rate of 
carbohydrate was 16% higher after low intensity training compared with 
before training at the exercise intensity which elicited a blood lactate 
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concentration of 2.5 mmoLl-1. The authors concluded that a similar lactate 
concentration despite a greater carbohydrate oxidation after training 
suggested that a smaller proportion of the pyruvate formed during glycolysis 
was converted to lactate and a greater proportion was channelled into the 
mitochondria. This in turn suggested an increase in the oxidative capacity of 
the skeletal muscles Le. an enhanced ability of the mitochondria within the 
muscles to compete with lactate dehydrogenase for pyruvate. 
In summary then, evidence exists to show that low intensity exercise such as 
walking can result in cardiovascular and metabolic adaptations which are 
similar to those elicited by training programmes of a higher intensity. 
Moreover, although the extent of the adaptations provoked by low intensity 
exercise may not be as great as those resulting from high intensity exercise, 
low intensity training may be more beneficial for health, especially in older 
populations, because of its reduced potential to cause injury. This has been 
clearly demonstrated by Seals and co-workers (1984a) who found that the 
incidence of orthopaedic injuries was much more common and of a greater 
severity during high intensity training than during low intensity training. 
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3 GENERAL METHODS 
3.1 Informed consent 
Prior to the start of the study the subjects were made fully aware of all of the 
procedures which they would have to undertake and any potential risks which 
they might incur. All subjects were then asked to sign a statement of informed 
consent (Appendix 1). 
3.2 Oxygen uptake and carbon dioxide production 
Oxygen uptake and carbon dioxide production during exercise were 
determined from samples of expired air collected in 150 litre capacity Douglas 
bags (Harvard Equipment Ltd.). During the collection subjects wore a nose 
clip (Harvard Equipment Ltd.) and a snorkel type mouthpiece (Harvard 
Equipment Ltd.). The mouthpiece was fitted to a lightweight two-way 
respiratory valve (Jakeman and Davies, 1979) which in turn was attached to a 
1.5 metre section of wide bore (30 mm diameter) lightweight tubing (Falconia: 
Baxter, Wood house and Taylor). The tubing terminated in a two-way tap 
(Harvard Equipment Ltd.) which was used to open and close the Douglas bag. 
The oxygen content (%) of expired air was measured using a paramagnetic 
oxygen analyser (Taylor: Servomex Model 570A) while carbon dioxide 
content (%) was determined using an infra-red carbon dioxide analyser (Lira: 
Mines Safety Appliances Ltd. Model 3030). Both analysers were calibrated 
before each exercise test using certified reference gases (CryoService Ltd. 
Worcester. U.K.). All reference gases were in turn calibrated against a gold 
standard reference gas (CryoService Ltd. Worcester. U.K.). This gold standard 
reference gas was used throughout all of the testing reported in this thesis to 
ensure consistency. The volume of expired air withdrawn for analysis was 
measured using a flow meter. 
Once the oxygen and carbon dioxide analysis had been completed the 
volume of air remaining in each Douglas bag was determined by evacuation 
(Moulinex vacuum pump 237) through a Harvard dry gas meter which had 
been calibrated against a 600 litre Tissot spirometer (Collins Ltd.). The air 
temperature was measured during evacuation by a thermistor placed in the air 
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outlet pipe of the dry gas meter. The thermister was linked to a thermometer 
(Edale: type 2984, Model C). 
Finally, the measured gas volumes were corrected to standard temperature 
and pressure for a dry gas (STPD) and the volume of inspired air (VI) was then 
derived using the Haldane transformation. After this the volume of oxygen 
consumed (V02) and carbon dioxide produced (VC02) were calculated 
(Appendix 2). 
3.3 Exercise tests 
Four different exercise tests were employed in the study, three involved 
walking on a motorised treadmill (Marquette electronics inc.) which was 
calibrated before and during the study (Appendix 3) while one took place on 
the University athletics track. Each subject was familiarised with treadmill 
walking before any tests were undertaken. 
3.3.1 Submaximal, incremental treadmill test 
The purpose of this test was to determine the relationship between oxygen 
uptake and work rate during submaximal exercise for each individual. This 
information was then used to predict each subject's V02max. The test was 
sixteen minutes long and divided into four, four minute exercise periods. The 
speed of the treadmill remained constant throughout the test at either 1.34 
m.s-l or 1.56 m.s-l (3.0 or 3.5 mph) while the treadmill incline was set at 0 or 
3% to begin with and subsequently elevated by 3% at the end of each four 
minute exercise period. The speed and incline used for the treadmill test were 
determined by a subjective assessment of each individual's capability. 
Douglas bag samples of expired air were collected for the last minute of each 
four minute exercise period and heart rate was monitored continuously during 
the test via an electrocardiograph (Rigel Cardiac Monitor 302. Rigel Research, 
U.K. Ltd.) and three chest electrodes (3M UK Ltd. Type 2255). The subject's 
perceived rate of exertion (PRE) was also measured at the end of each stage 
of the test using the Borg scale (Borg, 1973). 
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The data gained from this test were used to predict V02max (ml.kg-1 min-1) via 
a method outlined by Maritz and colleagues (1961). Firstly, the average heart 
rates attained during the last minute of each of the four stages of the test were 
used as independent (X) variables and matched against the corresponding 
oxygen uptakes (dependent or Y variables) to create a simple linear 
regression equation. Then maximum heart rate was predicted via Astrand's 
(1960) equation of 210 - (0.65 x age) and used as an independent variable to 
predict the oxygen uptake at maximal heart rate. This value was taken to be 
V02max (Figure 3.1). 
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Figure 3.1 Prediction of maximal oxygen uptake from submaximal heart rate 
and oxygen uptake data using simple linear regression. 
Once V02max had been predicted a second linear regression equation was 
calculated, this time using the oxygen uptakes attained during each stage of 
the test as the independent variables and the treadmill inclines (%) at which 
these oxygen uptakes were elicited as the dependent variables. The oxygen 
consumptions which would be attained if the subject was working at 50%, 
60%, 70% and 80% of V02max were then calculated (Le. 0.5 x V02max = 
oxygen consumption at 50% of V02max etc.) and used in the regression 
equation to predict the treadmill inclines necessary to elicit these oxygen 
consumptions (Figure 3.2). These inclines were subsequently incorporated 
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into two further treadmill tests which were thus 'individualised' for each subject 
as described below. 
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Figure 3.2 Calculation of the treadmill inclines required to elicit 50%, 60%, 
70% and 80% of predicted V02max. 
There are inherent problems in estimating V02max from submaximal exercise 
data and predictions of maximal heart rate (for a discussion see Astrand and 
Rodahl, 1986: p.372-380). Errors are obviously likely to occur if predictions are 
made from regression equations when data are extrapolated outside the 
range from which they were generated. Astrand and Rodahl (1986) also note 
that the standard deviation for maximal heart rate within an age group is ±10 
b.min-1, thus V02max is bound to be underestimated in some individuals and 
overestimated in others. Moreover, emotional factors, nervousness and 
apprehension may affect heart rate during light and moderate intensity 
exercise thus resulting in erroneous predictions of V02max. 
In contrast to heart rate, oxygen uptake is usually very constant at a given 
submaximal rate of exercise. This is true even after a period of training 
although small changes may take place. In view of this it should be recognised 
that changes in predicted V02max within an individual reflect changes in heart 
rate for a given oxygen uptake. Although these changes in heart rate may 
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result from training i.e. they may be due to an increase in stoke volume, there 
is also the chance that they merely reflect reductions in the subject's level of 
anxiety. If the latter is true then this will give the false impression that the 
subject's V02max has changed when this may not in fact be the case. 
Despite the above observations it was felt that the prediction of V02max was 
justified in the present study because it would have been inappropriate to 
conduct maximal exercise tests. This was due to the nature of the subject 
group (i.e. previously sedentary, middle-aged men) and the fact that medical 
supervision was not readily available while testing was in progress. 
Furthermore, the primary purpose of predicting V02max was to ensure that the 
subsequent submaximal exercise tests were set at an appropriate level for 
each individual. This should still have been the case even if there were small 
errors in prediction. 
3.3.2 Grade-lactate treadmill test 
The protocol for this test was similar to that of the first treadmill test but this time 
the treadmill grades generated from the regression equation described above 
were used. Thus, each subject was exercising at approximately 50% of 
V02max during the first four minutes of the test, 60% of V02max in the second 
four minutes, 70% of V02max during the third four minutes and 80% of 
V02max for the last four minutes of the test. Once again heart rate and PRE 
were recorded during the last minute of each stage of the test while collections 
of expired air were taking place. In addition duplicate 20 III thumb prick 
samples of capillary blood were collected at the end of each stage of the test 
and later analysed for lactate. 
From the results of this test the oxygen uptake and thus the %V02max attained 
by each subject at the reference blood lactate concentrations of 2 and 4 
mmol.l-1 could be ascertained. This was accomplished by plotting oxygen 
uptake (ml.kg-1 min-1) against blood lactate concentration and interpolating 
across from the 2 and 4 mmol.l-1 points on the blood lactate axis as shown in 
Figure 3.3. 
80 
5 
~ 
4 ------------------
"" "0 
E 
E 3 ~
Cl) 
-!'II 
U 
!'II 2 ------------
"0 
0 
0 1 CIl 
0 
10 20 30 40 
V02 (mVkg/min) 
Figure 3.3 Determination of the oxygen uptakes attained at the reference 
blood lactate concentrations of 2 and 4 mmol.l-1. 
3.3.3 Endurance walk 
This test was conducted to examine each subject's physiological and 
metabolic responses to steady state exercise. The test was 20 minutes in 
length and was conducted at a constant incline calculated to elicit 70% of 
V02max throughout. Expired air samples were collected between minutes four 
and five, nine and ten, 14 and 15 and 19 and 20 during the test at which times 
heart rate and PRE were also being recorded. Thumb prick samples of 
capillary blood were taken at five minute intervals and later analysed for 
lactate. 
3.3.4 1600 m Track walk 
The purpose of this test was to assess brisk walking pace and intensity (as 
percentage of maximum heart rate). The subjects walked exactly four laps of 
the track and thus covered slightly less than one mile (i.e. 1600 m as opposed 
to 1609 m). Instructions to the subjects were as follows: "walk at a pace which 
is brisk but not maximal and which you could maintain for about 30 to 45 
minutes if necessary". Heart rate was monitored at 15 second intervals 
throughout this test by means of a short range telemetry system (PE 3000 
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Sports-tester, Sweden) which also recorded the time taken to complete the 
walk. 
3.4 Blood Sampling 
Thumb prick samples of capillary blood were collected both at rest and during 
exercise for the measurement of lactate concentration. Before samples were 
taken at rest the hand was immersed in warm water to increase superficial 
blood flow and thus arterialise the capillary blood. The skin was punctured 
using an Auto-clix automatic lancet (Boehringer Mannheim, U.K. Ltd.) and two 
20 III samples of blood were collected into micro-pipettes (Acupette Pipettes; 
Scientific Industries Ltd.). The samples were immediately deproteinised in 200 
III of 2.5% perchloric acid and subsequently centrifuged (Eppendorf 
centrifuge: model 5414) at 12,000 rpm for 30 seconds before being placed in 
a freezer (-70 OC) where they remained until analysis. 
Twenty millilitre volumes of blood were obtained from the subjects by 
venepuncture after they had completed a 12 hour overnight fast. The fast was 
required because the concentration of triglycerides in the blood is affected by 
the proximity of meals (Durrington, 1990). Samples were usually collected 
between 8:00 and 10:00 am to standardise for any daily variation but 
exceptions were made occasionally if this time was-inconvenient. Subjects 
remained in the sitting position while the sample was being~drawn unless they 
had a tendency to faint in which case samples were collected while the 
subject laid on a couch. In most cases the sample was drawn within one 
minute of venepuncture. In an attempt to limit error due to biological variation 
two samples were collected from each subject not more than five days apart , 
and the mean value of these two samples was adopted as the b~st estimate of 
the true value. J 
Once the blood sample had been obtained, a 2 ml portion of this blood was 
poured into a plastic citrated tube (Sarstedt 9NC/2) and placed into a 
refrigerator (4 OC) while the remaining blood was dispensed into 10 ml plastic 
tubes (Sarstedt Zl1 0). From these tubes two 20 III samples were collected into 
micro-pipettes and immediately diluted in 5 ml of Drabkin's solution from 
which haemoglobin concentration was determined later in the day. Three 
further samples of blood were collected into heparinized micro-haematocrit 
tubes (Scientific Industries Ltd.) and subsequently centrifuged for 15 minutes 
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(Hawksley micro-haematocrit centrifuge). From these tubes haematocrit was 
determined. 
The blood left in the 10 ml plastic tubes was allowed to clot for 45 minutes 
before being centrifuged (Burkard Koolspin set at 4 OC) along with the 2 ml 
sample at 6,000 rpm for 15 minutes. The citrated plasma and most of the 
serum were then removed from the tubes using pasteur pipettes (Scientific 
Industries Ltd.) and divided into separate 1 ml plastic aliquots which were 
immediately frozen at -70 oC. A small (2-3 ml) portion of serum was not frozen, 
however, but placed into plastic tubes and stored in a refrigerator. Sometime 
within the next five days this sample underwent precipitation to remove LDL-C 
and VLDL-C and in some cases HDL2-C also. The supernatant resulting from 
this procedure was dispensed in 1 ml aliquots and stored with the others at 
-70 oC. 
3.5 Blood biochemistry 
Full details of the blood biochemistry are included in the Appendices while a 
brief overview is given here. Blood lactate was measured on a fluorimeter 
(Locarte, London. Model 8-9) using a modification of the enzymatic method 
described by Maughan (1982) (Appendix 4). Haemoglobin concentration 
(Appendix 5) was determined photometrically (Eppendorf photometer 1101 M) 
by a cyanmethemoglobin method using a commercially available test kit 
(Boehringer Mannheim, U.K. Ltd.). Haematocrit was ascertained using a 
micro-haematocrit reader (Hawksley). All of these procedures took place in the 
biochemistry laboratory at Loughborough University. 
Total cholesterol concentration (Appendix 6) was determined using an 
enzymatic kit (Boehringer Mannheim, U.K. Ltd.). To isolate HDL-C a 
manganese chloride/sodium heparin precipitation was performed and this 
was followed by a second precipitation using dextran sulphate if HDL3-C 
concentration was required (Appendix 7). The concentrations of HDL-C and 
H D L3-C were determined using an enzymatic kit (Appendix 8). The 
concentration of HDL2-C was calculated as HDL-C minus HDL3-C. 
Measurements of triglyceride (Appendix 9) were also made using an 
enzymatic kit (Boehringer Mannheim, U.K. Ltd.) and were not corrected for free 
glycerol. Low density lipoprotein cholesterol and VLDL-C were estimated in 
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chylomicron-free serum using the Friedewald formula (Friedewald et al. 1972) 
(Appendix 10). 
Apoproteins A-I and B (Appendix 11) were determined by immunoprecipitin 
analysis using commercially available kits (Atlantic Antibodies, Inc. U.SA). An 
enzyme-immumoassay was employed to determine Lp(a} concentration again 
using a commercially available kit (Appendix 12). The sensitivity of this assay 
was such that values below 5 mg.dl-1 could not be detected but since it has 
now been established that Lp(a} is present in virtually all individuals 
(Durrington, 1989) values of 1 mg.dl-1 were assigned to those subjects whose 
Lp(a} concentration was undetectable. 
The coefficient of variation for some of the above assays is included in 
Appendix 13. To ensure accuracy and precision were being maintained, 
quality control sera were used throughout (Precinorm L, Boehringer 
Mannheim, U.K. Ltd.). 
Except in the case of the storage study (see below) all of the lipid and 
lipoprotein assays were completed using an automated analyser (Cob as Mira) 
in the Department of Chemical Pathology at the Royal Free Hospital School of 
Medicine, London. The aliquots of serum were transported from 
Loughborough University to the Royal Free Hospital in an ice box which was 
filled with dry ice and polystyrene. Samples were stored until the end of the 
study before being transported thus enabling all of the serum from one 
individual to be analysed in the same batch. Furthermore, each batch included 
samples from both walkers and controls thus reducing the likelihood of finding 
systematic differences between the two groups as a result of experimental 
procedures. 
Lipid and lipoprotein analysis during the storage study was performed 
manually in the biochemistry laboratory at Loughborough University. A 
photometer (Eppendorf photometer 1101 M) was used to read the absorbance 
of the samples. 
Fibrinogen concentration was determined by a coagulation assay (Appendix 
14). Analysis was performed in the Department of Human Sciences at 
Loughborough University by Miss Jayshree Savania. Only one sample was 
analysed for each subject at each observation point during the brisk walking 
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study. Since fibrinogen is an "acute phase protein" it should be borne in mind 
that individual elevations in plasma fibrinogen concentration may occur when 
infections are present (Ernst, 1990). 
3.6 Blood pressure 
Arterial blood pressure was determined using a random zero sphygmomano-
meter (Hawksley) according to the procedures described by Elliott and 
Stamler (1988). Subjects were seated for five minutes with their legs 
uncrossed before measurements were initiated using the right arm. Usually 
two measurements were made and the mean value taken to represent the true 
value. In the case of poor agreement between measurements further 
determinations of blood pressure were made. 
3.7 Spirometry 
A dry spirometer (Vitalograph Ltd.) was used in the assessment of various 
indices of lung function including forced vital capacity (FVC), forced expiratory 
volume in one second (FEV1) and the percentage of FVC exhaled in one 
second (FEV l/FVC x 100). Subjects were fully familiarised with the equipment 
prior to testing. During the tests subjects assumed a standing position and 
wore a nose clip. They were first instructed to inhale as deeply as possible, 
and then after sealing their lips around the mouthpiece, they were encouraged 
to exhale as forcibly and completely as possible. Exhalation usually continued 
for six seconds. Measurements were repeated after a short rest interval if the 
subject or experimenter felt that a maximal effort was not achieved. 
3.8 Dietary analysis 
The seven day weighed food inventory technique was used to monitor 
subjects diets. The methods used for this analysis are described by 8rooke-
Wavell (1992). 
3.9 Anthropometry and body composition 
The procedures used for measuring height, body mass, various 
circumferences and skinfold thicknesses and body density (hydrostatic 
weighing) are described by 8rooke-Wavell (1992). From these measurements 
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the amount and distribution of body fat in each subject were determined. Body 
mass was also measured before each treadmill test using a beam balance 
(Avery). In this situation subjects remained lightly clothed but removed their 
shoes. 
3.10 Statistical analysis 
Most of the statistical procedures used in this thesis are outlined by Cohen 
and Holliday (1982). One way analysis of variance was used to test the 
difference between many means obtained by repeated measurement of one 
group. Two way analysis of variance for repeated measures was used to test 
for differences when repeated measurements were made on two groups. This 
enabled an evaluation of whether or not the responses of the two groups 
differed from each other (interaction effect) and also indicated any changes 
within each group over time (repeated measures). Relationships between 
variables were examined using the Pearson Product Moment correlation 
coefficient. 
When the assumptions underlying parametric statistics were not met non-
parametric methods were employed as follows. The Mann Whitney U test was 
used to detect differences between two sets of scores originating from different 
groups. The Wilcoxon matched pairs test was employed to test for significance 
when repeated measurements were made on the same group and the 
strength of a relationship between two variables was assessed via the 
Spearman rank order correlation coefficient. 
Due to the skewed nature of the triglyceride and Lp(a) data a logarithmic 
transformation (using natural logarithms) was employed to normalise the data. 
The anti log of the mean of the log data was then used to represent the 
geometric mean of the group and a 95% confidence interval on the log scale 
was antilogged to give a confidence interval on the original scale. The 
procedures for this form of data treatment are described by Gardner and 
Altman (1989). 
Values reported in this thesis are mean plus or minus the standard error of the 
mean (SEM) unless otherwise stated and the five per cent confidence level 
has been adopted throughout although in many cases the degree of 
significance is much higher. 
86 
3.11 Storage study 
3.11.1 Introduction 
Lipid and lipoprotein analysis should ideally be performed on fresh serum 
samples within 24 hours of collection, however, this is oiten unrealistic and 
samples are usually frozen and assayed at a later date. The effects of storage 
on lipid and lipoprotein concentrations are variable depending on, amongst 
other things, the length of time over which the sample is stored, the 
temperature at which the sample is stored and the type of lipid or lipoprotein 
being measured. The concentrations of both total cholesterol (Pini et al. 1990) 
and HDL-C (Kohlmeier and Schlierf, 1982) have been shown to change 
significantly over time when stored at -20 oC and although storage at -70 oC 
seems to provide a more stable environment (Nanjee and Miller, 1990) 
significant changes have been found even at this temperature (Bachorik, 
1982). Therefore, a storage study was initiated, the aim of which was to 
establish whether or not a systematic variation occurs in the concentrations of 
total cholesterol and/or HDL-C from serum samples frozen for various periods 
of time. A further aim of this study was to assess the extent to which storage 
affects the measurement of HDL3-C since this proved problematic during the 
walking study i.e. in many cases HDL2-C could not be precipitated. 
3.11.2 Methods 
Twenty millilitre samples of venous blood were collected from 16 fasted 
subjects on the same morning. Measurements of serum total cholesterol, 
HDL-C and HDL3-C were then made on a portion of the fresh serum from 
each subject. The remainder of the serum was dealt with in the following way 
for each subject. Four 50 I-lI samples of serum were pi petted into aliquots and 
frozen at -70 °C from which total cholesterol was later determined. Four 1 ml 
samples of serum were pi petted into plastic tubes and frozen at -70 °C for later 
precipitation and determination of HDL3-C. Four 1 ml samples of serum were 
precipitated immediately to remove LDL-C and VLDL-C and then frozen at -70 
°C. From these samples HDL-C was later to be determined. 
Thus, for each subject a total of 12 samples were now stored in the freezer, 
four for total cholesterol, four for HDL-C and four for HDL3-C. Each set of four 
samples was labelled 'A', 'B', 'C' and '0'. On the following day (i.e. 24 hours 
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after collection) each of the subject's 'A' samples (i.e. one for total cholesterol, 
one for HDL-C and one for HDL3-C) was thawed and analysed. The purpose 
of this was to assess the effects of the process of freezinglthawing per se. This 
routine was repeated for the 'B' samples three months later, for the 'C' 
samples six months later and for the '0' samples nine months later. The 
values gained from samples 'A', 'B', 'C' and '0' were now compared with 
those gained from the initial analysis of fresh serum in order to determine the 
effects of storage. The methods used for the determination of total cholesterol, 
HDL-C, and HDL-C subfractions were those described in Sections 3.4 and 
3.5. 
An alternative to the above protocol would have been to follow the approach 
used in the storage study of Nanjee and Miller (1990). In this study each fresh 
sample was divided into two portions. One of these portions was subsequently 
frozen at -70 0C while the other was frozen in liquid nitrogen. Both portions of 
the sample were analysed together after a given period of storage. The 
sample frozen in liquid nitrogen was then used as reference with which its 
paired sample, frozen at -70 oC, was compared. This method assumes 
stability of samples stored in liquid nitrogen but has the advantage that all 
samples are analysed in the same batch thus preventing error due to between 
batch variation. In the method described earlier this is not the case since the 
fresh (reference) samples are analysed separately from the frozen samples. In 
the event, however, the liquid nitrogen method was not used because it would . 
have created logistical problems and increased the expense of the study. 
3.11.3 Results 
Table 3.1 below displays the values obtained for each lipid and lipoprotein 
measured during the storage study in addition to giving calculated values for 
HDL2-C and the ratio of total cholesterol to HDL-C. The percentage change in 
each of these quantities during the study is shown in Table 3.2 while Table 3.3 
gives the correlation coefficients obtained when comparing the base-line 
values of each lipid and lipoprotein with those subsequently attained. 
Changes over time were assessed using one way analysis of variance for 
repeated measures. Significant changes are indicated on Table 3.2. 
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Base line 1 day 3 months 6 months 9 months 
TC 4.47 ± 0.14 4.29 ± 0.14 4.34 ± 0.14 4.57 ± 0.14 4.37 ± 0.14 
3.21 - 5.40 3.04 - 5.12 3.23 - 5.33 3.40 - 5.39 2.96 - 5.27 
HDL-C 1.50 ± 0.10 1.35 ± 0.10 1.50 ± 0.10 1.23 ± 0.10 1.48 ± 0.11 
0.93 - 2.56 0.85 - 2.32 1.01 - 2.52 0.89 - 2.15 0.98 - 2.69 
HDL3-C 0.92 ± 0.04 0.98 ± 0.04 0.67± 0.05 0.88 ± 0.04 0.91 ± 0.04 
0.67 - 1.38 0.74 - 1.37 0.39 - 1.19 0.68 - 1.30 0.75 - 1.30 
HDL2-C 0.62± 0.08 0.40 ± 0.08 0.86 ± 0.07 0.36 ± 0.07 0.60 ± 0.09 
0.25 - 1.45 0.02 - 1.22 0.51 - 1.62 -0.09 - 1.12 0.23 - 1.66 
TC/HDL-C 3.16 ± 0.23 3.37 ± 0.24 3.01 ± 0.18 3.96 ± 0.23 3.13 ± 0.20 
1.97 - 5.20 2.07 - 5.53 1.97 - 4.50 2.37 - 5.46 1.86 - 4.84 
Table 3.1 Values for total cholesterol (TC), HDL-C, HDL2-C, HDL3-C and the TC/HDL-C ratio during 
the nine month storage study. The top figures in each row are mean ± SEM while the bottom 
values give the range. 
1 day 3 months 6 months 9 months 
TC -4.0* -2.9* 2.2 -2.2 
HDL-C -10.0* 0.0 -18.0* -1.3 
HDL3-C 6S -27.7* -4.4 -1.1 
HDL2-C -35S 38.7* 41.9* -3.2 
TC/HDL-C 6.7 -4.8 25.3* -1.0 
Table 3.2 The percentage change from base-line values of the various 
lipids and lipoproteins assessed during the storage study. 
* Significantly different from base line. 
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Base line 1 day 3 months 6 months 9 months 
TC 0.994 0.961 0.990 0.977 
HDL-C 0.944 0.981 0.856 0.961 
HDL3-C 0.900 0.952 0.970 0.902 
HDL2-C 0.834 0.984 0.750 0.925 
TC/HDL-C 0.957 0.977 0.807 0.969 
Table 3.3 Pearson Product Moment correlation coefficients obtained 
from the storage study when comparing base-line lipid and 
lipoprotein concentrations with concentrations attained after 
one day, three months, six months and nine months. 
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3.11.4 Discussion 
The changes in total cholesterol were all small (Table 3.2), the greatest 
change being a decrease of around 4% after one day. Although total 
cholesterol concentrations at three and nine months were also lower than 
base-line values the difference was less than 3% while the mean cholesterol 
concentration after six months was 2.2% higher than base-line values. These 
findings contrast with those of Pini and colleagues (1990) who found 
progressive increases (up to 15%) in the concentration of cholesterol from 
samples stored over just a 14 day period, however, the storage temperature in 
this study was only -20 QC. Although the decreases found in the present study 
after one day and three months were significant they are probably simply a 
reflection of the between batch variation in the cholesterol assay. Nanjee and 
Miller (1990) note that between batch variation may be caused by many 
factors including changes in ambient assay conditions and the use of different 
reagent batches both of which occurred in the present study. 
There were significant decreases in HDL-C concentration of 10% and 18% 
after one day and six months respectively. The correlation coefficient 
comparing base-line HDL-C concentrations with those at six months is also 
rather poor. Previous studies have observed both increases and decreases as 
great as 13% in the concentration of HDL-C with storage (see Nanjee and 
Miller, 1990 for references) but these changes occur after prolonged periods 
and not after just one day. As far as the 18% decrement after 6 months is 
concerned this is greater than other changes reported in the literature. 
However, the mean values obtained at three and nine months are unchanged 
from base-line values and the correlation coefficients are comparable with 
those attained in the study by Kohlmeier and Schlierf (1982) though not as 
strong as those obtained by Demacker and Jansen (1983). Thus, there would 
not appear to be a systematic variation in the concentration of HDL-C over 
time but the changes after one day and six months are perplexing. 
Aside from the 27.7% decrease after three months the changes in HDL3-C are 
not too great although the reductions after one day and three months were 
both significant. Other studies have shown a significant variation in the 
concentration of HDL3-C with storage including that by Jung and associates 
(1986) who found a 35% increase in HDL3-C concentration after four days of 
storage at a temperature of -20 QC. Smaller but still significant changes have 
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also been observed by Khan and Elkeles (1984) after a three month period of 
storage at a temperature of -20 oC. Nanjee and Miller (1990), however, in their 
study comparing samples stored in liquid nitrogen with those stored at -70 oC 
did not find any deterioration in HDL3-C concentration. 
As with the total HDL-C samples discussed above it is difficult to ascertain 
whether the changes in HDL3-C concentration with storage are the direct 
result of sample deterioration or are due to some other factor. It was 
mentioned earlier that difficulty was experienced in the measurement of 
HDL3-C during the walking study and therefore one of the reasons for 
undertaking this storage study was to try and ascertain whether or not the 
length of time over which serum is stored negatively affects the precipitation of 
HDL2-C. From the results attained this does not appear to be the case since 
the greatest changes in HDL3-C concentration occurred at the beginning 
rather than the end of the study. 
An examination of the the values for HDL2-C is also unsupportive of the idea 
that the length of serum storage interferes with the precipitation procedure. 
The variation in HDL2-C concentration throughout the storage study was 
greater than the variation in either HDL-C or HDL3-C (Tables 3.1 and 3.2). 
This would be expected because HDL2-C is a derived value and therefore 
reflects the variation in both HDL-C and HDL3-C. As with the other 
lipoproteins, however, there was no systematic variation in HDL2-C which 
suggests that the problems experienced in the measurement of HDL3-C were 
related primarily to methodological factors and/or the freezing process per se 
rather than being due to the actual length of storage. 
3.11.5 Conclusion 
Although some significant changes were found during the storage study when 
comparing base-line values with those subsequently attained, none of the 
lipids or lipoproteins showed a systematic variation over time. However, the 
changes in HDL-C subfractions, especially the HDL2-C subfraction, were 
highly variable and suggest that values gained for these lipoproteins may be 
unreliable. Furthermore, on the basis of the evidence from this investigation it 
would appear that the main cause of the variation found in HDL-C subfractions 
was related to the methodology used, i.e. the precipitation procedure, rather 
than being due to a true sample deterioration caused by storage. 
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3.12 Pilot study 
3.12.1 Introduction 
The predominant methods for assessing endurance training status were 
referred to in the Section regarding training adaptations in Chapter Two. In 
this discussion it was mentioned that V02max is inadequate as a complete 
descriptor of training status due to its strong genetic component and the fact 
that it is not a sensitive indicator of the peripheral adaptations which occur as 
a consequence of training. A further limitation as far as the proposed walking 
study was concerned was the fact that direct determination of V02max was 
contraindicated in the subject group under observation. With these factors in 
mind it was felt that the assessment of changes in blood lactate concentration 
during submaximal exercise might be a more suitable method for discerning 
the improvements in exercise capacity likely to occur with training. 
Having decided to utilise the blood lactate concentration during submaximal 
exercise as an index of endurance it was necessary to validate this procedure 
before embarking on the brisk walking study. This was due to the fact that most 
of the studies examining the relationship between blood lactate concentration 
and endurance have used running as the mode of exercise and employed 
trained subjects. Therefore, a pilot study was initiated to examine this 
relationship during walking exercise. This study had two main aims. Firstly, to 
see how strongly the relative exercise intensity (%V02max) attained at a 
reference blood lactate concentration relates to endurance performance 
(determined by a walk to exhaustion at 80% of V02max). Secondly, to 
examine whether a rapid loss of metabolic (blood lactate concentration) or 
cardiovascular (heart rate) homeostasis during an endurance test is predictive 
of subsequent performance time. In the endurance walk used in the brisk 
walking study subjects could not be exercised to exhaustion for safety 
reasons. Therefore, the findings from this pilot study would be important for the 
interpretation of the endurance walk data collected in the brisk walking study. 
This investigation was undertaken jointly with a third year undergraduate 
student who submitted a dissertation on the findings in partial fulfilment of her 
degree requirements (Wallington, 1989). 
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3.12.2 Methods 
A group of 11 female students from Loughborough University agreed to take 
part in the study after a detailed explanation of the procedures involved. 
Young female subjects were chosen since it was thought that their physical 
capacity would best resemble that of middle-aged males and yet still permit 
the assessment of V02max and endurance capacity directly without great risk 
of endangering their health. The group was heterogeneous in nature as 
regards participation in physical activity and contained recreational runners, 
games players and sedentary individuals. During the study subjects were 
asked to complete four exercise tests as described below (two of the subjects 
did not manage to complete all four tests). The equipment used for these tests 
was identical to that described in Section 3.3. Table 3.4 displays the physical 
characteristics of the subjects participating in the study. Of particular note is 
large variation in body mass within the group. 
Mean ± SEM 
Range 
Age (years) Height (m) Mass (kg) 
21 ± 0.5 
18 - 23 
1.66 ± 0.02 60.3 ± 2.6· 
1.58 - 1.74 48.9 - 75.8 
BMI (kg/m2) 
21.9 ± 0.9 
17.5 - 27.1 
Table 3.4 Physical characteristics of the 11 subjects taking part in the pilot 
study. BMI (body mass index) = weight (kg)/height (m)2. 
V02max test: After an initial treadmill familiarisation V02max was determined 
directly for each subject using a modification of the protocol devised by Bruce 
(1972). This involved an incremental walking test which was divided into three 
minute stages. The speed of the treadmill remained constant throughout this 
test at either 1.56 m.s- l or 1.79 m.s· l (3.5 or 4.0 mph) depending on the 
subject's ability. The treadmill incline was set at 5% for the first three minutes, 
increased to 10% for the second three minutes and subsequently elevated by 
2.5% at the end of each three minute period. Douglas bag samples of expired 
air were collected between minutes 1 :45 and 2:45 of each stage of the test 
from which oxygen uptake and carbon dioxide production were measured. 
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Heart rate was monitored continuously throughout the test and the subject's 
PRE was measured at the end of each stage. The test was open ended and 
continued in the routine fashion described above until the subject signalled 
that she could only manage one more minute. At this point a final collection of 
expired air was taken and the test was terminated. 
Submaximal incremental treadmill walking test: The purpose of this test was to 
determine the submaximal relationship between treadmill grade and oxygen 
uptake for each person. The test was 16 minutes long and was divided into 
four, four minute exercise periods. As with the V02max test the treadmill speed 
remained constant at either 1.56 m.s· l or 1.79 m.s-l during the test. The 
treadmill incline was set at an appropriate level for each individual to begin 
with and was subsequently elevated by 3% at the end of every stage. Expired 
air samples were collected for the last minute of each four minute stage of the 
test. The information gained from this test was used to calculate the treadmill 
grades required to elicit 60%, 70%, 80% and 90% of each subject's V02max. 
as described in Section 3.3.1 above. These grades were then employed in the 
third exercise test. 
Grade-lactate treadmill test: This test was identical to that described in Section 
3.3.2 except that the relative intensities used ranged from 60% to 90% of 
V02max rather than 50% to 80%. From the results of this test the oxygen 
uptake and relative exercise intensity attained at the reference blood lactate 
concentration of 4 mmol.l-l were ascertained as described above (Section 
3.3.2). 
Endurance walk: The purpose of this test was to make an assessment of 
endurance performance for each subject. An exercise intensity equivalent to 
80% of V02max was chosen for the test in an attempt to ensure that fatigue 
was not primarily caused by substrate depletion but rather was related to other 
factors reflective of training status. 
The test began with a five minute warm up period during which subjects 
walked at an incline required to elicit 60% of their V02max. At the end of this 
period the grade of the treadmill was increased so that each subject was 
exercising at 80% of their V02max and the test continued at this intensity until 
the point of volitional fatigue. Expired air was collected during the last minute 
of the warm up period and during the 80% walk between minutes four and 
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five, nine and ten and subsequently every ten minutes until a signal was given 
by the subject initiating a final one minute collection of expired air. Thumb 
prick samples of capillary blood were taken at rest and at the end of each 
expired air collection for the determination of blood lactate concentration. 
Heart rate was also monitored continuously as with the other exercise tests. A 
clock was placed in sight of the subjects during the walk so that they knew 
how long they had been walking for but the final times were not communicated 
between subjects in order to prevent their use as target times. 
3.12.3 Results 
A summary of the results for V02max, V02 at 4 mmoLl-1, %V02max at 4 
mmol.l-1 and endurance time is presented in Table 3.5. As can be seen from 
Table 3.5 the range in all of these variables is considerable and reflects the 
heterogeneous nature of the group. 
V02max V02:4 mmol.l-1 %V02max End. time 
(ml.kg-1min-1) (ml.kg-1min-1) at 4 mmol.l-1 (mins) 
Mean ± SEM 41.9 ± 2.6 32.7 ± 3.1 76.7 ±3.0 24.5 ± 6.6 
Range 26.8 - 54.4 17.6 - 47.6 62.2 - 89.2 3.2 - 65.3 
Table 3.5 The mean ± SEM and range of values obtained for various 
physiological and performance variables assessed during the 
pilot study. 
Figures 3.4, 3.5 and 3.6 demonstrate the relationships between endurance 
time and the other variables shown in Table 3.5 i.e. V02max, V02 at 4 
mmol.l-1 and the %V02max at 4 mmol.l-1. Due to the sample size involved in 
the study the Spearman rank order correlation coefficient (rho) was thought to 
be the most appropriate means of assessing the strength of association 
between these variables. All three relationships shown are significant 
although in each case there are two outliers away from the main group. These 
represent the two recreational runners who participated in the study. With the 
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omission of these subjects (Le. n = 7) the relationships between V02max and 
endurance time and between the V02 at 4 mmoLl-1 and endurance time 
remained significant (rho = 0.86 for both). However, the relationship between 
the %V02max at 4 mmol.l-1 and endurance time became non-significant (rho = 
0.71). 
Figure 3.7 displays the relationship between the heart rate changes (10 
minute values - 5 minute values) during the endurance walk and subsequent 
endurance time. Figure 3.8 shows the relationship between blood lactate 
concentration changes (10 minute values - 5 minute values) during the 
endurance walk and performance time. Only eight subjects are included in 
these Figures because one subject did not manage to walk for ten minutes. 
Both of these relationships were significant (rho = -0.78 and -0.93 
respectively). With the removal of the two outliers the relationship between the 
heart rate changes and endurance time became non-significant (rho = -0.60) 
but the relationship between blood lactate concentration changes and 
endurance time remained significant (rho = -0.83). 
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Figure 3.4 The relationship between V02max and time to exhaustion during 
treadmill walking for nine female subjects. 
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Figure 3.5 The relationship between the oxygen uptake attained at a blood 
lactate concentration of 4 mmol.l-1 and time to exhaustion during 
treadmill walking for nine female subjects. 
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Figure 3.6 The relationship between the %V02max at a blood lactate 
concentration of 4 mmol.l-1 and time to exhaustion during treadmill 
walking for nine female subjects. 
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Figure 3.7 The relationship between the heart rate change (10 minute values 
- 5 minute values) during a treadmill endurance walk and 
subsequent exhaustion time for eight female subjects. 
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Figure 3.8 The relationship between the blood lactate concentration change 
(10 minute values - 5 minute values) during a treadmill endurance 
walk and subsequent exhaustion time for eight female subjects. 
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3.12.4 Discussion 
The fact that the relationship between V02max and time to exhaustion during 
the endurance walk was so strong (Figure 3.4) was unexpected. Many studies 
have demonstrated a strong relationship between V02max and endurance 
when performance is expressed in absolute terms i.e. running speed (Costill 
et al. 1973; Ramsbottom et al. 1987; Williams and Nute, 1983) but in this study 
endurance was assessed in relative terms i.e. time to exhaustion at 80% of 
V02max. For this group of individuals then the possession of a high V02max 
appeared to confer an improved ability to exercise at 80% of that V02max. 
This conflicts with the findings of Mayes and co-workers (1987) which did not 
show a relationship between V02max (I.min-1) and time to exhaustion at 80% 
of V02max during cycling exercise. However, as already mentioned the range 
of V02max values in the present study was considerable (Table 3.5), the 
lowest value being 26.8 ml.kg·1 min·1 which would suggest a very sedentary 
person. It is likely then that the individuals in this study who possessed the 
higher maximum oxygen uptakes also exercised more frequently and thus 
were better trained than individuals with lower maximum oxygen uptakes. 
The correlation between the 4 mmol.l·1 V02 and endurance time (Figure 3.5) 
was the same as that for V02max and endurance time (rho = 0.93). This 
relationship may be explained by the fact that the 4 mmol.l- 1 V02 is reflective 
of both V02max and training status. In other words if two individuals attain the 
same relative intensity at a blood lactate concentration of 4 mmol.l· 1, the 
individual with the higher V02max will be exercising at the higher oxygen 
uptake. Conversely, if two individuals possess similar V02max's then the one 
who is more highly trained will be able to exercise at a higher relative intensity 
at a blood lactate concentration of 4 mmol.l·1 and thus attain a higher oxygen 
uptake. This correlation between V02 at 4 mmol.l-1 and endurance time at 
80% of V02max is consistent with the findings from other studies which have 
demonstrated strong relationships between the running speed or work rate 
attained at a blood lactate concentration of 4 mmol.l·1 and performance time 
(Mayes et al. 1987; Sjodin and Jacobs, 1981; Williams and Nute, 1983). 
For the group as a whole the 4 mmol.l- 1 blood lactate concentration 
represented a relative exercise intensity of 77% (Table 3.5). This is lower than 
the value of 84% attained by the ten recreational runners examined by 
Williams and Nute (1983) probably due to differences in the two groups under 
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observation. Although the relationship between the %V02max attained at 4 
mmol.l-1 and endurance time was not as strong as that between either 
V02max or V02 at 4 mmoLl-l and endurance time it was still significant (rho = 
0.85). Thus, individuals who could exercise at the highest relative intensities at 
a blood lactate concentration of 4 mmoLl-l were also best able to sustain 
walking at 80% of their V02max (Figure 3.6). 
Figures 3.7 and 3.8 confirm the hypothesis that a rapid loss of cardiovascular 
and metabolic homeostasis is to some extent predictive of subsequent 
performance time. Both the changes in heart rate and blood lactate 
concentration between minutes five and ten of the endurance walk were 
significantly related to endurance time. This indicates that those individuals 
who experienced the greatest increase in either heart rate or blood lactate 
concentration between the fifth and tenth minutes of the endurance walk were 
likely to fatigue earliest and therefore have the shortest walking times. As 
mentioned in the results Section the relationship between heart rate changes 
and endurance time became non-significant when the values for the two 
recreational runners were excluded from the analysis. The relationship 
between blood lactate concentration changes and endurance time remained 
significant, although slightly weakened, when these two individuals were 
excluded. This suggests that changes in blood lactate concentration during 
the early stages of an endurance walk may be better predictors of subsequent 
performance than cardiovascular changes such as heart rate. 
3.12.5 Conclusion 
The results of this study show that the %V02max attained at a reference blood 
lactate concentration during submaximal walking can be used as an index of 
endurance fitness. There is no evidence from this study, however, to suggest 
that the %V02max attained at a reference blood lactate concentration is a 
better indicator of endurance fitness than V02max per se. This is probably due 
to the heterogeneous nature of the subject group and the likelihood that for 
these subjects V02max was reflective not only of genetic endowment but also 
habitual participation in physical activity. 
On the basis of these findings it might be permissible to use both V02max and 
the %V02max attained at a reference blood lactate concentration as indices of 
endurance fitness in the middle-aged men participating in the brisk walking 
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study. However, because these men are required to be previously sedentary 
they should form a more homogeneous group in terms of habitual physical 
activity levels. Moreover, the training performed by the walkers in the brisk 
walking study may have little influence on V02max. If this is the case then the 
%V02max attained at a reference blood lactate concentration may provide a 
better index of endurance fitness (Le. the ability to exercise at a given 
percentage of V02max) than V02max itself. 
Finally, the results of this pilot study reveal that a rapid loss of cardiovascular 
and metabolic homeostasis during an endurance test are predictive of 
subsequent endurance performance. This suggests that changes in heart rate 
and blood lactate concentration in the endurance walk employed in the brisk 
walking study may be adopted as indices of endurance fitness. 
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4 PROCEDURES 
4.1 Overview 
The following Chapter describes the procedures used in the one year brisk 
walking study. This investigation involved the recruitment of a group of middle-
aged men who were subsequently allocated into either a brisk walking group 
or a control group. The groups were then monitored during the following year 
in order to examine the effects of brisk walking on endurance fitness, 
lipoprotein metabolism and other selected risk factors for CHD. The study was 
a joint venture involving both the Department of Physical Education and 
Sports Sciences and the Department of Human Sciences at Loughborough 
University. Although each department had distinct and separate research 
interests many of the procedures described below were devised and 
accomplished jointly and the contribution of Miss Katherine Brooke-Wavell 
from the Department of Human Sciences is duly acknowledged. 
4.2 Recruitment 
All of the subjects participating in the study were volunteers and the majority 
came from Loughborough and the surrounding area although there were a 
few exceptions. Recruitment methods included the location of notices in 
doctor's and dentist's surgeries and other prominent places, advertisement in 
the local papers, participation in a health promotion day at Loughborough 
General Hospital and word of mouth. Although notices were posted around 
the University the response to these was limited and only a minority of 
subjects were University employees. 
Once sufficient interest had been generated three meetings were held at the 
University which were open to anyone wishing to know more about the study. 
The methods and procedures to be employed were detailed at these meetings 
and written handouts were also produced explaining the study protocol 
(Appendix 1). If required, individual meetings were arranged giving the 
opportunity for further discussion and allowing personal queries and 
apprehensions to be addressed. 
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4.3 Screening 
Following these meetings all men who were still interested in participating in 
the study were asked to make a preliminary visit to the laboratory for the 
purposes of screening. During this visit each subject's blood pressure was 
measured and a 2 ml sample of venous blood was collected for the 
determination of total cholesterol concentration. The session was concluded 
with a treadmill familiarisation in preparation for the exercise tests. Finally, all 
subjects were asked to visit the University Medical Officer for a routine medical 
examination. 
4.4 Criteria for acceptance into the study 
Following screening a decision was made as to whether to accept or reject 
each subject. Acceptance was based on the following criteria: 
1. Male, aged between 42 and 59 years on entry into the study. These 
cut off points were chosen because the ageing process has little 
influence on the concentrations of lipids and lipoproteins within this 
range (Mann et al. 1988). 
2. Neither currently involved in a programme of regular exercise nor 
employed in a strenuous job. This was assessed via a questionnaire. 
3. Free from known cardiovascular disease as assessed by the 
University Medical Officer. 
4. Not at high risk from CHD as determined by the major risk factors of 
cholesterol, blood pressure and smoking. Only non or occasional 
smokers were accepted on the study. High blood cholesterol was 
defined as >6.5 mmoLl-l and high blood pressure was defined as >90 
mm Hg for diastolic and> 160 mm Hg for systolic. However, in a few 
subjects whose serum total cholesterol concentration was initially 
found to be below 6.5 mmoLl-l subsequent values were higher (see 
Section 2.4 of Chapter Two on the variability in lipid and lipoprotein 
measurement). These subjects were not excluded from the study. 
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The above criteria provided a group of middle-aged men who were apparently 
healthy and currently sedentary. 
4.5 Randomisation 
A further criteria for entry into the study was the acceptance by the subjects of 
the principle of random allocation (in this case names were drawn from a hat) 
into either the walking or control group. This proved to be difficult for some 
individuals to accept because the motivation of many of the men for 
participating in the study was the desire to 'get fit'. However, randomisation 
was essential in order to prevent a self-selection effect. Therefore, to make this 
criterion more acceptable, a two to one ratio of walkers to controls was used, 
thus increasing each subject's likelihood of becoming a walker. Furthermore, 
the men who were allocated into the control group were promised the option 
of taking up an exercise programme with full monitoring once the first year of 
the study had been completed. Of course, an element of self-selection still 
existed since all of the subjects were volunteers and therefore were keen to 
participate in the study. Finally, it should be noted that the power of statistical 
tests will be reduced in this study because the experimental group is larger 
than the control group. This reduction should only be small, however, since 
Pocock (1983) estimates that a two to one ratio leads to a reduction of about 
2.5% (Le. from 95% to 92.5%) in statistical power. 
4.6 Subjects 
Around 100 men expressed a strong interest in participating in the study either 
over the telephone or by attending one of the open meetings arranged at the 
University. Seventy-nine of the men showed continued interest in the study 
after a full explanation of the procedures to be employed and the commitments 
necessary. A number of reasons were given for not wishing to enrol on the 
study. Some men were doubtful that they would have sufficient time to fulfil the 
obligations required of them while others were unwilling to accept the 
possibility of becoming a control subject. In addition two individuals were 
unwilling to undertake one or more of the procedures to be employed in the 
study Le. the blood sampling and underwater weighing. 
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The 79 men who were still interested in participating in the study were now 
subjected to the screening process described above and six were rejected 
either due to ill health or because they exhibited an unfavourable risk factor 
profile for CHD. Another subject withdrew from the study when he learned of 
his inclusion in the control group. Seventy-two subjects actually started the 
study (48 walkers and 24 controls) and, of these, seven (six walkers and one 
control) dropped out at various stages during the following six months, leaving 
a group of 65 subjects who actually completed all of the procedures required. 
Various factors contributed to the loss of subjects during the study. Two of the 
walkers had difficulty in attending the testing sessions because of work 
commitments and were unable to devote sufficient time to the exercise 
programme. Three subjects withdrew due to a combination of ill-health and 
motivational problems. One of the walkers suffered a recurrence of an old 
back injury and the control subject was forced to retire as a result of illness. A 
diagramatic representation of the numbers of men involved from initial 
recruitment through to the end of the study is given in Figure 4.1 and the 
physical characteristics of the 65 subjects who completed the study are shown 
in Table 4.1. 
100 men (approx.) expressed an interest in the study 
79 men attended screening for the study 
73 men were accepted into the study 
, 
65 men completed the study 
Figure 4.1 Summary of the number of men involved during each stage of the 
brisk walking study including recruitment, screening, acceptance 
and completion. 
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Age Height Body mass BMI 
(years) (m) (Kg) (kg/m2) 
Walkers 50.3 ± 0.8 1.77 ± 0.01 79.1 ± 1.5 25.3 ± 0.4 
(n = 42) 42.4 - 59.4 1.59 - 1.94 60.0 - 102.3 19.7-31.3 
Controls 51.6 ± 1.0 1.77 ± 0.01 78.2± 2.5 24.9 ± 0.6 
(n = 23) 42.6-60.6 1.69-1.90 49.2-113.9 17.3-33.5 
Table 4.1 Physical characteristics of the 42 walkers and 23 controls who 
completed the brisk walking study. BMI (body mass index) = weight 
(kg)/height (m)2. Values given are mean ± SEM and the range. 
All of the subjects in Table 4.1 were Caucasian. The social class of these men 
was determined using the occupational classification system devised by the 
Joint Industry Committee for National Readership Surveys (Abrams, 1968). 
According to this classification system six subjects (9.2%) were graded upper 
middle-class, 34 subjects (52.3%) were graded middle-class, 20 subjects 
(30.8%) were graded lower middle-class and five subjects (7.7%) were 
graded skilled working class. None of the subjects were in the bottom two 
categories of this classification system i.e. semi-skilled/unskilled working class 
and those at the lowest levels of subsistence. Thus, the group were 
predominantly middle-class and lower middle-class by occupation. 
4.7 Study protocol 
Approval for the procedures described below was granted by the University 
ethical committee. 
4.7.1 Structure of the study 
The study protocol involved testing the subjects at base line and after three, 
six and 12 months of participation in the study. Since the group was too large 
to deal with at anyone time it was split into three smaller cohorts each 
containing 16 walkers and eight controls. The inclusion of both walkers and 
controls in each cohort ensured that no systematic differences would occur 
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between groups because of the cohort approach. It was anticipated that it 
would take at least one month to test each cohort thus testing began on cohort 
one with cohort two starting a month later and cohort three starting two months 
later. Once the tests on cohort three had been completed the cycle began 
again with cohort one followed by cohort two etc. A summary of this protocol is 
shown below (Table 4.2). 
Year Month Cohort Testing period 
1989 April 1 Base line 
May 2 Base line 
June 3 Base line 
July 1 3 months 
August 2 3 months 
September 3 3 months 
October 1 6 months 
November 2 6 months 
December 3 6 months 
1990 January - -
February - -
March - -
April 1 12 months 
May 2 12 months 
June 3 12 months 
Table 4.2 Timescale over which the brisk walking study was conducted. 
4.7.2 Test battery 
The battery of tests completed by the subjects varied according to the testing 
interval (i.e. base line, three, six or 12 months). The base-line tests were the 
most extensive and included the following: 
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Exercise tests: Submaximal-incremental treadmill walking test 
Grade-lactate treadmill walking test 
Treadmill endurance walk 
Track walk 
Blood samples for the determination of: Total cholesterol 
HDL-C 
LDL-C 
VLDL-C 
Triglycerides 
Apoproteins A-I and B 
Lp(a) 
Fibrinogen 
Haemoglobin 
Haematocrit 
Resting arterial blood pressure: Systolic blood pressure 
Diastolic blood pressure 
Lung function measures: FVC 
FEV1 
FVC/FEV1 (%) 
Seven day weighed food inventory 
Anthropometry and body composition: Height 
Body mass 
Skinfold thicknesses 
Circumferences 
Body density (hydrostatic weighing) 
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Most of these tests were repeated after three, six and 12 months with the 
following exceptions. The submaximal-incremental treadmill test was 
discontinued having been used simply to aid in the development of the grade-
lactate treadmill test and the endurance walk. Lipoprotein(a) was not 
measured at three and six months due to expense. The subjects were not 
required to complete a seven day weighed food inventory at the three month 
stage. Finally, hydrostatic weighing (used for the determination of body 
density) was not performed at three and six months due to the time consuming 
nature of this measurement and the limited number of technical staff available. 
This thesis is primarily concerned with the data regarding the exercise testing, 
blood biochemistry, arterial blood pressure and lung function measures. The 
nutritional data and the data regarding anthropometry and body composition 
are discussed in detail by Brooke-Wavell (1992). 
4.8 Brisk walking 
4.8.1 The brisk walking programme 
After the base-line tests had been completed the control subjects were asked 
to maintain their habitual lifestyle while the subjects in the exercise group 
began the walking programme. Both groups were asked not to make any 
planned dietary changes during the study. The exercise regimen prescribed 
during the study was based on sound training principles such as those 
provided by the American College of Sports Medicine (ACSM) (1991). The 
walkers were given two targets to aim for during the study. Over the first three 
months they were asked to gradually build up their training until they were 
managing to average between 20 and 25 minutes of brisk walking per day. 
They were then required to increase this amount to between 40 and 45 
minutes of brisk walking per day over the next three months and to maintain 
this level thereafter until the end of the study. In order to achieve these targets 
it was not necessary for the subjects to walk every day, they could do more 
walking on some days and less on others if they wished. They were also 
allowed rest days provided they made the time up on other days. However, 
there were certain provisos and these included the following: 
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1. A minimum of three walks per week were required during the first month of 
the training programme. This was increased to four and five walks per 
week for the second and third months respectively. Although there were no 
further stipulations in this respect most men found that they needed to walk 
at least six days per week to meet the six month walking target. 
2. The minimum length of anyone walk was set at 20 minutes, anything less 
than this did not constitute part of the training programme. 
3. The walking had to be brisk. This was defined for the men as a pace which 
was faster than they normally walked but not 'flat out' and which increased 
their breathing beyond the normal rate. 
4. The walking had to be additional to any walking which was usually 
performed during the day. 
The subjects were also cautioned as to the dangers of overtraining. Thus, they 
were warned not to progress their training mileage or intensity too suddenly 
and to ease off in cases of illness or injury and forget about the training targets 
until they had made a full recovery. They were also advised on footwear, 
walking surfaces and any other aspect of the training programme which they 
wished to discuss. 
According to Haskell (1986) an exercise regimen requiring an increase in 
energy expenditure of 5 MJ (1200 kcal) per week will often be sufficient to 
stimulate an increase in HDL-C concentration in previously sedentary healthy 
persons. Previous research has shown that the energy cost of horizontal 
walking at 4.0 mph is around 6.4 kcal per minute for men weighing 82 kg 
(McArdle et al. 1981). Assuming a similar walking speed but adjusting for body 
mass (Le. 79.1 kg for the walking group) the estimated energy expenditure 
during walking, for the men in the present study, would be approximately 6.2 
kcal per minute or 93 kcal per mile. Moreover, if the training programme 
outlined above were rigidly adhered to the subjects in this study would be 
walking an average of 10.5 miles per week after three months and 21.0 miles 
per week after six months. This would result in a weekly energy expenditure of 
4.1 MJ (977 kcal) and 8.2 MJ (1953 kcal) at three and six months respectively 
according to the above calculations. This exercise regimen might therefore, on 
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the basis of the existing literature, be expected to influence lipoprotein 
metabolism. 
4.8.2 Monitoring of the brisk walking programme 
There were no structured training sessions during the study. The men 
incorporated the walking into their daily routines however they saw fit. 
Variations included walking before or after work, walking during the lunch 
hour or walking to and from work. Some men performed longer walks on the 
weekends in order to achieve the targets set, others simply walked the same 
distance every day. Training progress was monitored by means of self-report. 
Walkers were given diaries (an example is shown in Appendix 15) which they 
completed and sent to the University at the end of every month. Each diary 
sheet covered a two week period and subjects were asked to try and maintain 
the walking averages stipulated during each fortnight. The men were 
continually reminded of the importance of accurate recording. Thus, although 
the walkers were encouraged to achieve the targets set on the walking 
programme these were not stressed to the extent of encouraging false 
reporting. 
4.8.3 Adherence to the brisk walking programme 
Actual adherence to the walking programme is shown in Figures 4.2 and 4.3. 
Figure 4.2 gives the average minutes of brisk walking performed each day 
during the study. Data are divided into four week periods and for each of these 
periods the 25th, 50th and 75th percentiles are given together with the 
minimum and maximum values. Figure 4.3 displays the average minutes of 
brisk walking performed each day by each subject over the study year. For the 
group as a whole the average minutes of brisk walking performed each day 
over the training year was 27.9 ± 9.2 (mean ± SO) (range 10.9 - 46.6 mins per 
day). Although this fell short of the target set it still amounted to some 14.1 ± 
4.7 miles of brisk walking per week (calculated using an average brisk walking 
pace of 4.4 mph assessed via the track walks). 
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Figure 4.2 The average minutes of brisk walking per day completed 
each four weeks by the 42 subjects in the brisk walking group. 
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Figure 4.3 The average minutes of brisk walking per day for 
each subject during the one year training period. 
5 CARDIOVASCULAR AND METABOLIC ADAPTATIONS TO BRISK 
WALKING 
5.1 Introduction 
This Chapter examines the extent to which the brisk walking programme 
elicited changes in the cardiovascular and metabolic responses of the walkers 
to submaximal exercise. Improvements in either or both of these factors would 
indicate an enhanced potential for endurance exercise in the walking group. 
5.2 Methods 
The data presented in this Chapter relates to the exercise tests described in 
Chapter Three, namely the grade-lactate treadmill test (3.3.2), the endurance 
walk (3.3.3) and the track walk (3.3.4). All three of these tests were performed 
at base line and repeated after three, six and 12 months as described in 
Chapter Four (4.7). 
Each exercise test had a specific function. The grade-lactate treadmill test 
allowed for an assessment of the physiological and metabolic responses to 
steady state exercise at four different intensities. These intensities were 
initially set at 50%, 60%, 70%, and 80% of predicted V02max by manipulating 
the treadmill incline and speed. However, although the inclines and speeds 
used for each subject remained constant throughout the study, the relative 
intensities elicited would have been altered if there were any changes in 
V02max. 
The endurance walk was conducted to facilitate an examination of the 
subjects' physiological and metabolic responses to steady state exercise 
(70% of predicted V02max at base line) over a 20 minute period. This 
provided a means of determining if the brisk walking programme influenced 
the subjects' ability to maintain steady state responses i.e. whether or not 
there was any reduction in the homeostatic disturbance caused by exercise. 
Finally, the track walk was conducted in an attempt to assess brisk walking 
speed in the walking group and whether or not this speed changed during the 
study. The track walk also provided a simple index (heart rate) of the 
physiological response to brisk walking. 
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The responses of the walkers and controls were compared primarily using two 
way analysis of variance for repeated measures. For the PRE data the Mann 
Whitney U test was used to detect differences between walkers and controls 
while the Wilcoxon matched pairs test was employed to examine changes 
over time within each group. This was due to the fact that the PRE data was 
ordinal in nature. Relationships between variables were examined using the 
Pearson Product Moment correlation coefficient. 
For data displayed in Tables or Figures the number of subjects in each group 
is 42 and 23 for walkers and controls respectively unless otherwise stated. 
Throughout this Chapter the following abbreviations are used in Tables: 'W': 
walkers; 'C': controls; 'SL': base line and 'M': months. 
5.3 Results 
Oxygen uptake values (ml.kg-1 min-1) during the grade-lactate treadmill test 
are shown in Table 5.1. For the walkers, 12 month values for oxygen uptake 
were on average 3.0 ml.kg-1 min-1 (13.2%) lower than base-line values during 
each stage of the grade-lactate test. In the control group oxygen uptake was 
also reduced but the average reduction was not as great at 2.5 ml.kg-1 min-1 
(11.5%) and there were significant interactions between walkers and controls 
at stages two and three of the grade-lactate test. Reductions in oxygen 
consumption were also seen during the study when values were expressed in 
I.min-1 but body weight remained relatively stable throughout the study (Table 
5.2). 
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Stage: 1 2 3 4 
WBL 17.3 ± 0.4 20.5 ± 0.5 24.6 ± 0.5 29.1 ± 0.6 
W3M 16.4 ± 0.5 19.7 ± 0.5 23.6 ± 0.6 28.3 ± 0.6 
W6M 15.3 ± 0.4 18.9 ± 0.5 22.8 ±0.6 27.4 ± 0.6 
W12M 14.6 ± 0.4 17.8 ± 0.5 21.6 ± 0.5 25.7± 0.6 
C BL 16.9 ± 0.7 19.6 ± 0.8 23.5 ± 1.0 27.8±1.1 
C 3M 16.8 ± 0.8 20.0 ± 1.0 24.1 ± 1.1 28.0 ± 1.2 
C6M 15.7 ± 0.7 19.0 ± 0.8 23.1 ± 1.0 27.2± 1.1 
C 12M 14.7 ± 0.7 17.1 ± 0.8 21.0 ± 0.9 25.2 ± 1.1 
Table 5.1 Oxygen uptake (ml.kg·1 min·1) for walkers and controls during 
the last minute of each stage of an incremental treadmill 
walking test performed at base line and after three, six and 
12 months of the brisk walking study (mean ± SEM). 
Interaction significant at stages 2 and 3. 
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w 
c 
Base line 
79.1 ± 1.5 
78.2 ± 2.5 
3 months 
78.4 ± 1.5 
77.6 ± 2.5 
6 months 
79.2 ± 1.5 
78.8± 2.5 
12 months 
78.9 ± 1.5 
78.9 ± 2.7 
Table 5.2 Body weight (kg) during the brisk walking study for walkers 
and controls (mean ± SEM). Interaction not significant. 
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The heart rate attained during treadmill exercise was reduced in both the 
walking and control groups as the study progressed. However, as indicated in 
Table 5.3 the reduction in heart rate was greater in the walking group than in 
the control group. Thus, the average reduction in heart rate after 12 months 
was 9 b.min·1 (6.7%) for the walkers and 5 b.min-1 (3.8%) for the controls at 
each stage of the grade-lactate treadmill test and there was a significant 
interaction at all stages of the test. Individual heart rate changes during the 
grade-lactate test after three, six and 12 months were highly variable ranging 
from -27 to +19 b.min-l and from -30 to +27 b.min-l in the walking and control 
groups respectively. Heart rate changes in the endurance walk followed a 
similar pattern to those in the grade-lactate test (Table 5.4) and a significant 
interaction was obtained for minutes 14 to 15. 
L 
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Stage: 1 2 3 4 
WBL 111 ± 1 122 ± 1 137 ± 1 153 ± 1 
W3M 106 ± 1 118 ± 1 131 ± 1 147± 2 
W6M 104 ± 1 116 ± 1 129 ± 1 145 ± 1 
W12M 103 ± 1 114 ± 1 128 ± 1 143 ± 1 
C BL 110 ± 2 122 ± 2 136 ± 2 151 ± 2 
C3M 109 ± 1 121 ± 1 135 ± 2 150 ± 2 
C6M 108 ± 2 121 ± 2 135 ± 2 152 ± 2 
C 12M 104 ± 1 117 ± 1 132 ± 2 147 ± 2 
Table 5.3 Heart rate (b.min-1) for walkers and controls during the last 
minute of each stage of an incremental treadmill walking 
test performed at base line and after three, six and 12 months 
of the brisk walking study (mean ± SEM). Interaction 
significant at all stages. 
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Minutes: 4-5 9-10 14-15 19-20 
WBL 134 ± 1 140 ± 1 143 ± 1 145 ± 1 
W3M 130 ± 1 135 ± 2 138 ± 2 141 ± 2 
W6M 129 ± 1 135 ± 1 138 ± 1 141 ± 1 
W12M 125 ± 2 130 ± 2 133 ± 2 135 ±2 
C BL 134 ± 2 140 ± 2 144 ± 2 147±2 
C3M 132 ± 2 139 ± 2 143 ± 2 146 ±3 
C 6M 132 ± 2 139 ± 2 143 ± 2 146 ±2 
C 12M 130 ± 2 136 ± 3 141 ± 2 144±2 
Table 5.4 Heart rate (b.min-1) for walkers and controls during 20 
minutes of treadmill walking (70% of V02max) at base 
line and after three, six and 12 months of the brisk walking 
study (mean ± SEM). Interaction significant for minutes 14-15. 
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Although the reductions in heart rate and oxygen uptake were not much 
greater in the walkers than they were in the controls, when these two 
parameters were examined together the differences between the two groups 
became more apparent. This is demonstrated in Figure 5.1 which shows the 
heart rate/oxygen uptake relationship from the grade-lactate treadmill test for 
walkers and controls. In the case of the walkers this relationship remained 
largely unchanged throughout the study whereas the control group 
experienced an increased heart rate for a given oxygen uptake after 12 
months as compared to base line. 
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Figure 5.1 The oxygen uptake/heart rate relationship during a four staged 
treadmill walking test at base line and after 12 months of the brisk 
walking study for walkers and controls (mean ± SEM). 
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Blood lactate concentration during the grade-lactate test is presented in Table 
5.5 and Figure 5.2. As with the heart rate responses there were reductions in 
both the walkers and controls but changes were greater in the walkers and 
there were significant interactions at stages two, three and four of the test. In 
both groups the greatest reductions were seen after six months. In the walkers 
these reductions averaged 1.1 mmol.l-1 (36.8%) at each stage of the grade-
lactate test while control group reductions averaged 0.3 mmol.l-1 (11.6%). 
Although 12 month blood lactate concentrations were slightly higher than six 
month values they were still around 30% lower in the walkers than the 
corresponding base-line values. The 12 month blood lactate values for the 
controls were around 13% lower than the corresponding base-line values. For 
both the walkers and controls the changes in blood lactate concentration 
during the endurance walk were of a similar magnitude to those observed in 
the grade-lactate test (Table 5.6) and significant interactions were obtained at 
minutes four to five, nine to ten and 19 to 20. 
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Stage: 1 2 3 4 
WBL 1.8 ± 0.1 2.2 ±0.2 3.1 ± 0.2 4.9 ±0.3 
W3M 1.4 ± 0.1 1.6 ± 0.1 2.1 ±0.2 3.4 ±0.3 
W6M 1.2 ± 0.1 1.4 ± 0.1 1.9 ± 0.2 3.0 ±0.2 
W12M 1.5 ± 0.1 1.6 ± 0.1 2.0 ± 0.1 3.1 ± 0.2 
C BL 1.5 ± 0.1 2.0 ±0.2 2.9±0.3 4.6 ± 0.5 
C 3M 1.6 ± 0.1 2.0 ±0.2 2.8±0.3 4.3 ±0.5 
C6M 1.4 ± 0.1 1.7±0.1 2.5±0.2 4.1 ±0.3 
C 12M 1.4 ± 0.1 1.7±0.1 2.6 ±0.2 4.0 ±0.4 
Table 5.5 Blood lactate concentration (mmoU·1) for walkers and controls 
at the end of each stage of an incremental treadmill walking 
test performed at base line and after three, six and 12 months 
of the brisk walking study (mean ± SEM). Interaction significant 
at stages 2, 3 and 4. 
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Figure 5.2 Blood lactate concentration at the end of each stage of an 
incremental treadmill walking test at base line and after 12 months 
of the brisk walking study for walkers and controls (mean ± SEM). 
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Minutes: 4-5 9-10 14-15 19-20 
WBL 3.7± 0.2 3.9± 0.2 3.8±0.3 3.S ± 0.3 
W3M 2.8 ±0.2 2.7±0.2 2.5±0.2 2.3 ± 0.2 
WSM 2.S ± 0.1 2.5 ±0.2 2.3±0.2 2.1 ± 0.2 
W12M 2.8 ±0.2 2.S ± 0.2 2.S±0.2 2.4 ±0.2 
C BL 3.S ± 0.2 4.0± 0.3 4.0 ±0.4 3.7 ± 0.4 
C 3M 3.5 ± 0.3 3.S± 0.3 3.4±0.4 3.2 ±0.4 
CSM 3.1 ± 0.2 3.3 ± 0.2 3.3± 0.3 3.0 ±0.3 
C 12M 3.2 ±0.2 3.4 ± 0.3 3.4 ± 0.3 3 .. 2 ± 0.3 
Table 5.S Blood lactate concentration (mmoLl-1) for walkers and controls 
during a 20 minute treadmill walk (70% of V02max) at base line 
and after three, six and 12 months of the brisk walking study 
(mean ± SEM). Interaction significant for minutes 4-5,9-10 and 
19-20. 
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Table 5.7 displays the range of change in blood lactate concentration at each 
stage of the grade-lactate test. The values shown in this Table were obtained 
by subtracting base-line values from values subsequently obtained at three, 
six and 12 months. From this Table it can be seen that the range of change is 
quite large in the control group after three, six and 12 months with both 
increases and decreases in blood lactate concentration occurring at all stages 
of the test. A similar pattern emerged in the walking group for the first two 
stages of the test. During stages three and four of the test, however, the 
direction of the response was much more uniform in the walking group. As 
shown in Table 5.7 six month changes in blood lactate concentration for the 
walkers ranged from -4.6 to +0.8 and from -6.9 to +0.3 mmol.l·1 for stages 
three and four respectively. After 12 months equivalent values ranged from 
-3.8 to +0.4 and -5.3 to +0.6 mmoU·1. Thus, practically all of the walkers 
experienced reductions in blood lactate concentration during the last two 
stages of the grade-lactate treadmill test at six and 12 months and in one 
subject a decrease of almost 7 mmoLl-l was observed. 
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Stage: 1 2 3 4 
W3M - BL -3.3/ +4.0 -2.5/ +3.4 -3.6/ + 1.3 -4.9/ +3.1 
W6M - BL -3.5/ +2.1 -3.9/+1.7 -4.6/ +0.8 -6.9/ +0.3 
W 12M - BL -3.1/ +2.8 -2.9/ +1.6 -3.8/ +0.4 -5.3/ +0.6 
C 3M - BL -1.21 + 1.3 -1.1/ +1.8 -1.6/ +1.7 -2.7/ +2.3 
C 6M - BL -1.1/ +1.3 -1.5/ +1.5 -2.8/ +1.6 -4.2/ +2.7 
C 12M - BL -1.1/ +0.6 -1.4/ +0.5 -1.4/ +1.0 -2.8/ +1.4 
Table 5.7 The range of change in blood lactate concentration (mmoLl-1) 
at each stage of an incremental treadmill walking test 
performed after three, six and 12 months of the brisk waking 
study for walkers and controls. Values were obtained by 
subtracting base-line concentrations from concentrations 
at three, six and 12 months. 
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Figure 5.3 shows that the relationship between blood lactate concentration 
and oxygen uptake during the grade-lactate treadmill test has changed in 
opposite directions for walkers and controls. In the case of the walkers blood 
lactate concentration decreased for a given oxygen uptake after 12 months as 
compared to base line whereas in the control group blood lactate 
concentration was higher for a given oxygen uptake after 12 months. As a 
consequence of this changed relationship the oxygen uptake attained at a 
blood lactate concentration of 2 mmol.l-1 increased significantly during the 
study for the walkers but not for the controls (Table 5.8). The percentage of 
predicted V02max attained at a blood lactate concentration of 2 mmol.l-1 also 
tended to increase for the walkers but their response did not differ significantly 
from that of the controls (Table 5.8). 
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Figure 5.3 The oxygen uptake/blood lactate relationship during a four staged 
treadmill walking test at base line and after 12 months of the brisk 
walking study for walkers and controls (mean ± SEM). 
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Predictions of V02max (mLkg-1min-1) from the heart rate/oxygen uptake data 
collected during the grade-lactate treadmill test are shown in Table 5.9. At 
base line predicted V02max values ranged from 25.8 mLkg-1min-1 to 46.8 
ml.kg- 1min- 1 in the walking group and from 25.9 ml.kg-1min- 1 to 45.4 
ml.kg- 1 min-1 in the control group. Values for predicted V02max remained 
relatively stable in the walking group throughout the study but there was an 
8.5% decrease in predicted V02max in the control group by the end of the 
study. The interaction effect was significant. Within the walking group 
individual changes in V02max during the study ranged from -4.7 to +10.3 
mLkg-1min-1. 
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Base line 3 months 6 months 12 months 
W 35.9 ± 0.7 36.8 ± 0.8 37.0 ± 0.9 35.0 ± 0.8 
C 35.2 ± 1.1 35.4 ± 1.1 33.6 ± 1.1 32.2 ± 1.0 
Table 5.9 Predicted V02max values (ml.kg-1min·1) for walkers 
and controls during the brisk walking study (mean ± 
SEM). Interaction significant. 
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Figure 5.4 displays the ventilatory equivalent for oxygen values (VE.V02-1) 
obtained during the grade-lactate treadmill test at base line and after 12 
months. There was an increase in VE.V02-1 values for both walkers and 
controls during the study but the increase was greater in the controls than it 
was in the walkers and there were significant interactions at stages two, three 
and four of the grade-lactate test. The increased VE.V02-1 values were related 
to the fact that oxygen uptake (I.min-1) decreased during treadmill exercise in 
both the walking and control groups (Figure 5.5) without equivalent reductions 
in the rate of ventilation (Figure 5.6). 
The R values obtained during the grade-lactate test at base line and after 12 
months are shown in Figure 5.7. For the walkers, R values were decreased 
slightly after 12 months whereas there was a clear elevation in the R values of 
the control group after 12 months and significant interactions were obtained at 
stages two, three and four of the test. 
Analysis via the Mann Whitney U test did not reveal any differences in PRE 
values between walkers and controls at any point during the study. Within 
each group, however, there were significant changes from base-line values, 
assessed using the Wilcoxon matched pairs test. The PRE values obtained 
from the grade-lactate treadmill test for both walkers and controls are shown in 
Figure 5.8. 
Data from the track walk is presented in Table 5.10. This includes the average 
time taken to complete the walk, the average walking speed and the average 
heart rate and percentage of maximum heart rate attained during the walk 
over the course of the year. There were no significant interactions between the 
walkers and controls for any of these variables. 
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Figure 5.4 Ventilatory equivalent for oxygen values (VEN02) during an 
incremental treadmill walking test at base line and after 12 months 
of the brisk walking study for walkers and controls (mean ± SEM). 
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Figure 5.5 Oxygen uptake (V02) during the last minute of each stage of an 
incremental treadmill walking test at base line and after 12 months 
of the brisk walking study for walkers and controls (mean ± SEM). 
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Figure 5.6 Ventilation (VE) during the last minute of each stage of an 
incremental treadmill walking test at base line and after 12 months 
of the brisk walking study for walkers and controls (mean ± SEM). 
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Figure 5.7 Respiratory exchange ratio (R) values during each stage of an 
incremental treadmill walking test at base line and after 12 months 
of the brisk walking study for walkers and controls (mean ± SEM). 
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Figure 5.8 Mean PRE values during an incremental treadmill walking test at 
base line and after 12 months of the brisk walking study for 
walkers and controls. * indicates significance from base line 
(Wilcoxon test). 
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Base line 3 months 6 months 12 months 
Walk time W 14.2 ± 0.2 13.8 ± 0.2 13.7 ± 0.2 13.7 ± 0.2 
(minutes) C 14.3 ± 0.2 14.3 ± 0.2 14.0 ± 0.2 14.1 ± 0.2 
Walk speed W 1.90 ± 0.02 1.96 ± 0.03 1.97 ± 0.03 1.98 ± 0.03 
(m.s- l ) C 1.88 ± 0.03 1.89 ± 0.03 1.92 ± 0.03 1.91 ± 0.03 
HR W 120 ± 3 119 ± 2 121 ± 2 119 ± 3 
(b.min- l ) C 120 ± 3 115 ± 3 122 ± 3 120 ± 3 
%HRmax W 67.7±1.5 67.3 ± 1.4 67.9 ± 1.4 67.5 ± 1.5 
C 67.7±1.5 65.2 ± 1.9 69.0±1.7 67.9 ± 1.9 
Table 5.10 Data from the 1600m track walk for walkers and controls. Variables 
shown are walk time, walking speed and the average heart rate 
(HR) and percentage of maximum heart rate (%HRmax) at base 
line, three, six and 12 months (mean ± SEM). No significant 
interactions. 
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5.4 Discussion 
As discussed earlier (Section 4.8.3) the walkers had varying degrees of 
success in adhering to the training programme. This is demonstrated by the 
large range in the minutes of brisk walking completed during the training year 
which extended from 3,966 to 16,959 (or an average of 11 to 47 minutes per 
day). However, the targets set for the brisk walking programme were very 
demanding and perhaps a little unrealistic bearing in mind the other 
commitments which many of the men had (Le. work/family etc.). Nevertheless, 
the amount of training completed by the group was impressive and the 
average subject completed 10,154 minutes of brisk walking during the study 
which equated to 27.9 minutes (or approximately two miles) of brisk walking 
every day for one year. This is considerably more than the amount of training 
achieved in most other short or long term training studies. 
The average brisk walking speed of the walking group spanned from 1.90 
m.s·1 (4.3 mph) at base line to 1.98 m.s·1 (4.4 mph) after 12 months (Table 
5.10). These speeds are within the range proposed as being necessary for 
adult men to achieve cardiorespiratory benefit (Le. 1.78 m.s·1 to 2.00 m.s·1 or 
4.0 mph to 4.5 mph) (Porcari et al. 1989). The average training intensity of the 
walking group remained unchanged throughout the study at around 68% of 
maximum heart rate. This is very close to the criterion training intensity used 
by Porcari and co-workers (1987) in their walking studies (Le. 70% of HRmax) 
and is within the range of intensity suggested by the ACSM (1991) as being 
optimal in terms of improving cardiorespiratory endurance (Le. 40% to 85% of 
V02max or 55% to 90% of HRmax). However, the range of individual training 
intensities attained by the walkers during the track tests was large extending 
from 53% to 88% of HRmax. Thus, most though not all of the walkers were 
conforming to the ACSM guidelines. 
Within the training group walking speed correlated significantly with predicted 
V02max at base line (r = 0.41), 3 months (r = 0.47), 6 months (r = 0.45) and 12 
months (r = 0.49). No significant correlations were obtained between age and 
brisk walking speed. These results are consistent with those of Hudson (1991) 
who also found a significant correlation between brisk walking speed and 
predicted V02max but not age in her female walkers. 
146 
The reductions in oxygen consumption which occurred in both groups of 
subjects indicate that energy expenditure decreased at a given treadmill 
incline as the study progressed. This finding is important and partly explains 
the changes in some of the other variables measured during the treadmill 
tests. 
It is likely that the reduction in oxygen consumption during submaximal 
treadmill walking was primarily due to treadmill habituation. Although all of the 
study participants were familiarised on the treadmill before the study 
commenced the familiarisation was not extensive and it appears that the 
subjects continued to improve their treadmill walking economy (mechanical 
efficiency) throughout the study. As can be seen from Table 5.1 the reduction 
in submaximal oxygen uptake is gradual and progressive during the study 
supporting this last point. Improvements in mechanical efficiency would result 
from changes in walking gait such that vertical displacement is reduced to a 
minimum and only the necessary musculature is recruited in the walking 
action. These improvements would be achieved via adjustments in stride 
length and frequency until both were at an optimum (Lamb, 1984; McArdle et 
al. 1981). 
As mentioned above the walkers experienced a greater reduction in 
submaximal oxygen consumption during the grade-lactate treadmill test than 
the controls. This is advantageous since it means that the relative exercise 
intensity is reduced and therefore the stress of exercise decreased. The 
difference between the two groups was only small (an average of 0.5 
ml.kg-1min-1) but is nevertheless important and may be attributed to the brisk 
walking programme since the walkers did no more treadmill walking than the 
controls. This conclusion is supported by the results of some running studies 
which have shown that trained runners are more efficient (consume less 
oxygen at a given submaximal running speed) than untrained subjects 
(Bransford and Howley, 1977; Margaria et al. 1963). Moreover, running 
economy has been shown to improve with training (Conley et al. 1984) and 
the number of years engaged in training was significantly related to running 
efficiency in a group of nine male distance runners examined by Mayhew 
(1977). 
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There is little information regarding changes in submaximal oxygen 
consumption over a period of walking training although some does exist. 
Santiago and colleagues (1987), for example, found significant reductions in 
submaximal oxygen consumption in a group of previously sedentary women 
after 20 weeks of walking training. In contrast to this, however, Seals and co-
workers (1984a) reported that oxygen uptake at the same absolute work rate 
was unaffected by six months of walking training and Hudson (1991) found no 
differences between the submaximal oxygen consumption of female walkers 
and controls during a one year training study. 
Within the walking group the reductions in heart rate (Table 5.3) during each 
stage of the grade-lactate test, which averaged 6.7% after 12 months, suggest 
some degree of cardiovascular adaptation. These findings are consistent with 
those of other walking studies which have shown decreases in heart rate of 
between 4.2% and 11.0% during submaximal exercise after various periods of 
training (Hudson, 1991; Jette et al. 1988; Pollock et al. 1971; Santiago et al. 
1987; Seals et al. 1984a). However, the changes found in the present study 
are relatively small bearing in mind the fact that the walkers' submaximal 
oxygen uptake was decreased after training by an average of 13.2% during 
the grade-lactate test. Moreover, if the percentage change in heart rate for the 
control group is deducted from the percentage change in heart rate for the 
walking group, the net reduction in heart rate for the walkers is 2.9% (4 
b.min-1). 
It will be recalled from Section 5.2 that the purpose of the endurance walk was 
to assess whether or not there were any changes in the walkers ability to 
maintain steady state responses during exercise. As can be seen from Table 
5.4 heart rate increased progressively during the endurance walk both at base 
line and after 12 months and although heart rate is lower throughout the test 
after 12 months as compared to base line the magnitude of the increase from 
five minutes to 20 minutes is still the same i.e. around 8%. Thus, although the 
brisk walking programme did lead to reductions in heart rate during the 
endurance walk, the actual increase in heart rate over time remained 
unchanged. 
Within the walking group changes in blood lactate concentration during the 
study were profound and thus provide evidence of peripheral (skeletal) 
adaptations to exercise training. Reductions were particularly great during the 
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last two stages of the grade-lactate treadmill test. After 12 months for example, 
the average reductions in blood lactate concentration for the walkers at the 
end of stages three and four were 1.1 mmoLl-l (35.5%) and 1.8 mmoLl-l 
(36.7%) respectively (Table 5.5). Even if the reductions in the control group 
are deducted from these values the net changes in the walkers still amount to 
0.8 mmoLl-l (25.2%) and 1.2 mmoLl-l (23.7%) for stages three and four 
respectively. 
The findings from this investigation are consistent with those from former 
studies examining running (Hurley et al. 1984) cycling (Mayes et al. 1987) and 
walking (Seals et al. 1984b; Hudson, 1991), all of which have shown that 
blood lactate concentration is reduced at similar absolute exercise intensities 
after a period of training. Moreover, the decreases found in the present study 
averaged around 30 to 35% during some stages of the grade-lactate test and 
endurance walk. These changes are greater than the 25 to 30% reductions 
found by Seals and co-workers (1984b) after a six month walking programme 
and greater also than the 18% reductions found by Hudson (1991) after a one 
year walking programme. 
Ivy and colleagues (1980) have shown that the onset of blood lactate 
accumulation is strongly related to muscle respiratory capacity. Moreover, it 
has been demonstrated that the running speeds equivalent to various 
reference blood lactate concentrations correlate well with endurance 
performance (Farrell et al. 1979; Lafontaine et al. 1981; Londeree and Ames, 
1975; Sjodin and Jacobs, 1981; Williams and Nute, 1983). Thus, in the 
present study, the reductions in submaximal blood lactate concentration are 
indicative of improvements in the oxidative capacity of skeletal muscle in the 
walking group. This in turn would suggest that the walkers had acquired an 
enhanced ability to perform endurance exercise. 
Within the walking group there was a beneficial alteration in the oxygen 
uptake/blood lactate relationship during the grade-lactate test such that 
oxygen uptake at a given blood lactate concentration was higher post-training 
than pre-training (Figure 5.3). This adaptation to endurance exercise has been 
shown in other training studies involving both running (Hurley et al. 1984) and 
walking (Seals et al. 1984b). As a result of this changed relationship the 
oxygen uptake at which blood lactate concentration reached 2 mmoLl-l 
increased significantly in the walking group by 11.6%, 14.9% and 6.5% after 
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three, six and 12 months respectively (Table 5.8). This provides further 
evidence to support the conclusion that the respiratory capacity of skeletal 
muscle was enhanced in the walking group. However, although the walkers 
experienced an increase of around 10% in the relative intensity (%V02max) 
attained at a blood lactate concentration of 2 mmol.l-1, their response did not 
differ significantly from that of the control group in which corresponding values 
increased by an average of 4% (Table 5.8). Thus, changes in blood lactate 
concentration were not as great when expressed in relative terms as 
compared to absolute terms. 
As far as the time course for changes in blood lactate concentration is 
concerned most of the decrease found in the walking group occurred within 
the first three months. Although there were further reductions by six months 
these were only small and by 12 months blood lactate concentrations had 
risen again slightly. Thus, three months of brisk walking would seem to be 
adequate to provoke significant adaptations in skeletal muscle and if the brisk 
walking is continued for a longer period it appears to be a case of diminishing 
returns in terms of further adaptation. 
An examination of the blood lactate data from the endurance walk (Table 5.6) 
would suggest that there was an improvement in the walkers' metabolic 
responses to steady state exercise. At base line the walkers' blood lactate 
concentrations at the end of the endurance walk had decreased by 2.7% (0.1 
mmol.l-1) from the values at five minutes. During subsequent tests the average 
reduction was 17.1 % (0.5 mmoLl-1). For the control group, 20 minute blood 
lactate concentrations at three, six and 12 months averaged only 3.9% (0.1 
mmoLl-l) lower than five minute concentrations. In the pilot study (Chapter 
Three, Section 3.12) it will be recalled that blood lactate concentration tended 
to increase rather than decrease during the endurance walk (Figure 3.8). The 
differences between these two studies are possibly related to the different 
relative exercise intensities at which the walks were conducted i.e. 80% of 
V02max in the pilot study and 70% of predicted V02max in the walking study. 
Nevertheless it was shown in the pilot study that those subjects who 
experienced the smallest increases in blood lactate concentration between 
minutes five and ten of the walk were likely to continue walking for the longest. 
Therefore, the improved blood lactate response to steady state exercise which 
occurred in the walking group during the brisk walking study may be taken as 
evidence of improved endurance fitness. 
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The lowered concentrations of blood lactate in the walking group during 
submaximal exercise may have been related to a decreased rate of lactate 
production, an increased rate of lactate removal or a combination of these two. 
A decrease in the production rate of lactate during exercise would have 
resulted if there was a reduction in glycolysis. This would occur if fat 
metabolism was increased and some suggestion of this is provided by the 
small reductions in the R values of the walkers after 12 months (Figure 5.7). It 
is also possible that glycolysis was not reduced but that a greater portion of 
the pyruvic acid produced during glycolysis was shunted into the mitochondria 
to be oxidised in the citric acid cycle. This would reduce the amount of pyruvic 
acid which was converted to lactic acid. Again this is feasible since endurance 
training has been shown to cause an increase in the size and number of 
mitochondria (Saltin and Gollnick, 1983). Donovan and Brooks (1983), 
however, have shown that the primary result of endurance training in rats is to 
increase the rate of lactate removal during exercise. This increased removal 
may be caused by an increased oxidation of lactate during exercise and an 
increased uptake of lactate by the liver and perhaps also non-exercising 
muscles for resynthesis back to glycogen (Brooks and Fahey, 1984). 
Aside from the above factors some of the decrease in blood lactate 
concentration in the walking group and all of the decrease in blood lactate 
concentration in the control group may have been related to other factors 
which influence lactate production. Oxygen uptake, for example, was 
decreased during treadmill exercise and, as mentioned above, this reduction 
in oxygen consumption would indicate a reduced energy expenditure during 
exercise. It follows thaLglycolysis may also have been reduced during 
exercise due to the reduced energy requirement. It is also possible that as the 
study progressed the subjects experienced a diminished arousal response to 
exercise testing and thus a decreased adrenaline secretion. Adrenaline 
stimulates glycolysis in skeletal muscle and therefore if adrenaline secretion is 
decreased glycolysis will also be decreased. 
The pattern of change in predicted V02max (ml.kg-1min- 1) is at first sight 
slightly surprising (Table 5.9). Although V02max was elevated in the walking 
group by 2.5% and 3.1 % after three and six months respectively, by 12 months 
V02max values were 2.5% lower than base-line values. These findings 
contradict with those of previous walking studies which have shown increases 
in V02max of between 9.7% and 27.8% after various periods of training 
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(Hudson, 1991; Jette et al. 1988; Pollock et al. 1971; Pollock et al. 1975; 
Santiago et al. 1987; Seals et al. 1984a). Moreover, in the control group, 
V02max values were decreased from base line by 4.5% and 8.5% after six 
and 12 months respectively. These reductions are greater than those which 
might be expected to occur as a consequence of the ageing process alone i.e. 
less than 1 % per year from the age of 25 onwards according to Astrand and 
Rodahl (1986). 
When the changes in predicted V02max are considered alongside the 
changes in oxygen uptake and heart rate they become easier to interpret. For 
the walkers the oxygen uptake/heart rate relationship remained relatively 
stable over the course of the study and by 12 months there was only a slight 
decrease in the oxygen uptake attained for a given heart rate. In the control 
subjects, however, there was a greater change in the oxygen uptake/heart rate 
relationship and by 12 months oxygen uptake was reduced dramatically for a 
given heart rate (Figure 5.1). The apparent decrease in V02max in the control 
subjects then can be explained in the following way. Each subject's V02max 
was predicted using an age predicted maximum heart rate and the 
submaximal oxygen uptake/heart rate relationship from the grade-lactate 
treadmill test. Since oxygen uptake was reduced for a given heart rate after 12 
months, the oxygen uptake which was predicted to occur upon the attainment 
of maximum heart rate was also reduced. This may also explain the apparent 
lack of change in V02max in the walking group. 
The previous comments highlight one of the problems in interpolating from 
submaximal data to predict maximal oxygen uptake values. In all likelihood 
the decreases in predicted V02max in the control group were related primarily 
to the reductions in submaximal oxygen uptake which occurred as the study 
progressed and the actual V02max values of the control subjects probably did 
not change a great deal. Similarly, although the changes in V02max within the 
walking group were apparently small, actual increases may have been 
masked by the changes in submaximal oxygen consumption. Whatever the 
interpretation for the changes in V02max, an important finding in the present 
study was the differential response between the walkers and controls over 
time as indicated by the results of the two way analysis of variance. This 
suggests that the brisk walking programme did have a beneficial influence on 
V02max and the difference between the walkers and controls was 6.1 % by the 
end of the study (initial percentage difference in the V02max values of the 
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walkers and controls minus the final percentage difference in the V02max 
values of the walkers and controls). 
To assess whether or not the volume or intensity of brisk walking determined 
the extent of change (from base-line values) in heart rate, blood lactate 
concentration and V02max relationships between these variables were 
examined. The average estimated miles of brisk walking per day were 
significantly correlated with the changes in heart rate at stages two, three and 
four of the six month grade-lactate test and at stages three and four of the 12 
month grade-lactate test (range in r = -0.31 to -0.37). Similarly the changes in 
heart rate after 15 and 20 minutes of the endurance walk at six months and at 
all stages of the endurance walk at 12 months were significantly related to the 
average miles of brisk walking completed per day (range in r = -0.31 to -0.37). 
Only two significant correlations were obtained between the average miles of 
brisk walking per day and changes in blood lactate concentration and these 
were at minutes ten and 15 of the 12 month endurance walk (r = -0.35 and 
-0.32 respectively). Finally, the changes in V02max after 12 months correlated 
significantly with the average miles of brisk walking completed per day (r = 
0.35). Training intensity (as assessed by the average %HRmax attained 
during the track walk) did not correlate significantly with any of the changes in 
heart rate, blood lactate or V02max. 
One other interesting finding was that changes in heart rate and blood lactate 
were related to some degree. Thus, during the endurance walk changes in 
heart rate and lactate concentration after three, six and 12 months were 
significantly correlated at every observation point i.e. five, ten, 15 and 20 
minutes (range in r = 0.43 to 0.65). Similarly, changes in heart rate and lactate 
at stages two, three and four of the grade-lactate test were significantly related 
to each other after three, six and 12 months (range in r = 0.31 to 0.67). 
The above correlations suggest a tendency for greater reductions in heart rate 
and blood lactate concentration and greater increases in V02max in those 
walkers who completed the greatest volume of brisk walking. Training 
intensity, on the other hand, appeared to have little or no influence on the 
extent of change in heart rate, blood lactate concentration and V02max. 
Finally, changes in heart rate and blood lactate concentration were related to 
some degree, suggesting that cardiovascular change was greatest in subjects 
who demonstrated the greatest metabolic change and vice versa. 
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After 12 months VE.V02-1 values were increased in the walking group by an 
average of 7.3% during the grade-lactate test. This change is in the opposite 
direction to that which might be expected since it would indicate that the 
walkers had to exhale a greater amount of air in order to utilise one litre of 
oxygen at the end of the study as compared to the beginning. When the values 
of the walking group are compared with those in the control group, however, 
they do suggest a beneficial influence of brisk walking since VE.Y02-1 values 
increased in the control group by almost twice as much as they did in the 
walking group i.e. 13.9% (Figure 5.4). 
In both the walking and control groups the increased VE.V02-1 values were 
related to the fact that oxygen uptake values were decreased during the 
treadmill test (Figure 5.5) without accompanying decreases in ventilation 
(Figure 5.6). It is difficult to explain why this should be. Taken at face value 
these results suggest that the subjects in both groups became more 
economical throughout the study in terms of oxygen consumption but that 
there were no equivalent adjustments in the rate of ventilation (although there 
was a small reduction in ventilation in the walking group). This is perplexing 
since it would be logical to expect that ventilatory adjustments would occur 
concurrently with changes in oxygen uptake. It is possible that errors occurred 
in the measurement of ventilation or oxygen uptake during the study and that 
this explains the above findings. There is no reason to suspect that this was 
the case, however, since reference gases were used to calibrate the oxygen 
analyser and these gases were in turn calibrated against a gold standard 
reference gas. Moreover, the dry gas meter was calibrated using a Tissot 
spirometer. 
The non-protein respiratory exchange ratio (R) gives an indication of the 
individual contributions of fat and carbohydrate to the total energy yield during 
exercise. Lower R values indicate a greater fat oxidation and vice-versa (an R 
value of 0.7 indicates 100% fat oxidation while an R value of 1.0 indicates 
100% carbohydrate oxidation). One of the major adaptations to running 
exercise is an increased ability to oxidise fat at a given absolute exercise 
intensity thus sparing muscle glycogen and delaying fatigue (Sjodin and 
Svedenhag, 1985). Wallington (1989) has also observed that trained subjects 
rely on fat metabolism to a greater extent than untrained subjects during 
submaximal treadmill walking. However, no differences in the R values of 
154 
walking and control subjects were evident in the one year training study of 
Hudson (1991). 
In the present investigation there was a slight decrease in the R values of the 
walkers at some stages of the grade-lactate treadmill test after 12 months 
although the changes were small (Figure 5.7). In the control group, however, R 
values were increased after 12 months and there was a significant interaction 
between the walkers and controls at stages two, three and four of the grade-
lactate test. The 12 month R values of the walkers were on average 2.7% 
lower than those of the controls. This indicates that the walking programme 
had a small but significant influence on the walkers ability to oxidise fat which 
in turn would suggest an improved potential for endurance exercise. 
The reductions in PRE (Figure 5.8) which occurred in both the walking and 
control groups during the study are probably due simply to habituation. At the 
beginning of the study the test procedures were new to the subjects and some 
of the men expressed doubts as to their ability to complete the exercise tests. 
Once they had been through all of the testing procedures, however, the 
subjects knew that they were capable of completing the exercise tests and 
thus became more confident. The reduced PRE values which occurred after 
three, six and 12 months then may simply be a reflection of the subjects' 
increased self-confidence. The Mann-Whitney U test did not reveal any 
differences in the PRE values of the walkers and controls during the study, a 
finding consistent with that of other training studies which have measured PRE 
during walking exercise (Hudson, 1991; Santiago et al. 1987). 
5.5 Conclusion 
The findings presented in this Chapter demonstrate that the endurance fitness 
of the subjects in the training group was markedly improved by the brisk 
walking programme. Particularly impressive were the reductions in blood 
lactate concentration demonstrated by the walkers during standardised 
treadmill exercise. This would suggest that the primary benefit derived from 
the brisk walking programme was an enhanced metabolic capacity within 
skeletal muscle although there was evidence also of cardiovascular 
adaptation. Moreover, most of the changes occurred within the first three to six 
months of the training programme with the second part of the training year 
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acting as a maintenance period. It appears that training volume rather than 
training intensity was the primary determinant of the extent of adaptation. 
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6 L1PIDS AND L1POPROTEINS 
This Chapter is divided into two main Sections. In the first Section the 
repeatability in serum lipid and lipoprotein measurement is assessed to give 
some indication of the precision with which these variables were quantified. In 
the second Section the effects of the brisk walking programme on lipid and 
lipoprotein metabolism are examined. 
6.1 Repeatability in serum lipid and lipoprotein measurement 
6.1.1 Introduction 
The problems associated with the measurement of serum lipids and 
lipoproteins were discussed in Section 2.4 of Chapter Two. In this Section it 
was noted that biological variation accounts for the greatest portion of the total 
variability in serum lipid and lipoprotein measurement in most cases. To 
reduce biological variation and therefore total variation it is desirable that 
multiple samples be collected and that the mean value from these samples be 
adopted to represent the true value. Thus, in the brisk walking study, two 
samples were collected from each individual at each observation point. To 
examine the extent to which precision in measurement was improved by this 
procedure the agreement between the two samples was assessed. 
6.1.2 Methods 
The procedures for lipid and lipoprotein collection and analysis are described 
in Chapter Three (Sections 3.4 and 3.5) and in the Appendices. Two 20 ml 
venous blood samples were collected from each of the 65 subjects, not more 
than five days apart, at base line and after three, six and 12 months of the brisk 
walking study. Subjects completed a 12 hour overnight fast before blood 
samples were collected. The serum form the samples was stored at -70 °C 
until required for analysis to determine the concentrations of total cholesterol, 
HDL-C, triglyceride and apoproteins A-I and B. 
Statistical analysis of the data was performed using a method to assess 
repeatability in measurement described by Bland (1987). This involved first 
plotting a scattergram of the differences between the first and second sample 
(Le. sample 1 - sample 2) against the mean to establish whether the errors 
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depended on the value of measurement Le. whether there were larger errors 
for larger values. An example of such a plot is shown in Figure 6.1. If the 
measurement error was not related to the value of measurement (which it did 
not appear to be in any of the cases examined) the next step involved the 
calculation of the error standard deviation. This was ascertained using the 
following formula: 
s - j..1.. L (X - y)2 
- 2n 
where s = error standard deviation; n = the number of subjects; X = sample 1 
and Y = sample 2. Finally, the value below which the difference between the 
two measurements (sample 1 and sample 2) would lie with a probability of 
95% was calculated as 1.96 XJ(2S2). This is subsequently referred to as the 
95% difference. 
Two tailed T tests were used to test for significant differences between 
samples 1 and 2 while the relationship between samples was examined using 
the Pearson Product Moment correlation coefficient. 
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Figure 6.1 Absolute difference plotted against the mean for paired total 
cholesterol values collected from 57 subjects at the start of the 
brisk walking study. 
6.1.3 Results 
Table 6.1 shows serum concentrations of each of the assessed variables. For 
each variable the sample 1 mean, sample 2 mean and overall mean are given 
at base line, three, six and 12 months together with the mean difference 
between samples 1 and 2. For a few subjects, only one sample was obtained 
at certain observation points and therefore these subjects were excluded from 
the analysis. Also included in Table 6.1 are the probability values resulting 
from two tailed T tests used to compare samples 1 and 2 and the coefficients 
of determination obtained from correlations between samples 1 and 2. As can 
be seen from the Table, of the 20 comparisons made there were three 
significant differences between the first and second samples. These were for 
triglyceride concentration after three months, for HDL-C concentration after 
three months and for Apo A-I concentration at base line. Finally, the Table 
shows the error standard deviation (s) and the greatest value which the first 
and second samples are likely to be separated by in 95% of cases (95% 
difference). 
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Variable Time n mean 1 mean 2 mean diff. mean P value r2 s 95% diff. 
TG BL 60 1.505 1.514 -0.008 1.510 0.903 0.742 0.376 1.042 
(mmoLl-1) 3M 57 1.478 1.314 0.164 1.396 0.023- 0.622 0.387 1.072 
6M 61 1.577 ·1.567 0.010 1.572 0.893 0.694 0.418 1.157 
12M 62 1.493 1.456 0.037 1.475 0.489 0.825 0.291 0.807 
TC BL 57 5.685 5.654 0.030 5.670 0.602 0.861 0.305 0.845 
(mmoLl-1) 3M 58 5.665 5.696 -0.031 5.681 0.421 0.923 0.206 0.569 
6M 61 5.705 5.744 -0.039 5.725 0.377 0.917 0.242 0.673 
12M 62 5.628 5.583 0.046 5.606 0.426 0.839 0.316 0.876 
HDL-C BL 59 1.404 1.421 -0.107 1.413 0.134 0.932 0.063 0.175 
(mmoLl-1) 3M 54 1.390 1.420 -0.030 1.405 0.023- 0.913 0.068 0.190 
6M 56 1.249 1.262 -0.013 1.256 0.373 0.900 0.078 0.215 
12M 57 1.296 1.309 -0.013 1.303 0.349 0.917 0.075 0.209 
Apo A-I BL 59 1.472 1.380 0.091 1.426 0.002- 0.516 0.167 0.462 
(g.I-1 ) 3M 58 1.409 1.385 0.024 1.397 0.065 0.839 0.070 0.195 
6M 61 1.409 1.424 -0.015 1.417 0.257 0.801 0.073 0.202 
12M 61 1.393 1.396 -0.003 1.395 0.786 0.867 0.056 0.155 
Apo B BL 59 0.731 0.715 0.016 0.723 0.273 0.687 0.080 0.222 
(g.l-l) 3M 58 0.731 0.721 0.010 0.726 0.093 0.918 0.033 0.090 
6M 61 0.757 0.760 -0.003 0.759 0.650 0.924 0.036 0.098 
12M 61 0.770 0.761 0.008 0.766 0.218 0.919 0.037 0.101 
Table 6.1 Comparison of serum lipid and lipoprotein values from each of two samples obtained no more than five 
days apart from the same individual. s = error standard deviation. 95% diff. = the value below which the 
difference between the two measurements will lie with a probability of 95%. - indicates significance. 
6.1.4 Discussion 
An examination of Table 6.1 reveals that the sample 1 and sample 2 mean 
values were actually quite close in all cases. In fact, if these values are 
rounded up to one decimal place then there are only three cases where the 
paired means are not identical i.e. for triglyceride after three months, for 
HDL-C after six months and for Apo A-I at base line. On this basis then, it 
appears that there is fairly good agreement between samples 1 and 2. 
However, in three cases the difference between samples 1 and 2 was 
significant, as indicated in the Table. The greatest difference was seen for 
triglyceride at three months. Here the sample 2 mean was 11 % lower than the 
sample 1 mean. 
Although the agreement between the mean value of sample 1 and the mean 
value of sample 2 was generally good the picture is different when examining 
individual subject variation. This was especially true for the triglyceride 
measurements as revealed in the last two columns of Table 6.1. In the first of 
these columns the error standard deviation is shown. The error standard 
deviation, as calculated above, gives a value which is lower than that which 
would have been obtained if the standard deviation of the differences 
(between samples 1 and 2) had been calculated in the usual way. 
Nevertheless, the error standard deviation for triglyceride is still large and the 
differences between samples become even more apparent when examining 
the next column i.e. the 95% differences. The 95% differences average around 
1.0 mmoLl-l for triglyceride. In other words, in 95% of cases the difference in 
triglyceride concentration between sample 1 and 2 is likely to be no greater 
than 1.0 mmoLl-l.However, 1.0 mmoLl-l amounts to nearly 70% of the mean 
values for triglyceride and shows that the individual variation in triglyceride 
concentration between samples 1 and 2 was large in many cases. 
The 95% differences for total cholesterol, HDL-C and apoproteins A-I and B 
were much smaller than they were for triglyceride. If, for each of these four 
variables, the 95% difference is expressed as a percentage of the mean of 
samples 1 and 2, the following average percentages are gained: 13.1 %; 
14.8%; 18.0% and 17.3% for total cholesterol, HDL-C and apoproteins A-I and 
B respectively. This reveals that in all four cases the agreement between 
samples 1 and 2 was much better than it was for triglyceride concentration, 
while the total cholesterol and HDL-C measurements demonstrated the best 
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precIsion. This last pOint is also clearly indicated by the coefficient of 
determination values shown in Table 6.1. All the r2 values for total cholesterol 
and HDL-C are above 0.8 with lower values being obtained for triglyceride 
and apoproteins A-I and B. 
6.1.5 Conclusion 
The individual variations between the first and second samples were large in 
the case of triglyceride, though there was a much better agreement between 
samples for the other variables assessed, particularly total cholesterol and 
HDL-C. These findings support those from previous studies which have shown 
that biological variation is greater for triglyceride concentration than than it is 
for the concentrations of other lipids and lipoproteins (Bookstein et al. 1990; 
Mogadam et al. 1990; Demacker et al. 1982). Nevertheless, there were 
significant differences between the first and second samples for HDL-C and 
Apo A-I concentration in addition to triglyceride concentration. Therefore, 
these findings suggest that measurement precision was improved by the 
procedure of collecting and analysing two samples from each subject and in 
some cases this procedure was essential. 
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6.2 The effects of brisk walking on serum IIpids and lipoprotelns 
6.2.1 Introduction 
It is clear from the discussion in Chapter Five that the brisk walking 
programme had a beneficial influence on the endurance fitness of the walking 
group. This was demonstrated by the profound reductions in blood lactate 
concentration which occurred during treadmill exercise and also by the 
indications of cardiovascular adaptation. The following Section examines the 
effects of these changes on serum lipids and lipoproteins and in particular on 
HDL-C which responds more consistently to exercise training than other 
lipoprotein variables. 
6.2.2 Methods 
Two 20 ml venous blood samples were collected from each subject, not more 
than five days apart, at base line, three, six and 12 months. A portion of this 
blood was used immediately for the measurement of haemoglobin 
concentration and haematocrit while the concentration of total cholesterol, 
HDL-C, triglyceride, apoproteins A-I and Band Lp(a) was determined later 
from frozen serum. Additionally, LDL-C and VLDL-C were estimated using the 
Friedewald formula (Friedewald et al. 1972). Measurement of HDL-C 
subfractions by precipitation proved unreliable and thus no information for 
H DL2-C or HDL3-C is presented here. The procedures employed in the 
measurement of the above variables are described in more detail in Sections 
3.4 and 3.5 and in the Appendices. 
Measurements of body density were made at the beginning and end of the 
study by means of hydrostatic weighing and from these the percentage of 
body fat was determined for each subject (Section 3.9). 
Energy intake was assessed at base line and six and 12 months into the study 
via the seven day weighed food inventory technique (Section 3.8). 
As in the previous Chapter the responses of the walkers and controls were 
compared using two way analysis of variance for repeated measures and 
relationships between variables were examined using the Pearson Product 
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Moment correlation coefficient. Unless otherwise stated the number of 
subjects in each group is 42 and 23 for walkers and controls respectively. 
6.2.3 Results 
Tables 6.2 and 6.3 display base-line, three, six and 12 month values for all of 
the lipids and lipoproteins determined during the study. Although there were 
significant changes through the year in HDL-C, the ratio of total cholesterol to 
HDL-C, LDL-C, Apo 8 and Lp(a) concentration, no significant interactions 
were obtained between the walkers and controls for any of these variables. 
Changes in body composition during the study are shown in Table 6.4 while 
the values for energy intake are displayed in Table 6.5. Interactions between 
walkers and controls were not significant for any of these variables although 
the body composition measures did vary significantly through the year. 
Haemoconcentration or haemodilution will affect the concentrations of blood 
lipids and lipoproteins. To ensure that these were accounted for haemoglobin 
and haematocrit were measured during the study and the results are shown in 
Table 6.6. 80th the walkers and the controls experienced a small but 
significant decrease in haemoglobin concentration as the study progressed. 
There were also significant changes in haematocrit but again these changes 
were small. No significant interactions were found when comparing the 
haemoglobin or haematocrit values of the walkers and controls. Moreover, 
serum lipoprotein concentrations were not adjusted to compensate for 
changes in haematocrit. 
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Variable Group Base line 3 months 6 months 12 months 
TC W 5.7±0.2 5.8 ± 0.2 5.8±0.2 5.8 ± 0.2 
(mmoLl-1) C 5.7 ± 0.3 5.6 ± 0.2 5.7± 0.3 5.6 ±0.2 
HDL-C W 1.4 ± 0.1 1.4± 0.0 1.3 ± 0.1 1.3 ± 0.1 
(mmoLl-1) C 1.4 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 
TC/HDL-C W 4.1 ± 0.2 4.3± 0.2 4.7± 0.2 4.6 ± 0.2 
C 4.3 ± 0.3 4.5 ± 0.3 5.0 ±0.3 4.7± 0.3 
LDL-C W 3.6 ± 0.1 3.8± 0.2 3.8 ± 0.1 3.8 ± 0.2 
(mmoLl-1) C 3.6± 0.3 3.6 ± 0.2 3.7± 0.2 3.6 ± 0.2 
VLDL-C W 0.7±0.1 0.6 ± 0.1 0.7 ± 0.1 0.7±0.1 
(mmoLl-1 ) C 0.7±0.1 0.7±0.1 0.8 ± 0.1 0.8 ± 0.1 
Apo A-I W 1.4 ± 0.0 1.4± 0.0 1.4 ± 0.0 1.4 ± 0.0 
(g.I-1) C 1.4 ± 0.1 1.4 ± 0.0 1.4 ± 0.0 1.4 ± 0.0 
Apo B W 0.7± 0.0 0.7±0.0 0.8 ± 0.0 0.8±0.0 
(g.l-l) C 0.7±0.0 0.7± 0.0 0.8±0.0 0.8 ± 0.0 
Table 6.2 Serum lipoprotein parameters for walkers and controls during the 
brisk walking study (mean ± SEM). No significant interactions. 
165 
~ 
0> 
0> 
Variable Group Base line 3 months 6 months 12 months 
TG W 1.3 (1.1 - 1.6) 1.2 (1.0 - 1.5) 1.3 (1.1 - 1.5) 1.3 (1.1 -1.5) 
(mmol.l-1 ) 
C 1.4 (1.1 - 1.8) 1.4(1.1-1.8) 1.5 (1.1 - 1.9) 1.4 (1.1 - 1.8) 
Lp(a) W 13.2 (8.5 - 20.6) 16.8 (11.1 - 25.5) 
(mg.dl-1) 
C 7.1 (3.6 -14.1) 13.3 (8.1 - 21.8) 
Table 6.3 Serum triglyceride (TG) and Lp(a) concentrations from the brisk walking study for walkers and 
controls. Values are antilogs of the mean and 95% confidence intervals of log data. No 
significant interactions. 
Variable Group Base line 3 months 6 months 12 months 
Body mass W 79.1 ± 1.5 78.4 ± 1.5 79.2 ± 1.5 78.9 ± 1.5 
(kg) C 78.2 ± 2.5 77.6 ± 2.5 78.8±2.5 78.9 ± 2.7 
BMI (kg/m2) W 25.4 ± 0.4 25.2±0.4 25.4 ± 0.4 25.4 ± 0.4 
C 24.9 ±0.7 24.8 ±0.7 25.1 ±0.7 25.1 ± 0.7 
%fat W 28.8 ± 0.8 27.7 ± 0.8 
C 29.9 ± 1.5 29.6 ± 1.6 
Table 6.4 Body mass, body mass index (BMI) and the percentage of body fat 
for walkers and controls during the brisk walking study (mean ± 
SEM). No significant interactions. 
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Variable Group Base line 
Energy (MJ) W 10.7 ± 0.3 
C 10.7 ± 0.3 
6 months 
10.4 ± 0.3 
11.0 ± 0.4 
12 months 
10.5 ± 0.3 
10.9 ± 0.5 
Table 6.5 Daily energy intake for walkers and controls during the brisk 
walking study (mean ± SEM). No significant interaction. 
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Variable Base line 3 months 6 months 12 months 
Haemoglobin W 15.0 ± 0.1 14.9 ± 0.2 14.8 ± 0.2 14.7±0.1 
(g.100 ml-1) C 15.2 ± 0.1 15.1 ± 0.1 15.1 ± 0.2 14.8 ± 0.1 
Haematocrit W 45.0 ± 0.3 44.3 ±0.5 44.9 ± 0.4 44.3 ± 0.4 
(%) C 45.5 ± 0.4 44.9 ±0.3 45.9 ± 0.4 44.8 ± 0.4 
Table 6.6 Haemoglobin concentration and haematocrit for walkers and 
controls during the brisk walking study (mean ± SEM). No 
significant interactions. 
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6.2.4 Discussion 
From Tables 6.2 and 6.3 it can be seen that the random allocation procedure 
was successful in matching the walking and control groups in terms of serum 
lipid and lipoprotein concentrations. Considering the volume of training 
completed by the walking group it is surprising that there were no significant 
interactions between the two groups for any of the lipoprotein variables or for 
the body composition and energy intake measures. 
The fact that there was no hint of change in HDL-C in this investigation is 
particularly surprising, bearing in mind the findings from many previous 
studies. Possible reasons for the lack of change in HDL-C include one or more 
of the following; 1: an insufficient volume of training; 2: an insufficient intensity 
of training; 3: the lack of an associated change in body weight/body fatness 
and 4: the base-line concentrations of serum lipids and lipoproteins. It may be, 
for example, that the initial concentrations of HDL-C were sufficiently high that 
further change was unlikely. These points will be taken in turn in the following 
discussion. 
Before commencing this discussion it is worth noting that the initial lipid and 
lipoprotein concentrations of the men in this study compare favourably with 
those of the typical British male. For example, mean total cholesterol 
concentration at base line was 5.7 mmol.l·1 for the walkers and controls (Table 
6.2). Although this is higher than desirable «5.2 mmol.l· 1) according to the 
British Hyperlipidaemia Association (Shepherd et al. 1987) it is still lower than 
the values found by Mann and colleagues (1988) for British males aged 40 to 
59 years (between 6.0 and 6.1 mmol.l-1). It is lower also than the value found 
by Pocock and colleagues (1986) in the British Regional Heart Study. In this 
study, data on over 7000 asymptomatic men aged 40 to 59 years was 
collected and the mean total cholesterol concentration of these men was 6.3 
mmol.l-1. Furthermore, the serum triglyceride concentrations of the walkers 
and controls at base line (Table 6.3) were lower than the mean triglyceride 
concentration of the British males aged 45 to 59 years in the study of Mann 
and colleagues (1988) i.e. 1.9 mmol.l-1. Mann and colleagues (1988) did not 
log transform their data, however, which may partly explain the differences. 
Finally, the mean HDL-C concentration for both the walking and control 
groups at base line was 1.4 mmol.l·1. This is higher than the mean 
concentration of HDL-C found by Pocock and colleagues (1986) in the 
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asymptomatic men examined in the British Regional Heart Study i.e. 1.1 
mmol.l·1. Thus, the subjects in the brisk walking study exhibited lipid and 
lipoprotein profiles which compare favourably with aged matched, 
asymptomatic, British males. 
In his review on exercise training and lipoproteins Haskell (1986) proposes 
that an elevation in HDL·C will frequently occur when exercise energy 
expenditure is increased by around 5 MJ (1200 kcal) per week in previously 
sedentary healthy persons. Moreover, some studies have shown significant 
changes in HDL·C concentrations with increases in energy expenditure which 
are probably less than 5 MJ per week (Hardman et al. 1989a; Marti et al. 1990; 
Stein et al. 1990). In Chapter Four (Section 4.8.1) it was estimated that the 
energy expenditure of horizontal walking for the males in the brisk walking 
study would have been approximately 93 kcal per mile assuming a walking 
speed of 4 mph. Moreover, based on the average walking speed and the 
average time spent walking it was estimated that the walkers completed an 
average of 14.1 miles of brisk walking per week (Section 4.8.3). This gives an 
estimated weekly energy expenditure of around 5.5 MJ (1300 kcal) which, if 
anything, is an underestimate as the average walking speed of the training 
group was over 4 mph. Nevertheless, this estimate exceeds the value of 5.0 
MJ suggested by Haskell (1986) as being sufficient to stimulate increases in 
HDL·C concentration. It is also greater than the weekly energy expenditures 
attained during exercise in many of the training studies mentioned above, yet 
no changes in HDL·C concentration were observed. 
Wood and colleagues (1984) argue that a certain threshold of exercise must 
be reached before beneficial changes in lipoproteins occur. Their findings 
suggest that this threshold is around eight to ten miles of running per week 
(Williams et al. 1982; Wood et al. 1983). Other authors also propose the idea 
of a threshold effect, including Superko (1991) in a recent review. This issue 
was addressed in the present investigation by re·examining the HDL·C data 
after excluding those subjects who completed less than an average of ten 
miles of brisk walking per week. This process was subsequently repeated two 
more times by removing subjects who had completed less than 15 miles of 
brisk walking per week and finally less than 20 miles of brisk walking per week 
from the analysis. The results are shown below (Table 6.7). 
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Group Controls All Walkers >10 mile.wk-1 >15 mile.wk-l >20 mile.wk-l 
n 23 42 34 16 7 
mile.wk-1: mean 14.1 ±0.7 15.7 ± 0.6 19.0 ± 0.6 21.3±0.5 
mile.wk-1: range 5.5 - 23.3 10.2 - 23.3 15.3 - 23.3 20.1 - 23.3 
HDL-C BL 1.4 ± 0.1 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.2 
HDL-C 3M 1.3 ± 0.1 1.4 ± 0.0 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.2 
HDL-C 6M 1.2 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 1.3 ± 0.2 
HDL-C 12M 1.3 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.3 ± 0.2 
Table 6.7 Miles per week of brisk walking and HDL-C concentration (mmol.l-1) for the walking group as a 
whole and for subgroups of walkers comprising those completing above 10, 15 and 20 miles per 
week. For reference purposes control values for HDL-C are also included. Values are mean ± 
SEM. 
As can be seen from Table 6.7 the amount of brisk walking performed each 
week had no influence on the change in HDL-C concentration. In all groups 
HDL-C concentration was decreased from base-line values by around 7% 
after 12 months. Furthermore, there were no significant correlations within the 
walking group as a whole between either the minutes or miles of brisk walking 
performed during the study and changes in HDL-C concentration after three, 
six or 12 months. This finding conflicts with that of some previous studies 
which have shown significant correlations between training volume and 
changes in HDL-C (Marti et al. 1990; Wood et al. 1983; Wood et al. 1988). 
The lack of change in HDL-C in the present study probably cannot be 
attributed solely to an inadequate volume of training because previous studies 
have shown changes in HDL-C with somewhat smaller volumes of training 
(Marti et al. 1990; Stein et al. 1990; Wood et al. 1983; Wood et al. 1988). It is 
possible, however, that training volume and intensity interact and that a larger 
volume of low intensity training would have had an effect on HDL-C. There is 
also the possibility that a longer period of training would have provoked 
changes in HDL-C concentration. This suggestion is supported by the study of 
Wood and associates (1983) where correlations between reported miles run 
and changes in HDL-C concentration only became significant after 12 months. 
The question of exercise intensity is a difficult one to address because in many 
longitudinal studies training intensity is not closely monitored and therefore 
can only be estimated approximately. Even when training intensity is 
measured precisely there are often factors which make comparison with other 
studies difficult. For example, there may be differences in the mode and 
frequency of training and also in the characteristics of the subject groups 
studied. In other cases the way in which exercise intensity is measured and 
defined makes cross comparison between studies difficult. Marti and co-
workers (1990), for example, used a training intensity equivalent to 85% of the 
heart rate attained at the anaerobic threshold in their study while Sasaki and 
associates (1987) prescribed their training on the basis of running velocity at 
the blood lactate threshold. 
In the present study exercise intensity was assessed during the track walks 
and averaged 68% of HRmax (range = 53% to 88%) which corresponds to 
approximately 57% of V02max (ACSM, 1991). It was assumed that the 
exercise intensity attained during the track walks was equivalent to the 
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intensity at which the walkers performed their brisk walking. It is possible that 
this intensity was too low to provoke changes in HDL-C concentration since 
most studies showing increases in HDL-C concentration with exercise training 
have employed intensities equal to or above 70% of HRmax (Faria and Faria, 
1991; Kiens et al. 1980; Mendoza et al. 1991; Stein et al. 1990; Stubbe et al. 
1983; Thompson et al. 1988; Wood et al. 1983). However, very few studies 
have examined the effects of lower intensities of exercise on serum lipids and 
even when this has been attempted the results have not always been 
conclusive. Gaesser and Rich (1984) and Savage and co-workers (1986), for 
example, have compared the effects of low (40% to 45% of V02max) and high 
(75% to 85% of V02max) intensity exercise on serum lipids. In both studies, 
however, there were no changes in HDL-C concentration in either condition. 
Ward and colleagues (1989) found no significant changes in HDL-C 
concentration in a group of overweight men who followed a walking 
programme (50 to 55% of HRmax) over a 16 week period. Brisk walking has, 
however, been shown to increase HDL-C concentration in women (Hardman 
et al. 1989a). In the latter study the average exercise intensity was 60% of 
V02max, which is similar to that of the present study, and HDL-C was 
increased by 27% over a one year period. It is possible that the conflicting 
results of these two studies may be attributed to a sex difference in the 
lipoprotein response to exercise training. It has been shown previously, for 
example, that exercise training at 70% of HRmax is sufficient to increase 
HDL-C concentration in women but not in men (Hill et al. 1989). However, in 
this same study total cholesterol concentration was reduced significantly in 
men but not in women demonstrating how confusing many of the findings from 
these studies can be. 
In an attempt to take a closer look at the effects of exercise intensity on HDL-C 
the data from the present study was re-examined in the following way. 
Subjects were removed from the data bank in a step wise fashion starting with 
those who exercised at an intensity which was below 60% of HRmax. Next 
those subjects who exercised at an intensity which was below 70% of HRmax 
were removed from the data bank and finally those subjects who exercised at 
an intensity which was below 80% of HRmax were deleted from the data bank. 
High density lipoprotein cholesterol concentration was re-calculated in each 
case and the results are displayed in Table 6.8. 
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Group Controls All Walkers >60% HRmax >70% HRmax >80% HRmax 
n 23 42 30 11 4 
%HRmax: mean 67.4 ± 1.6 67.6 ± 1.3 71.5 ± 1.3 79.2 ± 1.5 84.4 ± 1.3 
%HRmax: range 52.5 - 85.0 52.5 - 88.1 63.0 - 88.1 70.3 - 88.1 82.7 - 88.1 
mile.wk·1: mean 14.1 ± 0.7 13.7±0.8 17.1 ± 0.9 15.6 ± 0.8 
mile.wk-1: range 5.5 - 23.3 5.5 - 21.5 13.8 - 21.5 13.8 - 17.8 
HDL-C BL 1.4 ± 0.1 1.4 ± 0.1 1.5 ± 0.1 1.5 ± 0.1 1.6 ± 0.1 
HDL-C 3M 1.3 ± 0.1 1.4 ± 0.0 1.5 ± 0.1 1.5 ± 0.1 1.6 ± 0.1 
HDL-C 6M 1.2 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.5 ± 0.1 
HDL-C 12M 1.3 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 
Table 6.8 Exercise intensity (%HRmax) and HDL-C concentration (mmol.l·1) for the walking group as a 
whole and for subgroups of walkers training at intensities above 60%, 70% and 80% of HRmax. 
For reference purposes the miles per week of brisk walking completed by each group is included 
together with the control group values for HDL-C. Values are mean ± SEM. 
As can be seen from Table 6.8 there is a trend for increased concentrations of 
HDL-C in the groups exercising at higher intensities. However, the pattern of 
change over the course of the study is similar regardless of exercise intensity, 
that is, for each group shown in Table 6.8 HDL-C concentration is lower after 
12 months than it is at base line. Furthermore, correlations for the whole group 
of walkers between training intensity, as assessed by %HRmax during the 
track walk, and the changes in HDL-C concentration after three, six and 12 
months were all low (r = 0.09, 0.34 and 0.19 respectively), although the 
correlation at 6 months was significant. These results do not suggest that the 
lack of change in HDL-C concentration during this study was due solely to an 
insufficient training intensity. 
In many, but not all longitudinal studies changes in HDL-C concentration after 
a period of exercise training have occurred concomitantly with changes in 
body weight/body fat (Despres et al. 1990; Hespel et al. 1988b; Marti et al. 
1990; Sasaki et al. 1987; Wood et al. 1985; Wood et al. 1988). Although there 
were reductions in both body weight and body fat in some of the walkers in the 
present study, values for the walking group as a whole remained largely 
unchanged (Table 6.4). Thus, it is possible that the inability of the exercise 
programme to increase HDL-C was due to a lack of change in body fatness. 
However, within the walking group changes in percent body fat did not 
correlate significantly with changes in HDL-C concentration after 12 months (r 
= 0.03). This would not support the argument that the lack of change in HDL-C 
was due to the lack of change in body fat. 
When the individual data were examined more thoroughly it was found that 23 
of the 42 walkers experienced a reduction in body fat during the study. 
However, HDL-C concentration was not increased even in these subjects after 
12 months (Table 6.9). The relationship between changes in percent body fat 
and changes in HDL-C concentration after 12 months was not significant in 
this group either (r = 0.05). Moreover, in one individual body weight was 
decreased by 5.7% (from 102.3 kg to 96.5 kg) and body fat was decreased by 
24.9% (from 41.0% to 30.8%) by the end of the study and yet HDL-C 
concentration was still 9.1 % lower after 12 months than it had been at base 
line (base-line HDL-C = 1.1 mmoLl-l; 12 months HDL-C = 1.0 mmoLl-l). 
Therefore, an increase in HDL-C concentration is not an inevitable 
consequence of fat loss in some individuals. 
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Variable Observation Mean ± SEM Range 
%fat Base line 30.2 ± 1.2 21.0 - 41.0 
12 months 27.2 ± 1.0 19.3 - 35.7 
Net change -3.0 ± 0.5 -10.3 - -0.1 
Weight (kg) Base line 79.1 ± 2.2 60.0 - 102.3 
12 months 78.1 ± 1.9 59.6 - 96.5 
Net change -1.0±0.5 -5.9 - 2.7 
HDL-C (mmoLl-1) Base line 1.5 ± 0.1 0.8 - 2.4 
12 months 1.4 ± 0.1 0.8 - 2.2 
Net change -0.1 ± 0.0 -0.6 - 0.2 
Table 6.9 Percentage body fat, body weight and HDL-C concentration in 23 . 
walkers who experienced a net reduction in their percentage body 
fat by the end of the brisk walking study. 
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It has been shown previously that the extent of change in HDL-C 
concentration with training is related to pretraining values, i.e. those subjects 
who have the lowest levels of HDL-C initially are likely to experience the 
greatest changes in HDL-C after a period of training (Sutherland and 
Woodhouse, 1980). Moreover, the initial HDL-C concentration of the walking 
group in the present study was 1.4 mmoLl-l. This is higher than the base-line 
concentrations of HDL-C found in many other studies where there are 
subsequent increases in HDL-C with training. For example, in the studies of 
Hardman and colleagues (1989a), Marti and co-workers (1990), Thompson 
and associates (1988) and Wood and colleagues (Wood et al. 1983; Wood et 
al. 1988) base-line HDL-C concentrations ranged from between 1.0 and 1.3 
mmoLl-l. It is true that the different precipitation procedures used in these 
studies may partly account for the differences in HDL-C concentration. 
However, the maximum difference between procedures should not be more 
than around 0.1 mmoLl-l and if anything the manganese chloride - sodium 
heparin precipitation procedure, used in the present study, underestimates 
rather than overestimates HDL-C concentration (Valiance, personal 
communication). Thus, base-line values in the present study may actually 
have been slightly higher than 1.4 mmoLl-l. 
In view of the fact that the base-line concentration of HDL-C may have had an 
impact on the subsequent HDL-C response to exercise training, the data from 
the present study was re-examined by grouping the subjects according to their 
initial HDL-C concentrations as shown in Table 6.10. 
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Group Controls All Walkers HDL <1.8 HDL <1.5 HDL <1.2 
mmol.l-l mmoLl-l mmoLl-l 
n 23 42 35 26 10 
%HRmax: mean 67.6 ± 1.3 67.8 ± 1.5 65.3 ± 1.5 65.8 ± 2.7 
%HRmax: range 52.5 - 88.1 55.2 - 88.1 55.2 - 82.9 57.4 - 79.7 
mile.wk-l: mean 14.1 ±0.7 14.1 ± 0.8 14.0±1.0 14.9 ± 1.6 
mile.wk-1: range 5.5 - 23.3 5.5 - 23.3 5.5 - 23.3 6.7 - 21.0 
HDL-C BL 1.4 ± 0.1 1.4 ± 0.1 1.3 ± 0.0 1.2 ± 0.0 1.1 ± 0.0 
HDL-C 3M 1.3 ± 0.1 1.4 ± 0.0 1.3 ± 0.0 1.3±0.0 1.2 ± 0.1 
HDL-C 6M 1.2 ± 0.1 1.3 ± 0.1 1.2 ± 0.0 1.1 ± 0.0 0.9±0.0 
HDL-C 12M 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 1.1 ± 0.1 1.0 ± 0.0 
Table 6.10 HDL-C concentration (mean ± SEM) for the walking group as a whole and for subgroups of 
walkers whose base-line HDL-C concentrations were below 1.8, 1.5 and 1.2 mmoLl-l. The 
estimated miles per week of brisk walking and training intensity (%HRmax) of each group are 
also given together with the HDL-C concentration of the control group. 
It is evident from Table 6.10 that base-line HDL-C concentrations had little 
influence on subsequent changes in HDL-C concentration with training. In all 
subgroups the tendency was for HDL-C concentration to decrease over the 
training period. Moreover, although there was a significant correlation for the 
walking group as a whole between base-line HDL-C concentration and the 
change in HDL-C concentration after three months of training (r = -0.44), a 
similar relationship was observed in the control group (r = -0.43). It is possible 
that some of the control subjects were tempted to do some training and that 
this explains the latter correlation. However, this seems unlikely because the 
changes in blood lactate concentration, presented in Chapter Five, were much 
greater in the walkers than in the controls. Moreover, correlations between 
initial HDL-C concentration and the changes in HDL-C concentration after six 
and 12 months were not significant for either the walking or control groups. 
On the basis of the previous discussion then there is no clear cut answer as to 
why HDL-C concentration did not change with training. There is no strong 
evidence linking the lack of change in HDL-C to an inadequate volume or 
intensity of training, to the absence of any change in body fat percentage or to 
the base-line concentrations of HDL-C. However, it is possible that a 
combination of two or more of these factors may explain the lack of change in 
HDL-C. 
One other possible explanation as to why HDL-C concentration was not 
significantly increased in the walking group during this study relates to energy 
balance. In their one year training study Wood and colleagues (1983) found 
that changes in energy intake were positively correlated with changes in 
HDl-C. In the present study there was no evidence that energy intake 
(assessed via the weighed food inventory technique) had changed after six or 
12 months (Table 6.5). Bearing in mind the presumed increase in energy 
expenditure and the fact that there were no significant changes in body 
fatness in the walkers this finding is surprising. It may be that the walkers 
compensated for the increased energy expenditure during the walking by 
reducing their energy expenditure during the rest of the day. If this is true then 
it is possible that the lack of change in energy intake partly explains the 
HDL-C findings. However, other studies have shown increases in HDL-C with 
training in the absence of any changes in body fatness and energy intake 
(Hudson, 1991). 
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while there was a trend for a slight increase in triglyceride concentration in the 
control group, the difference between the two groups was not significant 
(Table 6.3). This finding conflicts with some previous reports of low triglyceride 
concentrations in trained subjects (Thompson et al. 1988; Weintraub et al. 
1989; Wood et al. 1988). Other studies, however, have failed to show 
significant changes in triglyceride concentration after a period of exercise 
training even when increases in HDL-C concentration have occurred 
(Despres et al. 1990; Marti et al. 1990). 
The significance of apoproteins A-I and B for CHD was discussed in the 
literature review (Section 2.3). Here it was mentioned that Apo A-I is the major 
protein present in HDL while Apo B is virtually the sole protein component of 
LDL. Moreover, it was noted that in some cases the discriminative powers of 
these apoproteins in detecting CHD have proved superior to those of HDL-C 
and LDL-C. Due to their significance, apoproteins A-I and B were measured in 
the brisk walking study. 
Apoprotein A-I concentrations remained extremely stable throughout the study 
in both the walking and control groups at 1.4 g.I-1. Apoprotein B 
concentrations increased in both groups after six months from 0.7 g.l-1 to 0.8 
g.I-1 and remained at this level at 12 months (Table 6.2). There was no 
difference in the response of the walkers and the controls for either Apo A-I or . 
Apo B. These findings conflict with those of several cross-sectional studies 
which have reported higher concentrations of Apo A-I (Herbert et al. 1984; 
Nagao et al. 1988; Sady et al. 1988; Thompson et al. 1983) and Apo B (Giada 
et al. 1988) in trained as compared to sedentary subjects. However, the results 
from longitudinal studies have not been as consistent as those from 
observational studies and many have found, as in the present study, that 
concentrations of Apo A-I (Despres et al. 1990; Hespel et al. 19B8a; litis et al. 
1984; Marti et al. 1990; Thompson et al. 1988; Weintraub et al. 1989; Wood et 
al. 1983) and Apo B (Despres et al. 1988; litis et al. 1984; Marti et al. 1990; 
Weintraub et al. 1989; Wood et al. 1983) are unchanged with training. 
One of the most novel aspects of this study was its examination of the effects of 
brisk walking on Lp(a) concentration. As mentioned in Chapter Two (Section 
2.3.12) individuals with elevated Lp(a) concentrations have an increased risk 
of developing CHD. This relationship is independent of other risk factors 
(Dahlen et al. 1986). The metabolic role Lp(a) is largely unknown but is 
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thought to be related to either blood clotting, lipoprotein metabolism or both. 
There has recently been an upsurge of interest in Lp(a) due to the finding that 
the amino acid sequence of apolipoprotein(a) (present in Lp(a)) is almost 
identical to that of plasminogen (Lawn, 1992). Plasminogen is a precursor of 
plasmin which is involved in the dissolution of fibrin and therefore, blood clots. 
The implication of this finding is that Lp(a) may interfere with fibrinolysis and in 
this way be related to the long term development of CHD and/or the final acute 
event precipitating a heart attack. 
The concentration of Lp(a) within an individual is largely genetically 
determined (Boerwinkle, 1992) and varies over an enormous range. Dahlen 
(1988), for example, has observed values of between 0 and 130 mg.dl·1. In the 
present study values ranged from below 5 mg.dl-1 to 79 mg.dl·1 when the 
walking and control groups were combined. Moreover, at base line 21 
subjects had Lp(a) concentrations which were above 30 mg.dl·1 and after 12 
months 25 subjects had Lp(a) concentrations which were above 30 mg.dl·1. 
According to Rees and colleagues (1990) these subjects have a relative risk of 
CHD which is two fold greater than those with lower concentrations of Lp(a). 
The mean concentrations of total cholesterol and LDL-C were also slightly (0.2 
to 0.4 mmol.l·1) higher in these subjects than the overall group means but the 
other lipid and lipoprotein concentrations of these subjects were similar to the 
group means. 
There is very little data on the effects of environmental factors on Lp(a) 
concentration. Dietary changes and drug treatments which have previously 
been shown to be effective in lowering other lipid risk factors have little or no 
effect on Lp(a) concentration (Lawn, 1992; Loscalzo, 1990). Even less is 
known regarding the effects of such factors as weight loss and exercise. In a 
study by Sonnichsen and colleagues (1990) weight loss by dieting led to an 
average 19% decrease in the Lp(a) concentrations of obese patients. Only 
one study could be found concerning the effects of exercise on Lp(a) 
concentration and this was that of Hellsten and co-workers (1989). These 
authors reported a 22% decrease (from 16.6 mg.dl-1 to 12.9 mg.dl-1) in the 
mean Lp(a) concentration of 16 men after eight days of cross-country skiing 
(seven to 16 miles per day). However, the validity of these findings is 
questionable due to the absence of a control group. 
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In the present study Lp(a) concentrations increased in both groups after 12 
months (Table 6.3). The reason for these increases is not clear although they 
were possibly related to a storage effect i.e. the concentration of Lp(a) in the 
base-line samples, which were stored for a longer period, may have 
decreased resulting in the higher values found after 12 months. Little is known 
regarding the effects of storage on Lp(a) concentration and thus this 
suggestion remains speculative. The response of the two groups did not differ 
significantly, however, and there was no evidence that exercise had a 
beneficial influence on Lp(a) concentration. 
6.2.5 Conclusion 
A significant volume of training was performed by the walkers during this study 
which resulted in an improvement in the groups capacity for endurance 
exercise as discussed in Chapter Five. Despite the improvements in fitness, 
however, the walkers did not exhibit any beneficial changes in HDL-C 
concentration or in any of the other lipids, lipoproteins or apoproteins 
monitored during this study. Neither were there any beneficial changes in 
body weight or the percentage of body fat in the walking group. Thus, the 
amount of brisk walking performed during this study showed no potential for 
improving the serum lipid or lipoprotein concentrations of this group of 
previously sedentary, normolipidaemic, middle-aged men. 
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7 THE EFFECTS OF BRISK WALKING ON BLOOD PRESSURE, 
FIBRINOGEN AND PULMONARY FUNCTION 
7.1 Introduction 
As mentioned in the literature review hypertension is one of the major risk 
factors for CHD. Moreover, there is increasing evidence to suggest that 
elevations in plasma fibrinogen concentration and impairments in pulmonary 
function are also linked to the development of CHD. Furthermore, there is 
some evidence to suggest that exercise may be of benefit in lowering systolic 
and diastolic blood pressure and reducing plasma fibrinogen concentration. 
Exercise may also lead to improvements in pulmonary function. The purpose 
of this Chapter is to examine the effects of the brisk walking programme on 
each of these factors. 
7.2 Methods 
Resting arterial blood pressure was determined using a random zero 
sphygmomanometer (Section 3.6). Plasma fibrinogen concentration was 
measured using a coagulation assay (Sections 3.4 and 3.5; Appendix 14). A 
dry spirometer (Vitalograph Ltd.) was used to evaluate various lung function 
indices (Section 3.7). All of the above variables were measured at base line 
and after three, six and 12 months. 
The responses of the walkers and controls were compared using two way 
analysis of variance for repeated measures and relationships between 
variables were examined using the Pearson Product Moment correlation 
coefficient. Unless otherwise stated the number of subjects in each group is 42 
and 23 for walkers and controls respectively. 
7.3 Results 
Systolic and diastolic blood pressure are displayed in Table 7.1. Plasma 
fibrinogen concentration is given in Table 7.2. Lung function indices including 
FVC, FEV1 and FEV1/FVC (%) are shown in Table 7.3. There were no 
significant interactions between the walking and control groups for any of 
these measures. There were significant changes through the year in plasma 
fibrinogen concentration and in FVC and FEV1. 
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Measure Group Base line 3 months 6 months 12 months 
Systolic BP W 115 ± 2 115 ± 2 115 ± 2 114 ± 2 
(mm Hg) C 122 ± 3 120 ± 3 123 ± 4 118 ± 3 
Diastolic BP W 79±2 80 ±2 79 ±2 80 ± 2 
(mm Hg) C 81 ± 3 83 ±2 84±3 83 ±2 
Table 7.1 Resting arterial blood pressure (BP) for walkers and controls during 
the brisk walking study (mean ± SEM). No significant interactions. 
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Group 
W (n = 35) 
C (n = 23) 
Base line 
238 ± 12 
251 ± 11 
3 months 
232 ± 11 
256 ± 16 
6 months 
240 ± 10 
259 ± 13 
12 months 
252 ± 11 
276 ± 15 
Table 7.2 Plasma fibrinogen concentration (mg.dl-1) for walkers and controls 
during the brisk walking study (mean ± SEM). No significant 
interaction. 
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Measure Group Base line 3 months 6 months 12 months 
FVC W 5.0 ± 0.1 4.9 ± 0.1 4.8 ± 0.1 4.8 ± 0.1 
(Litres) C 4.9 ± 0.1 4.8 ± 0.1 4.7±0.2 4.8 ± 0.1 
FEV1 W 3.9 ± 0.1 3.9 ± 0.1 3.7±0.1 3.7±0.1 
(Litres) C 3.6±0.1 3.6 ±0.1 3.4 ± 0.1 3.6 ± 0.1 
FEV1/FVC W 77.8±0.9 77.7 ± 0.8 77.7± 0.8 77.4 ± 1.0 
(%) C 74.2± 1.0 74.1 ± 1.0 73.8 ± 1.0 74.4± 1.1 
Table 7.3 Lung function measures for walkers and controls during the brisk 
walking study (mean ± SEM). No significant interactions. 
188 
7.4 Discussion 
Throughout the study mean values (Table 7.1) for resting arterial blood 
pressure in both the walking and control groups were close to values which 
would be considered normal (Le. 120/80 mm Hg). An examination of the 
individual data revealed that 11 of the subjects (six walkers and five controls) 
were mild hypertensives at the start of the study according to the criteria of 
Tipton (1991) Le. systolic and/or diastolic blood pressure> 140/90 mm Hg. Of 
these subjects, nine had elevated diastolic blood pressure. one had elevated 
systolic blood pressure and one had elevations in both diastolic and systolic 
blood pressure. There were significant but low correlations between predicted 
V02max and both systolic and diastolic blood pressure at base line when all 
65 subjects were included in the analysis (r = -0.27 and -0.30 respectively). 
This would indicate that higher V02max values were to some extent 
associated with lower resting systolic and diastolic blood pressure. 
The lack of change in blood pressure for the walking group as a whole is not 
unexpected since base-line blood pressure was not elevated. Other studies 
examining the effects of exercise on blood pressure in normotensive subjects 
have also failed to show significant changes in blood pressure with training 
(Gilders et al. 1989; Verity et al. 1990). Moreover. Tipton (1984) in his 
extensive review concerning the effects of .exercise on blood pressure 
concluded that reductions were only likely to occur in normotensive subjects 
whose initial values were above 125/85 mm Hg. 
To pursue the premise of Tipton (1984) more thoroughly changes in blood 
pressure were examined in two subgroups of walkers. One of these 
subgroups contained eight individuals whose systolic blood pressure was 
found to be above 125 mm Hg at base line. The other group consisted of 14 
subjects whose diastolic blood pressure was initially above 85 mm Hg. The 
results are displayed in Table 7.4 below. From this Table it can be seen that 
there were mean reductions of 3 mm Hg in both systolic and diastolic blood 
pressure after 12 months. These are modest reductions especially when 
considering the fact that the control group experienced a 4 mm Hg reduction in 
systolic blood pressure after 12 months (Table 7.1). However, an examination 
of the range of values reveals that although the top end of the range remains 
relatively stable during the study, the bottom end of the range is reduced 
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substantially in each group. Thus, there is some evidence that exercise had a 
beneficial influence here. 
Group n Base line 3 months 6 months 12 months 
Systolic BP 8 134± 3 131 ± 4 130 ± 6 131 ± 5 
>125 mm Hg 126 - 148 116 - 156 100 - 150 112 - 146 
Diastolic BP 14 91 ± 2 88 ± 3 91 ±2 88 ± 3 
>85 mm Hg 86 - 102 68 - 104 76 - 104 58 - 102 
Table 7.4 Systolic and diastolic blood pressure (BP) during the brisk walking 
study for walkers whose base-line values were above 125 mm Hg 
and 85 mm Hg respectively. For each variable the top row gives 
the mean ± SEM and the bottom row gives the range. 
For the walking group as a whole there were no significant correlations 
between the average minutes or miles of brisk walking completed each day 
and the changes in systolic or diastolic blood pressure after three, six or 12 
months (Le. three month values minus base-line values etc.). Similarly training 
intensity (%HRmax) did not correlate significantly with changes in blood 
pressure. When the same relationships were examined for the subgroups of 
subjects in Table 7.4, however, some interesting findings emerged. For the 
eight walkers whose base-line systolic blood pressure was above 125 mm Hg, 
changes in systolic blood pressure after six and 12 months correlated 
significantly with the average miles of brisk walking completed per day (r = 
-0.78 and -0.87 respectively). Furthermore, average minutes of brisk walking 
completed each day had an even stronger relationship with changes in 
systolic blood pressure after 12 months (r = -0.93) (Figure 7.1). Similarly there 
were significant correlations between the average miles of brisk walking 
completed per day and changes in diastolic blood pressure after three and six 
months in the 14 subjects whose base-line diastolic blood pressure was 
above 85 mm Hg (r = -0.60 and -0.58 respectively). Thus, within these 
subgroups, the subjects who walked the most miles each day were likely to 
have the greatest reductions in systolic and diastolic blood pressure during 
the study. 
190 
20 
~ 
Cl • I 
E 10 • 
E r = -0.93 ~ 
a... 
CD 0 en • • c: 
• (I) 
• Cl 
-10 c: 
III 
.s::: • U 
• 
-20 
10 20 30 40 50 
Brisk walking (minutes/day) 
Figure 7.1 The relationship between the average minutes of brisk walking per 
day and 12 month changes in systolic blood pressure (SBP) in 
eight walkers whose base-line values were above 125 mm Hg. 
There were no significant correlations between training intensity and changes 
in blood pressure in the subgroups of subjects discussed above. This supports 
the findings of Roman and colleagues (1981) that reductions in arterial blood 
pressure are not necessarily dependent on training intensity. 
In summary then, brisk walking did not influence resting arterial blood 
pressure in this group of normotensive middle-aged men. There were some 
indications, however, that exercise had a beneficial influence on blood 
pressure if base-line values were elevated above either 125 mm Hg in systole 
or 85 mm Hg in diastole. In these cases there was evidence of a dose 
response relationship with the greatest reductions in blood pressure occurring 
in those subjects who walked the most miles. 
Plasma fibrinogen concentration was determined in the present study due to 
the findings from prospective studies such as the Northwick Park Heart Study 
(Meade et al. 1986) which have shown that high concentrations of plasma 
fibrinogen predispose individuals to an increased risk of CHD. The 
mechanisms responsible for the link between plasma fibrinogen concentration 
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and CHD are not fully understood but high fibrinogen concentrations may 
promote the development of atherosclerotic plaques in addition to increasing 
the likelihood of clot formation in coronary vessels. 
The mean plasma fibrinogen values of the walkers and controls in the brisk 
walking study (Table 7.2) are lower than those obtained for healthy individuals 
in many of the prospective studies examining plasma fibrinogen and CHD 
(Table 7.5). This probably reflects the fact that the subjects in the present study 
were non or occasional smokers, since smoking is known to influence plasma 
fibrinogen concentration. For example, in the Northwick Park Heart Study 
(Meade et al. 1986) plasma fibrinogen concentrations were 30 mg.dl-1 lower 
in non-smokers compared with smokers. The plasma fibrinogen values in the 
present study are similar to those of the non-smokers in the Northwick Park 
Heart Study (Meade et al. 1986) i.e. 275 mg.dl-1. 
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Reference Age at entry (yrs) Developed CHD Healthy/free of CHD 
Meade et al. 1986 40 - 64 315 mg.dl-1 (n = 109) 290 mg.dl-1 (n = 1280) 
Stone and Thorpe, 1985 40 - 69 392 mg.dl-1 (n = 40) 300 mg.dl-1 (n = 209) 
Wilhelmsen et al. 1984 54 356 mg.dl-1 (n = 92) 330 mg.dl-1 (n = 608) 
Yarnell et al. 1991 45 - 59 409 mg.dl-1 (n = 233) 366 mg.dl-1 (n = 4408) 
Table 7.5 Plasma fibrinogen concentration at base line for healthy individuals and for those who 
subsequently developed coronary heart disease in the Northwick Park Heart Study (Meade et at 
1986), the Leigh Study (Stone and Thorpe, 1985), the Goteborg Study (Wilhelmsen et al. 1984) 
and the Caerphilly and Speedwell collaborative heart disease Studies (Yarn ell et al. 1991). 
Plasma fibrinogen concentration did not significantly differ between walkers 
and controls during the study although there was a significant increase in 
plasma fibrinogen in both groups as the study progressed. The reason for this 
increase is unknown although it may be due to the effects of storage. No other 
longitudinal studies examining the effects of exercise on plasma fibrinogen 
concentration could be found but the results from the present study do not 
concur with previous reports that endurance trained individuals have lower 
fibrinogen levels than sedentary controls (Ernst, 1990). As with the changes in 
blood pressure discussed above the lack of an exercise effect may be partly 
explained by the fact that fibrinogen values were relatively low at base line. It 
is also possible that the exercise intensity was too low to have an effect on 
plasma fibrinogen. Connelly and colleagues (1992) have recently shown, for 
example, that strenuous but not mild exercise is associated with decreased 
plasma fibrinogen concentrations. 
The mean values for the lung function parameters of the subjects in the 
present study (Table 7.3) are similar to previously reported values for lung 
function in healthy males aged 52 years and standing 1.78 metres tall i.e. 
FVC: 4.6 litres; FEV1: 3.7 litres; FEV1/FVC (%): 77.9 % (European Community 
for Coal and Steel Standardised Lung Function Testing, 1983). The reason for 
the decrease in FVC (4% in the walkers and 2% in the controls) and FEVl (5% 
in the walkers) at the end of the study is unknown. According to Astrand and 
Rodahl (1986) FVC and FEV 1 decrease by around 0.4% per year in healthy 
males aged between 20 and 70 years old. This may account for some, though 
not all, of the decrease seen in the present study. 
It has previously been reported by Newman and colleagues (1961) that 
physically active people have enhanced pulmonary function values. More 
recently a positive association between FEV 1 and physical activity was found 
in the British Regional Heart Study (Shaper and Wannamethee, 1991). In this 
study a physical activity index was calculated for each individual using 
questionnaires. Individuals were then categorised into groups according to 
their physical activity score. The results revealed a positive and graded 
response between physical activity and FEVl throughout the groups. The 
findings in the present study do not conform with the above studies but are 
consistent with previous reports that marathon runners (Kaufmann et al. 1974) 
and competitive swimmers (Ness et al. 1974) have similar values for 
pulmonary function to those of their sedentary peers. 
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When the 65 subjects from the present study were examined as a single group 
some significant relationships between base· line measures of pulmonary 
function and other CHD risk factors emerged. Height adjusted FEVl 
(FEV1/Ht2) correlated positively with V02max (r = 0.26) and HDL·C (r = 0.34) 
and negatively with triglyceride concentration (r = ·0.33) and body fat 
percentage (r = ·0.45). These findings are remarkably similar to those of 
Higgins and colleagues (1991) who observed that height adjusted FEVl was 
correlated positively with a history of strenuous physical activity, duration of 
treadmill exercise and HDL·C, and negatively with serum triglyceride and 
skinfold thicknesses in the CARDIA participants. Forced vital capacity and 
FEV 1 were also significantly and negatively correlated with systolic blood 
pressure at base line (r = ·0.32 and ·0.27 respectively) providing some 
evidence to support previous reports of a relationship between impaired lung 
function and arterial hypertension (Selby et at. 1990; Sparrow et at. 1988). 
Taken together these findings are consistent with the hypothesis that 
measures of pulmonary function are related to the incidence of heart disease 
through their association with other CHD risk factors. 
7.5 Conclusion 
Brisk walking had no influence on resting arterial blood pressure, plasma 
fibrinogen concentration or pulmonary function in this group of previously 
sedentary, asymptomatic, middle·aged men. 
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8 GENERAL DISCUSSION 
This study sought to examine the potential of brisk walking to influence 
endurance fitness and to modify some of the established risk factors for CHD 
in a group of previously sedentary, middle-aged men. These men were 
asymptomatic for CHD as defined by many of the commonly accepted CHD 
risk factors. For example, as a group the men were not obese, hyperlipidaemic 
or hypertensive. Moreover, the group was composed of only non or occasional 
smokers. Nevertheless, although the individual risk of CHD was low, a large 
number of deaths occur in these sort of men in the U.K. each year. 
In addition to the commonly accepted risk factors for CHD such as total 
cholesterol, HDL-C and blood pressure, other variables which have only more 
recently been added to the CHD risk factor list, including plasma fibrinogen, 
Lp(a) concentration and measures of pulmonary function, were examined. The 
main findings of the study were that brisk walking had a significant influence 
on the endurance fitness of the subjects but had no measurable affect on any 
6f the CHD risk factors examined. 
The physiological and metabolic changes indicative of enhanced endurance 
fitness were examined in Chapter Five. The most pronounced change to occur 
in the walkers was the marked reduction in blood lactate concentration during 
standardised submaximal exercise. This reduction averaged around 35% and 
confirmed initial expectations that endurance training invariably results in 
metabolic adaptations i.e. improvements in the oxidative capacity of skeletal 
muscle, in the absence of profound changes in V02max. 
The specific adaptations which would lead to a reduction in blood lactate 
concentration during standardised submaximal exercise were discussed in 
Chapter Two. Possible changes would include an increase in the size and 
number of mitochondria within skeletal muscle and an increase in 
mitochondrial enzyme activity. These adaptations in turn would be likely to 
enhance fat metabolism during exercise (of which there was some evidence in 
the reduced R values of the walkers) and perhaps also to improve control over 
glycogenolysis as suggested by Matoba and Gollnick (1984) and Holloszy 
and Coyle (1984). As a consequence of these changes a reduced muscle 
glycogen utilisation would be expected at a given submaximal exercise 
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intensity which would result in a sparing of muscle glycogen and therefore an 
improved capacity for endurance exercise. 
It is also possible that the reductions in blood lactate concentration during 
submaximal exercise were related to increases in the capillary density of 
skeletal muscle. Ingjer (1979), for example, found a significant increase in the 
average number of capillaries per muscle fibre in young females who trained 
by cross-country running over a 24 week period. Astrand and Rodahl (1986) 
state that an increase in capillary density will reduce the distance between the 
blood and the cell interior and therefore enhance the exchange of gases 
substrates and metabolites. This would allow for a greater aerobic contribution 
to energy provision at a given exercise intensity thus reducing the flux through 
the glycolytic pathway. It is not known whether exercise such as brisk walking 
can increase muscle capillarisation but bearing in mind the above evidence it 
is certainly a possibility. 
There was some indication also of cardiovascular adaptation within the 
walking group. Although V02max was not increased there was a significant 
reduction in heart rate during standardised, submaximal exercise. As 
mentioned in Chapter Five, it is possible that the lack of change in V02max 
was due to inaccuracies in prediction caused by alterations in the oxygen 
uptake/heart rate relationship. An increase in V02max would not necessarily 
be expected with low intensity exercise but previous studies have shown that 
elevations in V02max are possible after a period of brisk walking training 
(Jette et al. 1988; Seals et al. 1984a). The reductions in heart rate during 
submaximal exercise may have been due partly to a decreased arousal 
response to treadmill walking but it is possible also that there was a small 
increase in both maximal and submaximal stroke volume. If this was the case 
then a lower heart rate would be required to attain a given cardiac output. 
The lack of change in any of the established risk factors for CHD was 
disappointing and in the case of HDL-C perhaps surprising in the light of 
previous studies which have shown increases in HDL-C after various periods 
of endurance training. In the present study there was no indication that 
exercise had a beneficial influence on HDL-C. It is possible that the lack of 
change in HDL-C could have been related to many factors acting separately 
or in conjunction with one another. For example, the initially high HDL-C 
concentrations of the subjects and the low training intensity used relative to 
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many other studies may together explain the lack of change in HDL-C 
concentration. Coupled with the above factors it may be that the duration of the 
exercise programme was too short to provoke detectable changes in HDL-C. 
Williams and colleagues (1982) observed in their one year training study, for 
example, that endurance fitness improved sooner and at lower exercise levels 
than required for HDL-C concentration changes. However, in the present 
study there was no increase in HDL-C in a subgroup of 14 walkers who 
continued to train for a second year (Sara Herd, personal communication). 
One of the primary mechanisms which has been forwarded to explain how 
exercise might increase HDL-C concentration involves the enzyme lipoprotein 
lipase (see Chapter Two, Section 2.5.6). Lipoprotein lipase facilitates the 
removal of triglyceride from chylomicrons and VLDL. In this process 
cholesterol, protein and phospholipid remnants are transferred to 'nascent' 
HDL particles thus augmenting HDL-C production. It has been shown that 
endurance training can lead to an increase.in lipoprotein lipase activity 
(Peltonen et al. 1981; Thompson et al. 1988). Moreover, in a study by Kiens 
and Lithell (1989), eight weeks of dynamic exercise training resulted in an 
increased capillarisation of skeletal muscle as well as a 70% elevation in 
muscle lipoprotein lipase activity and an 8% increase in HDL-C concentration. 
Bearing in mind the above findings it is again surprising that the brisk walking 
programme did not result in an increase in HDL-C concentration since there 
was convincing evidence to suggest that the oxidative capacity of skeletal 
muscle was enhanced in the walking group. This enhanced capacity was 
possibly related to an increased activity of the enzymes involved in fat 
metabolism in addition to an improved supply of substrate, and thus 
triglyceride, to the muscle for use as an energy source. This in turn would 
suggest a greater triglyceride dissolution and according to the above evidence 
an increased formation of HDL-C. However, this did not appear to be the case. 
It is possible that the lack of change in HDL-C in the present study may be 
explained on the basis of energy expenditure. According to the results of the 
seven day weighed food inventories completed by the subjects after six and 
12 months there was no increase in energy intake in the walking group during 
the study. Moreover, body fat percentage was not significantly reduced in the 
walking group either. Therefore, it is feasible that the walkers may have 
compensated for the increased energy which they expended in walking by 
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reducing the amount of energy they expended in other activities. If this was the 
case, overall energy expenditure would have been unchanged and thus 
lipoprotein lipase activity and triglyceride hydrolysis may have remained 
constant. 
The results of this study are in sharp contrast to those of the women's study 
previously performed in this laboratory in which a one year programme of 
. brisk walking was effective in increasing HDL-C concentration by 27% 
(Hardman et al. 1989a; Hardman and Hudson, 1991). This difference is not 
easy to explain. The males in the present study did more walking than the 
females in the previous study (28 minutes per day or approximately 14 miles 
per week for the males versus 22 minutes per day or 11 miles per week for the 
females). Average brisk walking speed was also faster forthe males (males: 
1.90 m.s-1 (4.3 miles.hour1) at base line; 1.98 m.s-l (4.4 miles.hour1) after 12 
months; females: 1.72 m.s-l (3.8 miles.hour1) at base line; 1.87 m.s-1 (4.2 
miles.hour- 1) after 12 months). However, the average relative exercise 
intensity was similar in both studies at around 60% of predicted V02max. In 
both studies also there were indications of improved endurance fitness i.e. 
reductions in heart rate and blood lactate concentration during submaximal 
exercise, but body fatness did not change in either study. 
One explanation for the disparate findings between the two studies is that they 
are due to a sex difference. It may be, for example, that in women the 
interaction of exercise with the sex hormone estrogen causes a more profound 
effect on HDL-C than that found in men. However, there is no clear evidence 
to support this suggestion. Previous longitudinal studies examining the effects 
of exercise on HDL-C in both men and women with have yielded conflicting 
results. For example, Brownell and colleagues (1982) found an increase in 
HDL-C in men but not in women while Hill and co-workers (1989) found the 
exact opposite i.e. an increase in HDL-C in women but not in men and Farrell 
and Barboriak (1980) observed an increase in HDL-C in both men and 
women. If there is a consistent sex related difference in the HDL-C response to 
training it is not obvious from these studies. Moreover, although one previous 
review of the literature concluded that there may be a sex difference this was 
in the favour of men i.e. women were thought less likely than men to 
experience changes in HDL-C with exercise training (Goldberg and Elliot, 
1987). However, Wood and colleagues (1984), in their review on HDL-C and 
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exercise, concluded that there was no real evidence to support the suggestion 
that women are less likely than men to increase their HDL-C. 
It should be noted that the increase in HDL-C in the women's study, while 
being consistent with the differences found in cross-sectional studies, is 
unusually large compared with many longitudinal studies examining both men 
and women. Haskell (1986) states that the differences in HDL-C between 
trained and untrained subjects in observational studies are usually between 
20 and 35% while increases in HDL-C with training are usually in the order of 
5 to 16%. Thus, it could be that the change in HDL-C in the women's study 
was related to other factors as well as exercise. Increases in alcohol or fat 
consumption may cause increases in HDL-C, for example. However, there 
was no indication from seven day weighed food intake records that any 
qualitative changes occurred in the women's diets. Moreover, even if this had 
been the case the change in HDL-C was too great to be explained by modest 
dietary change alone (Hardman and Hudson, 1991). Oral contraceptives and 
hormone replacement therapy are also known to influence lipoproteins and 
therefore it is possible that these could have elicited changes in HDL-C in the 
women. Even low doses of hormone replacement therapy can increase 
HDL-C dramatically when estrogens only are used (Miller and La Rosa, 1991). 
However, only two of the 28 walkers in the women's study were on hormone 
replacement therapy (Jones et al. 1991). Moreover, although two other 
walkers were taking oral contraceptives these usually decrease HDL-C or it 
remains unchanged (Miller and La Rosa, 1991). 
Aside from sex another obvious difference between the subjects which may 
explain the incompatible findings of the two studies is the base line values for 
HDL-C. Base line HDL-C concentration was lower in the females than the 
males (1.2 mmoLl-l for women versus 1.4 mmoLl-l for men). This is surprising 
since women usually have higher HDL-C concentrations than men (Goldberg 
and Elliot, 1987). Although the precipitation procedures used in the two 
studies were dissimilar (phosphotungstic acid and magnesium chloride versus 
manganese chloride and sodium heparin in the women's and men's studies 
respectively) the difference between these methods (a maximum of 0.1 
mmoLl-l, Valiance, personal communication) is not large enough to explain 
the lower values of the women. Accepting the results at face value then it is 
possible that there was a greater potential for an exercise induced increase in 
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HDL-C concentration in the women because their initial HDL-C concentration 
was lower than that of the men. 
Finally, physical fitness levels in the women appear to have been poor when 
they began their study. The mean value for predicted V02max at base line, for 
example, was 26.7 ml.kg-1min-1 in the women. This is low considering that the 
average age of the women was 45 years and that the average predicted 
V02max value obtained for women aged 45 to 54 in the National Fitness 
Survey was 31.9 ml.kg-1min-1 (The Sports Council and the Health Education 
Authority, 1992). It is feasible, therefore, that the combination of low HDL-C 
and poor absolute fitness in the women meant that they were especially 
susceptible to increases in HDL-C with training. It is true that the average 
V02max of the men was also low compared with men of similar age in the 
National Fitness Survey, but poor fitness did not co-exist with low HDL-C 
concentration in the men's study as it did in the women's study. Despite all this 
conjecture and in the absence of more conclusive evidence, however, the 
difference between the two studies remains unresolved. 
Returning to the present study, the fact that the brisk walking programme did 
not influence any of the other CHD risk factors examined in the men was less 
surprising than its ineffectiveness in influencing HDL-C because the effects of 
exercise on these other factors are more contentious than are the effects of 
exercise on HDL-C. Moreover, the walking group as a whole did not exhibit 
undesirable levels of many of these risk factors to begin with. Although the 
mean total cholesterol concentration of the walking group was above ideal, for 
example, it was still below the national average for men of similar age. 
Moreover, mean blood pressure, plasma fibrinogen and lung function values 
for the walking group were not undesirable at the outset of the study and thus 
their potential for change may have been limited. 
The characteristics of the subject group may partly explain some of the 
findings in the present study then. These characteristics were dictated to a 
great extent by the subject selection criteria, which excluded those already at 
high risk of CHD, and perhaps also by the randomisation procedures used. In 
short the subject group represented a sample of convenience comprising only 
those who were willing to take part. Moreover, Kraemer (1981) has pointed out 
that the process of randomisation in clinical trials tends to exacerbate 
recruitment problems and dropout rates since subjects who are allocated into 
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placebo groups often feel that they have little to gain from their participation. 
Thus, the possibility of being assigned to the control group may have 
dissuaded many men who felt that they were at risk i.e. had the potential for 
lifestyle change, from participating in the present investigation. As a result, the 
subjects studied may have been healthier than average and as noted by 
Kraemer (1981), "patients who are relatively most healthy tend to be very 
unresponsive to treatment". 
What are the implications of these findings? Do they suggest that brisk walking 
is an inappropriate means of reducing CHD risk? Bearing in mind the 
epidemiological evidence the answer to this question must be no. As 
mentioned in Chapter Two, many epidemiological studies have demonstrated 
an inverse link between physical activity and mortality from CHD. On the basis 
of these studies Powell and colleagues (1987) have calculated that sedentary 
individuals have an approximately twofold greater chance of suffering from 
CHD compared with their physically active counterparts. Moreover, some 
epidemiological studies have specifically examined walking exercise and 
again the results have been positive. In the British Regional Heart Study 
(Shaper and Wannamethee, 1991), for example, men who walked 41 to 60 
minutes per day showed a decreased risk of heart attack compared with less 
active men. Paffenbarger and colleagues (1986) also examined walking 
exercise and found that all-cause mortality was 21 % lower in men who walked 
nine miles or more per week compared with those who walked below three 
miles per week. Moreover, in the most recent study of Morris and colleagues 
(1990) men who " ... rated the pace of their regular walking as fast (>4 mph) 
experienced less than half the non-fatal and fatal CHD of other men". 
In the present study, 86% of the walkers trained at a pace which was faster 
than 4 mph and 83% of the walkers covered nine or more miles per week. 
According to the above epidemiological evidence, this would confer a reduced 
risk of CHD provided the walking was continued on a regular basis. Moreover, 
although brisk walking did not influence any of the established CHD risk 
factors examined in the present study it did have a significant influence on 
endurance fitness. This would support the contention that at least part of the 
association between exercise and heart disease may be attributable to a 
direct and independent influence of exercise itself. Perhaps, as Morris and 
colleagues (1990) suggest, endurance fitness protects against CHD. This 
suggestion is substantiated by the results of many epidemiological studies 
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which have shown that exercise is independently related to the incidence of 
CHD even after the relationship between exercise and other risk factors has 
been adjusted for. 
The mechanisms which may explain the independent relationship between 
exercise and CHD are uncertain but many possibilities exist. For example, 
exercise training enhances coronary collateral development in dogs (Neill and 
Oxendine, 1979) and can retard atherosclerosis and enlarge the coronary 
arteries of monkeys (Kramsch et al. 1981). Moreover, an autopsy study on the 
marathon runner Clarence DeMar revealed that his coronary arteries were two 
to three times the normal diameter (Currens and White, 1961). Additionally, 
exercise may contribute to the "general health" of the heart by reducing resting 
heart rate, increasing stroke volume and therefore improving the efficiency of 
heart muscle (Astrand, 1988). Thus, it is biologically plausible that exercise 
training may reduce CHD risk by increasing myocardial oxygen supply or by 
reducing myocardial oxygen demand. 
Epidemiological studies such as those of Morris and colleagues (1990) and 
Paffenbarger and co-workers (1978) have shown that only those individuals 
who maintain high physical activity levels are at reduced risk of CHD, while a 
previous history of physical activity alone is not protective. On the basis of 
these results it may be that exercise protects from the acute phases of CHD 
rather than influencing its development. It has been shown, for example, that 
exercise training enhances the electrical stability of the heart (Hollmann, 
1988) and even modest physical activity associated with a " ... minimal 
improvement in physical fitness can reduce vulnerability of the myocardium for 
fatal ventricular dysrhythmias" (Leon, 1988). 
Another possibility relates to thrombosis. Blair and colleagues (1992) state 
that "total occlusion of a coronary artery as a result of thrombus formation at 
the site of an atherosclerotic stenosis is believed to be the final precipitating 
event in more than 90% of acute myocardial infarctions". Exercise training has 
been shown to reduce blood and plasma viscosity (Ernst, 1985; Ernst, 1987) 
and platelet adhesiveness and aggregability (Eichner, 1986; Rauramaa et al. 
1986). Furthermore, acute exercise increases fibrinolytic activity (EI-Sayed, 
1990). Thus, exercise training may reduce the likelihood of thrombus 
formation and/or lead to an improvement in the body's ability to dissolve 
thrombi. 
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Tunstall-Pedoe and Smith (1990) have emphasised that CHD risk is 
multifactorial and that the " ... management of risk factors in individuals should 
involve ... a flexible and multi-dimensional individual regimen, comprising all 
modifiable factors". In view of this and the above evidence, brisk walking ought 
to be considered as part of an intervention package by which CHD risk can be 
modified. There is much to recommend brisk walking in this role. Apart from 
the possibility that it may directly influence CHD risk, Tunstall-Pedoe (1990) 
has emphasised that exercise also " ... makes people think about their bodies, 
what they can do with them and how they should eat, (and therefore) performs 
a useful promotional function". Moreover, brisk walking is an acceptable form 
of exercise. This was demonstrated clearly in the present study in which 42 of 
the original 48 walkers (88.5%) continued to exercise regularly throughout. 
This represents only a 12.5% attrition rate which is substantially lower than the 
attrition rates typifying many exercise programmes i.e. 50% or more according 
to Martin and Dubbert (1982). The incidence of injuries in the present study 
was also very low which was especially encouraging considering that the men 
were previously sedentary. This supports the evidence from other studies that 
orthopaedic injuries occur more frequently during running programmes than 
during walking programmes (Seals et al. 1984a). 
Astrand (1988) argues that "from many points of view, it is a risk factor to 
quickly change from the life style of a huntergatherer to one of an urbanised 
high-technologist". The epidemiological evidence supports this viewpoint and 
demonstrates that individuals who perform moderate amounts of brisk walking 
on a regular basis are at a decreased risk of suffering from CHD in 
comparison with individuals who are less active. It remains to be shown 
exactly how brisk walking lowers an individuals risk of contracting CHD. 
However, brisk walking does not appear to be influencing CHD risk through 
any of the mechanisms which this study has examined markers for. Therefore, 
the results of this study strengthen the hypothesis that endurance fitness, in its 
own right, protects against CHD. 
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Appendix 1: Information supplied to the subjects and statement of 
Informed consent 
BRITISH HEART FOUNDATION PROJECT -1989 
Purpose of the study: 
The purpose of the study is to examine the influence of regular brisk walking 
on i) physical fitness, ii) the amount and distribution of body fat, iii) the 
concentration in blood of cholesterol and other markers of coronary heart 
disease risk and iv) psychological well being. 
Criteria for acceptance into the study: 
1. Aged 42-59 on entry into the study. 
2. Neither currently on a programme of regular exercise nor employed 
in a strenuous job. 
3. Free of known cardiovascular disease. 
4. Not at high risk of coronary heart disease (CH D), i.e. non-smoker or 
occasional smoker, blood pressure and blood cholesterol below the 
high range. 
5. Willing to accept random allocation to either the Walking Group or to 
the Control Group, with a 2 : 1 chance of being in the Walking 
Group. A programme of walking and monitoring will be conducted 
for the Control Group after the present study is complete. 
Explanation of the procedures: 
A) Four exercise tests will be undertaken, three of these in the laboratory -
after a practice session to become familiar with the apparatus. 
i) Test one involves walking uphill on a motorised treadmill at a fixed 
speed for 16 minutes. The gradient will be increased at the end of 
each four minute period. Heart rate will be recorded throughout from 
three chest electrodes and expired air will be collected at intervals 
using a mouthpiece and respiratory valve. 
ii) The test described above will be repeated but using treadmill 
gradients selected to represent 50%, 60%, 70% and 80% of each 
man's estimated maximal capacity. Five very small (20 Ill) samples 
of blood will be obtained by pricking the thumb, before exercise and 
at the end of each four minute period of walking. 
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iii) On another occasion, subjects will walk for 20 minutes on the 
motorised treadmill at a gradient selected to be equivalent to 70% of 
their own estimated maximum capacity. Heart rate and expired air 
will be collected as described above and thumbprick blood samples 
will be taken before and on three occasions during the test. In 
addition, a 10 ml blood sample will be taken from a vein in the arm 
before and after the test. Subjects will also exhale maximally into an 
instrument which measures lung function before and after exercise. 
iv) Finally, each subject will walk one mile outside, at a brisk pace. 
During the walk heart rate will be recorded from two chest 
electrodes using short range telemetry. 
8) The amount of fat under the skin will be determined using calipers at ten 
different sites and a number of body girths will be measured. Total body fat 
will be determined from body density derived by underwater weighing. 
This is done in a tank of warm water (36 OC) and involves breathing out 
maximally through a snorkel whilst submerged. The volume of air left in the 
lungs, after breathing out as far as possible, is determined by taking three 
deep breaths from a bag of 100% oxygen fitted to the snorkel. 
C) Two, 20 ml samples of blood will be taken from a vein in the arm for the 
analysis of serum cholesterol and other markers for CHD. This needs to be 
done in the morning after a 12 hour fast. Haemoglobin concentration and 
the proportion of red cells in blood will also be measured in these blood 
samples. 
D) Resting blood pressure will be measured. 
E) All food and drink consumed over a period of one week will be weighed 
and recorded so that average daily nutrient and energy intake can be 
determined. 
F) Several questionnaires will be completed. These can all be done at home. 
They ask questions about i) your current physical activity level, ii) previous 
and past smoking habits and, iii) how you feel about yourself (self-esteem). 
Walking: 
Those allocated to the Walking Group will follow a brisk walking programme. 
This will be individually prescribed on a fortnightly basis and will increase to 
an average of about three miles a day by the end of six months and thereafter. 
The first session will be on the University site so that each man's self-selected 
brisk pace can be determined. 
The Control Group will be asked to maintain their habitual lifestyle until this 
trial is complete. After one year the subjects in this group will embark on the 
brisk walking programme described above. 
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Repeated measurements: 
The measurements described above, with the exception of the underwater 
weighing, will be repeated after three months of regular walking and again 
after six months. After one year all measurements, including the underwater 
weighing, will be repeated. 
Risks and discomforts: 
Although all exercise testing will be at a submaximallevel, the possibility 
exists that, very occasionally, certain changes may occur during the test. They 
include abnormal blood pressure, fainting, disorder of the heart beat and, in 
very rare instances, heart attack. The preliminary screening undertaken before 
the study is designed to minimise such risks. Sampling of venous blood may 
cause minor bruising or haematoma (a small accumulation of blood under the 
skin). All experiments will be conducted by trained and experienced staff and 
closely monitored. You should feel free to ask for more information or 
explanation at any time. 
Benefits: 
The trial is being conducted because it is not known whether regular, brisk 
walking can influence fitness and/or health in men. There can therefore be no 
guarantee that you personally will benefit from taking part. We do, however, 
have every expectation that you will enjoy contributing to a worthwhile study. 
The very least you will gain is a greater understanding of the body's 
responses to exercise. 
If you need more information please contact Oavid Stensel (4326), Katherine 
Brooke-Wavell (3005) or any other member of the BHF Research Group. 
Or Adrianne Hardman (3265) 
Or Peter Jones (3003) 
Or Nick Norgan (3009) 
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BRITISH HEART FOUNDATION PROJECT -1989 
Statement of informed consent. 
I understand that I will be asked to undertake the series of tests described 
above. All procedures have been described and explained to me and I am 
aware that I may withdraw from the study at any time without the need for 
explanation. 
I agree to take part in the British Heart Foundation walking study. 
Signed ............................................................... . 
Date .................................. . 
Witnessed by ......................................................... . 
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Appendix 2: The calculation of oxygen uptake and carbon dioxide 
production 
VE STPD = VE ATPS x (BP - Swyp,) x 2Z.a 
760 273 + t 
Where: 
BP = barometric pressure in mm Hg. 
SWYP = saturated water vapour pressure (mm Hg) at ambient temperature. 
t = ambient temperature (degrees Celsius). 
ATPS = ambient temperature and pressure, saturated with water vapour. 
SWVPt was calculated as follows: (1.001 x t) - 4.19 
V02 = Vol. 02 inspired - Vol. 02 expired. 
Vol. 02 inspired =VI X fl~ 
100 
Vol. 02 expired 
Similarly VC02 = Vol. C02 expired - Vol. C02 inspired. 
It is assumed that F102% is 20.93% and FIC02% is 0.03% as the composition 
of inspired air is very stable. 
FE02%, FEC02% and VE are measured in the expired air sample. VI is 
derived from the Haldane transformation. 
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The Haldane transformation uses the concentration of nitrogen (assumed to 
be metabolically inert) in the inspired and expired air to derive the volume of 
air inspired from direct measurements of the volume expired. 
i.e. As concentration = ~ 
volume 
malZlZ !:lI2 illlZgir~d = FIN2% and 
VI 
malZlZ !:lI2 ~~gi r~d = FEN2% 
VE 
But mass of N2 inspired = mass of N2 expired 
therefore 
and VI = EE!:lI2% x VE 
FIN2% 
VI can therefore be derived if VE is measured and FIN2% and FEN2% are 
known. 
FIN2% and FEN2% are found by subtracting the concentration of carbon 
dioxide and oxygen from 100%. 
Finally, the respiratory exchange ratio (R) is calculated as: veo? 
V02 
240 
Appendix 3: Treadmill calibration 
Treadmill calibration took place every three months during the brisk walking 
study. Calibration was performed by measuring the length of the treadmill belt 
and the time taken for it to complete 50 revolutions at the speeds used in the 
tests (Le. 1.34 m.s-l and 1.56 m.s-1). By multiplying the length of the belt by 50 
this gave the total distance (in metres) the belt would have travelled. This 
distance was then divided by the number of seconds taken to complete it to 
determine the actual speed at which the belt was travelling. The Table below 
gives the actual speeds obtained during the calibrations where the dial 
speeds were set at 1.34 m.s-l and 1.56 m.s-l. At the bottom of the Table the 
mean, standard deviation (SO) and coefficient of variation (CV) for each speed 
are shown. 
Calibration 
Base line 
3 months 
6 months 
9 months 
12 months 
15 months 
Mean 
SO 
CV (%) 
Dial speed = 1.34 m.s-l 
1.38 
1.33 
1.38 
1.37 
1.38 
1.36 
1.37 
0.02 
1.5 
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Dial speed = 1.56 m.s·l 
1.64 
1.59 
1.59 
1.63 
1.58 
1.56 
1.60 
0.03 
1.9 
Appendix 4: Blood lactate assay 
Blood lactate was measured using a modification of the enzymatic method 
described by Maughan (1982). Samples were assayed in duplicate. 
Principle. 
LDH 
lactate + NAD+ ------------------> pyruvate + NADH + H+ 
NAD = nicotinamide-adenine-dinucleotide 
LDH = lactate dehydrogenase 
peprotejnjsatjoo, 
20 III of blood was deproteinised in 200 III of perchloric acid (2.5%). The 
sample was then mixed thoroughly, centrifuged and stored at -70 0C until 
required. 
Solutions. 
Perchloric acid (2.5%): 10.4 ml of 60% perchloric acid made up to 250 ml with 
distilled water gave a 2.5% perchloric acid solution. 
Hydrazine buffer (pH 9.1): 6.5 g hydrazinium sulphate; 24.26 ml hydrazine 
hydrate; and 1 g ethylenediaminetetra-acetic acid (EDTA) made up to 500 ml 
with distilled water. 
Lactate diluent (0.07 mole hydrochloric acid): this was made up from a 1 mole 
solution of hydrochloric acid (86 ml of hydrochloric acid, specific gravity 1.18, 
made up to 1 litre with distilled water). 70 ml of 1 mole hydrochloric acid was 
made up to 1 litre with distilled water giving a 0.07 mole hydrochloric acid 
solution. 
Reaction mixture: prepared immediately before use: 2 mg of NAD and 10 III of 
LDH per ml of hydrazine buffer. 
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Standards. 
These were made up from 1.0 mole lactate stock and included the following 
concentrations: 2.5; 5.0; 7.5; 10.0 and 15.0 mmoLl-l. 
Procedure. 
1. Samples were allowed to warm up to room temperature for at least one 
hour. 
2. Samples were mixed thoroughly in a vortex. 
3. Samples were centrifuged for four minutes at 12,000 rpm. 
4. 20 III of supernatant or standard was pipet1ed into a glass test tube. 
5. 200 III of reaction mixture was added to each test tube. 
6. Tubes were vortexed and left to incubate for 30 minutes. 
7. 1 ml of lactate diluent was added to the test tubes which were again 
vortexed. 
8. The fluorescence of the samples and standards was determined using a 
Locarte fluorimeter. Lactate diluent was used as a blank. 
g. A linear regression equation was calculated using the known standard 
concentrations and their respective fluorescence values. The concentration 
of lactate in the samples was ascertained using this regression equation. 
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Appendix 5: Haemoglobin assay 
Haemoglobin concentration was determined using a test kit. Samples were 
assayed in duplicate. 
Kit: Test - Combination Haemoglobin. 
Supplier: Boehringer Mannheim, U.K. Ltd. 
Principle. 
haemoglobin + cyanide + ferricyanide ----------------> cyanmethemoglobin 
Solution. 
Drabkin's solution: one bottle of potassium hexacyanoferrate("I) solution and 
one bottle of potassium cyanide solution (both supplied with the kit) were 
dissolved in distilled water and made up to 1 litre in a graduated cylinder. 
Procedure. 
1. 20 III of whole blood was collected into micro-pipettes and immediately 
diluted into 5 ml of Drabkin's solution. 
2. The samples were shaken vigorously. 
3. The absorbance of the samples was measured at a wavelength of 546 nm 
using an Eppendorf photometer (model 1101 M). Drabkins' solution was 
used as a blank. 
4. Haemoglobin concentration (g.1 00 ml-1) was determined by multiplying the 
absorbance value of the sample by 36.77. 
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Appendix 6: Total cholesterol assay 
Total cholesterol concentration was determined from serum samples by an 
enzymatic colourimetric method using a commercially available kit. Samples 
were assayed in duplicate on a Cobas Mira automated analyser. 
Kit: Cholesterol C-system, CHOD-PAP method. 
Standards: Preciset Cholesterol. 
Quality control: Precinorm L. 
Supplier: Boehringer Mannheim, U.K. Ltd. 
Principle. 
cholesterol esterase 
cholesterol ester + H20 ------------------------------> cholesterol + ReOOH 
cholesterol oxidase 
cholesterol + 02 -----------------------------> A4-cholestenone + H202 
POD 
2 H202 + 4-aminophenazone + phenol ---------> 4-(p-benzoquinone-mono-
imino)-phenazone + 4 H20 
Solution. 
Bottles of reagent solution supplied were dissolved in distilled water and 
made up to 32 ml. 
Procedyre, 
1. Samples were removed from the freezer and allowed to warm to room 
temperature. 
2. Samples were mixed in a vortex, dispensed into plastic tubes and loaded 
onto the Cobas Mira analyser. 
3. 5 ~I of sample or control sera was pi petted into a cuvette. 
4. 350 ~I of reagent was added to each cuvette. 
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5. Samples were mixed and left to incubate for 7.5 minutes. 
6. The absorbance of the samples was read at a wavelength of 500 nm. 
7. Sample concentrations were calculated by the Cobas Mira analyser using 
a regression equation derived from a reagent blank and one pOint 
standard (Precinorm L). 
NB During the storage study (Section 3.11) the above assay was performed 
manually at Loughborough University. In this case the procedures varied 
slightly as follows. The volumes of sample and reagent were 1 0 ~I and 1 ml 
respectively. The incubation period was 30 minutes. Samples were read on 
an Eppendorf photometer (model 1101 M) at a wavelength of 546 nm. 
Absorbance values from Preciset cholesterol standards were paired with the 
respective known concentrations of the standards to calculate a linear 
regression equation. Sample concentrations were derived from this equation. 
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Appendix 7: Precipitation procedures for the determination of 
HDL-C and HDL3- C 
Serum samples requiring precipitation were stored at 4 oC after collection. 
Precipitation was performed within five days of sample collection. Further 
details of the precipitation procedures used have been reported elsewhere 
(Farish and Fletcher, 1983; Warnick and Albers, 1978). 
Principle. 
An insoluble complex is formed between a polyanion-divalent cation and 
lipoprotein particles. Manganese and heparin selectively precipitate 
chylomicrons, VLDL and LDL leaving HDL in solution. Following 
centrifugation, HDL is measured in the supernatant. 
Solutions. 
Sodium Heparin: this solution was made up fresh each day using Sigma 
grade I sodium salt from porcine intestinal mucosa which was dissolved in 1 
ml of 9 g.I-1 saline. The weight of sodium heparin used depended on the 
number of USP units as follows: 
181 USP units = 31.5 mg per ml of saline 
178 USP units = 32.0 mg per ml of saline 
176 USP units = 32.4 mg per ml of saline 
Manganese Chloride (1 moLl-I): 4.95 g of MnCL2.4H20 were dissolved in 25 
ml of distilled water in a volumetric flask. 
EDTA (Ethylenediaminetetra-acetic acid) (0.4 moLI·1): 14.88 g of EDTA, 
disodium salt, was dissolved in 100 ml of distilled water. Solubilisation of the 
EDTA was achieved by adjusting to pH 7.7 while stirring. 
Dextran sulphate (15.4 g.l-1): 77 mg of dextran sulphate was dissolved in 5 ml 
of 9 g.l-l saline. This solution was only required if HDL subfractions were 
being measured. 
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Procedure for HPL-C determination. 
1. 40 III of sodium heparin solution was added to 1 ml of serum. 
2. The sample was immediately mixed in a vortex for ten seconds. 
3. 100 III of manganese chloride was added to the sample. 
4. The sample was again mixed in a vortex for ten seconds. 
5. The sample was incubated in an ice bath at 4 oC for 30 minutes. 
6. The sample was centrifuged (4 OC) for 25 minutes at 4,000 rpm. 
7. The supernatant was removed and stored at -70 0C until' required for total 
HDL analysis (Appendix 8) or for further precipitation of HDL2 cholesterol 
as described below. If precipitant was floating the supernatant was 
removed using a Millipore filter. 
Procedure for HPLa-C determination. 
1. 50 III of dextran sulphate was added to 500 III of the thawed heparin/ 
manganese chloride supernatant. 
2. The sample was mixed in a vortex for five seconds. 
3. The sample was left to stand for 20 minutes at room temperature. 
4. The sample was centrifuged (4 OC) for 30 minutes at 4,000 rpm. 
5. The supernatant was removed and used for HDL3-C determination as 
described in Appendix 8. 
NB Problems were experienced in the precipitation of HDL2-C from the serum 
samples obtained during the brisk walking study. In the event no reliable 
information was gained from the brisk walking study regarding HDL 
subfractions. A study (Section 3.11) was conducted to investigate whether or 
not the problems in HDL-C subfraction measurement were caused by storage. 
In this study there were slight variations to the above procedures (see Section 
3.11.2). 
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Appendix 8: HDL-C and HDL3-C assay 
Procedure. 
1. Precipitated samples were removed from the freezer and given at least one 
hour to warm to room temperature. 
2. Samples were mixed in a vortex. 
3. 250 III of supematant was added to 10 III of EDTA. 
4. Samples were again mixed in a vortex and left to stand for five minutes. 
5. The procedure for total cholesterol (Appendix 6) was then followed using 
15 III of sample or, in the case of the storage study, 20 III of sample. 
6. The concentrations of HDL-C and HDL3-C derived from the cholesterol 
assay were multiplied by correction factors as follows: 1.1856 x HDL-C 
concentration and 1.2896 x HDL3-C concentration. These correction 
factors were required to adjust for dilution of the samples by heparin, 
manganese chloride and dextran sulphate. 
7. HDL2-C concentration was calculated as HDL-C - HDL3-C. 
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Appendix 9: Triglyceride assay 
Triglyceride concentration was determined from serum samples by an 
enzymatic colourimetric method using a commercially available kit. All 
samples were assayed in duplicate on a Cobas Mira automated analyser. 
Kit: Triglycerides GPO-PAP 
Quality control: Precinorm L. 
Supplier: Boehringer Mannheim, U.K. Ltd. 
Principle, 
lipase 
triglycerides + 3 H20 ---------------> glycerol + 3 RCOOH 
GK 
glycerol + ATP -------> glycerol-3-phosphate + ADP 
GPO 
glycerol-3-phosphate + 02 -----------> dihydroxyacetone phosphate + H202 
peroxidase 
H202 + 4-aminophenazone + 4-chlorophenol __________________ c_> 
Solutions. 
Buffer solution 
Reagent strips 
4-(p-benzoquinone-mono-imino)-phenazone + 2 H20 + HCL 
Both of the above were supplied with the kit. A reagent strip was immersed in 
a bottle of buffer solution, stirred for ten seconds and left for five minutes. The 
buffer was again stirred with the reagent strip for ten seconds and the strip was 
discarded. 
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Procedyre. 
1. Serum samples were removed from the freezer and given at least one hour 
to thaw. 
2. Samples were mixed in a vortex, dispensed into plastic tubes and loaded 
onto the Cobas Mira analyser. 
3. 5 111 of sample or control sera was pipetted into cuvettes. 
4. 350 111 of reaction mixture was added to the cuvettes. 
5. The samples were mixed and left to incubate for 7.5 minu1es. 
6. The samples were read at 500 nm. 
7. Sample concentrations were calculated by the Cobas Mira analyser using 
a regression equation derived from a reagent blank and one point 
standard (Precinorm L). 
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Appendix 10: Calculation of LDL-C and VLDL-C 
Friedewald and colleagues (1972) devised the following formula to calculate 
LDL-C and VLDL-C (mg.dl-1): 
triglyceride concentration + 5 = VLDL-C 
LDL-C = total cholesterol - HDL-C - VLDL-C 
This formula is based on two observations. One is that the ratio of the mass of 
triglyceride to that of cholesterol in VLDL is relatively constant at about 5:1 in 
normal subjects. The other is that when chylomicrons are not detectable (as is 
the case in serum from fasted subjects), most of the triglyceride in plasma is 
contained in VLDL. 
If values are expressed in mmol.l-1 (as in this thesis) then triglyceride 
concentration is not divided by 5 but by 2.2 to obtain VLDL-C. 
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Appendix 11: Assay for Apoprotelns A-I and B 
Apoproteins A-I and B were determined from serum samples by 
immunoprecipitin analysis. Measurements were made on a Cobas Mira 
automated analyser using a commercially available kit. 
Kit: Antibody reagent set II for Apo A-I or Apo B. 
Standards: Calibration set for Apo A-I or Apo B, concentrations as follows: 
Apo A-I: 0.26, 0.65,1.30,1.96,2.61 g.I-1. 
Apo B: 0.29, 0.72, 1.44,2.15,2.87 g.l-l. 
These standards were calibrated against Centre for Disease (CDC) reference 
material. 
Supplier: Atlantic Antibodies 
Stillwater 
Minnesota 
55082 USA. 
Principle. 
A microvolume of sample (antigen) is diluted and mixed with antiserum 
(antibody) in a reaction cuvette. Insoluble antigen-antibody complexes form 
producing turbidity in the mixture and thus increasing the amount of light 
scattered by the solution. The absorbance of the solution is then measured at 
the analytical wavelength. A calibration curve is generated by assaying a 
series of standards. The concentration of apoprotein in the sample is 
interpolated from the calibration curve. 
Solytions. (supplied with kit) 
Antibody reagent. 
Antibody diluent: Apo A-I antibody diluent for Apo A-I 
Polymer diluent for Apo B. 
Diluent A. 
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Procedure. 
1. Samples were removed from the freezer and allowed to warm to room 
temperature. 
2. Samples were mixed in a vortex. 
3. Antibody reagent was diluted 1 :21 in antibody diluent (1 part antibody 
reagent plus 20 parts antibody diluent). 
4. Standards, controls and samples were diluted 1 :21 in diluent A (1 part 
sample and 20 parts diluent A). These were then mixed thoroughly and 
loaded onto the Cobas Mira analyser. 
5. 5 (Apo A-I) or 10 (Apo B) III volumes of sample were mixed with 250 III 
volumes of reagent and incubated for eight minutes. 
6. Samples were read at 340 nm. 
7. A calibration curve was developed by the Cobas Mira using the 
absorbances of the standards and their respective assigned 
concentrations. Sample concentrations were calculated from this 
calibration curve. 
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Appendix 12: Lp(a) assay 
Lp(a) concentration was determined from serum samples using an enzyme 
linked immunosorbant assay (ELlSA). 
Kit: Enzyquick Lp(a). 
Supplier: Immuno Ltd. 
Artic House 
Dunton Green 
Sevenoaks 
Kent. 
Additional equipment. 
Titertek mUlti-scan plate reader (model MCC/340) 
Titertek washer (model S8/12) 
Both of the above were purchased from: ICN Flow 
Highwickham 
Buckinghamshire. 
Principle. 
During an initial incubation period Lp(a) from the sample binds to Lp(a) 
antibodies which have been coated onto the surface of test strip wells. Non 
specifically bound protein material is subsequently removed from the wells 
during a washing procedure. 
In a second incubation step anti-Lp(a) antibodies conjugated to the enzyme 
peroxidase bind to the Lp(a) fixed to the solid phase antibody in the wells. A 
further washing step removes unbound conjugate and then the peroxidase 
enzyme substrate TMB (3.3.5.5. Tetramethylbenzidine) is added. The 
substrate produces a colour after reacting with the conjugated second 
antibody. After stopping the reaction with sulphuric acid the amount of colour 
produced is measured (450 nm) and will be directly proportional to the Lp(a) 
concentration in the sample. 
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Kit contents. 
Twelve test strips containing eight wells each coated with Lp(a) antibodies. 
Two vials of peroxidase conjugated anti-Lp(a). Lyophilised. 
One vial of Lp(a) negative human control serum. Lyophilised. 
Six vials of Lp(a) reference standards (5,10,20,40,60,80 mg.dl-1). 
Lyophilised. 
One vial of buffer concentrate for samples and conjugate. 
One vial of substrate TMB (3,3,5,5, Tetramethylbenzidine) liquid: 500 Ill. 
Two vials of substrate dilution buffer, 12 ml each. 
One vial of 4N H2S04 (sulphuric acid), 5.5 ml. 
Reconstitution of reagents, 
Buffer concentrate: 100 ml diluted in 1 litre of distilled water. 
Peroxidase conjugated anti-Lp(a): reconstituted with 1.2 ml of buffer 
concentrate. Reconstituted contents were then diluted 1 + 10 with buffer 
concentrate. 
Lp(a) reference sera: reconstituted in 200 III of distilled water and left to stand 
for 30 minutes. 
Lp(a) negative control serum: reconstituted in 1 ml of distilled water and left to 
stand for 30 minutes. 
Substrate (TMB) solution: 40 III of substrate solution was diluted in 2 ml of 
substrate buffer per eight tests. 
Procedure. 
1. Samples were removed from the freezer and allowed to warm to room 
temperature. 
2. Samples were mixed in a vortex. 
3. The standards and samples were diluted 1 : 500 with buffer concentrate 
using a two step dilution as follows. 100 III of standard or serum was 
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added to 1 ml of buffer concentrate, then 100 III of this diluted standard or 
serum was added to 5 ml of buffer concentrate. 
4. Standard and sample dilutions were mixed thoroughly. 
5. 200 III of negative control serum was pi petted into the first four wells of 
the first test strip. 
6. 200 III of each standard was pi petted in duplicate into the remaining 
wells of test strip one and test strip two. 
7. 200 III of each sample was pipetted into a test well starting from strip 
three. 
8. The test strips were covered with foil and incubated for one hour. 
9. The test strips were emptied and washed five times with the buffer 
concentrate solution using a Titertek washer. After the final wash, 
remaining liquid was removed by inverting the strips and tapping them on 
absorbant material. 
10. 200 III of peroxidase conjugated anti-Lp(a) was pi petted into each well of 
the test strip and incubated for one hour. 
11. The test strips were emptied and washed as above. 
12. 200 III of substrate solution was added to each well of the test strips 
which were then incubated for ten minutes. 
13. 50 III of sulphuric acid was added to each well to stop the enzymatic 
reaction. 
14. The absorbances were read at 450 nm using a Titertek multi-scan plate. 
15. A reference curve was produced by plotting the absorbance of the 
standards against their known concentrations. The Lp(a) concentration of 
the samples was calculated by reading their absorbance values on the 
reference curve. 
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Appendix 13: Between and within batch precision on the Cobas 
Mlra analyser 
Between batch precision Within batch precision 
Mean SO CV{%) Mean SO CV{%) 
Cholesterol 3.4 0.11 3.2 3.25 0.03 1.03 
(mmol.l-1) 6.8 0.16 2.4 10.50 0.06 0.64 
10.3 0.31 3.0 
Triglyceride 0.58 0.02 3.9 0.58 0.01 1.75 
(mmol.l-1) 1.3 0.06 4.5 1.24 0.03 2.50 
3.9 0.09 2.4 
HOL-C 1.33 0.05 3.6 1.07 0.02 1.40 
(mmol.l-1) 2.27 0.07 3.3 
Apo A-I 1.30 0.02 1.2 0.71 0.01 1.00 
(g.l-l) 1.46 0.03 2.2 1.37 0.02 1.14 
2.10 0.05 2.4 
Apo B 0.77 0.01 1.8 0.55 0.01 1.60 
(g.l-l) 1.31 0.02 1.4 
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Appendix 14: Fibrinogen assay 
Plasma fibrinogen concentration was measured via a coagulation assay using 
a commercially available kit. 
Kit: Multifibren. 
Supplier: Behring 
Principle. 
P.O. Box 1140 
Marburg 
W. Germany. 
Citrated plasma is clotted by the addition of thrombin. The clotting time is 
measured and will depend primarily on the fibrinogen content of the blood 
sample. 
Plasma separa1ion. 
Two millilitre samples of blood were poured into citrated tubes (Sarstedt 
9NC/2) and centrifuged for 15 minutes at 6,000 rpm in a koolspin (4 OC). The 
plasma was then removed using pasteur pipettes and dispensed into a 1 ml 
plastic tubes. These were frozen (-70 OC) until required for analysis. 
Solutions. 
Multifibren: lyophilised alpha-thrombin from bovine plasma (supplied with kit). 
Control plasma: lyophilised human plasma (supplied with kit). 
Barbital buffer solution (pH 7.35): 11.75 g of sodium diethyl barbiturate and 
14.67 g of sodium chloride were dissolved in a mixture of 1570 ml of distilled 
water and 430 ml of 100 mmol.l-1 hydrochloric acid. 
Kaolin suspension: this was purchased separately from Behring. 
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Reconstitutjons. 
Multifibren: 10 ml of multifibren was reconstituted with 5 ml of kaolin 
suspension and left to stand for ten minutes. 
Control Plasma: one vial of control plasma was dissolved in 1 ml of distilled 
water and allowed to stand for 15 minutes. 
Procedyre. 
1. Plasma was diluted 1:9 with barbital buffer solution (0.1 ml of plasma and 
0.9 ml of buffer). In the case of plasma samples with very low or very high 
fibrinogen concentrations different dilutions were used (Le. 1 + 4 and 1 + 
19 respectively). 
2. 0.1 ml of reconstituted multifibren was added to 0.2 ml of citrated plasma 
dilution. 
3. Clotting time was measured on a fibrintimer (Behring). 
4. Clot time (seconds) was converted to fibrinogen concentration (mg.dl-1) 
using a table of values enclosed with the kit. The values on these tables 
applied only to samples diluted 1 :9. For samples diluted 1:4 or 1 :19 the 
tabular values were multiplied by correction factors as follows: 
Factor 0.5 for 1 :4 dilutions 
Factor 2 for 1 :19 dilutions 
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Appendix 15: One page example of the training diaries used by 
the walkers 
BRITISH HEART FOUNDATION STUDY 
LOUGHBOROUGH UNIVERSITY 
TRAINING DIARY 
Name ............................ . 
Fortnight beginning ..................... / ....................... 1989/90 
Day Minutes of brisk walking 
Mon 
Tues 
Weds 
Thurs 
Fri 
Sat 
Sun 
Mon 
Tues 
Weds 
Thurs 
Fri 
Sat 
Sun 
Fortnightly total (mins) ............ . 
Fortnightly target (m ins) ........... . 
Comments: 
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